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Thesis Summary 
A crucial step towards our understanding of ageing is the identification and characterisation of 
lifespan modifiers. Currently, investigations into lifespan modifiers use the non-parametric 
Kaplan-Meier estimator and the log-rank statistical test. Few studies employ parametric 
modelling to investigate lifespan modifiers and those that do use models which demonstrate 
monophasic lifespan. Recent studies have identified two phases of lifespan in C. elegans 
which cannot currently be modelled by monophasic parametric models. The aim of this 
research was to develop a biphasic parametric model (Bilogistic model) capable of modelling 
biphasic lifespan in C. elegans. The Bilogistic model has 5 parameters: the f parameter defines 
the proportion of lifespan in the early phase and late phase, and two death rates (k1 & k2) and 
two time phases (t1 & t2) for the early and late phases. The Bilogistic model was applied to 
lifespan data from flies, bees and mice to identify and quantify parameters. Two predictive 
models (chronological and biological) which used the Bilogistic model were developed and 
applied to temperature interventions in both wild type and trpa-1(ok999) mutants. Critical time 
points of interventions were identified, and indicated times at which the effects of intervention 
were lost. Also observed was that early lifespan conditions are important in determining the 
overall lifespan. The relationship between the HIF-1 (hypoxia) and TRPA-1 (temperature) 
signalling pathways were investigated in C. elegans mutants at different temperatures and 
oxygen concentrations. A relationship whereby TRPA-1 signals to HIF-1 was identified in 
mammalian cells but was not found to be applicable to C. elegans. In conclusion, a novel 
Bilogistic model has been developed and used to investigate the role of the TRPA-1 and HIF-
1 pathways in C. elegans lifespan. However further work is required to fully understand the 
interaction between these pathways and how they act to regulate lifespan. 
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1.1 Ageing and its implications 
Ageing is an intricate process involving complex genetic networks and molecular pathways, 
which is further influenced by environmental factors. It is broadly defined as the intrinsic 
deterioration of function with age (Flatt, 2012, Mansfeld et al., 2015). Ageing is additionally 
considered to be one of the greatest risk factors for many diseases including 
neurodegenerative diseases, cardiovascular diseases, metabolic syndrome and cancer 
(Niccoli and Partridge, 2012, Dillin et al., 2014). In most organisms, as chronological age 
progresses, mortality increases (and survival decreases) with higher mortality rates later on in 
life. Evolutionarily, it is suggested that this is due to natural selection being unable to play a 
role in removing deleterious genes causing it to be more common in populations which then 
results in ageing (Medawar, 1952). It has also been suggested that pleiotropic genes which 
are beneficial earlier in life and are required to maintain fitness lead to ageing as the genetic 
pleiotropy results in detrimental consequences later in life by displaying itself as ageing 
(Williams, 1957). However, this explanation is incomplete as ageing is an adaptive process, in 
which the rate of ageing can alter over time under different circumstances (Lenart and 
Bienertova-Vaska, 2017). 
Although numerous genes and genetic pathways have been identified to play a role in the 
ageing process, a single master controller of ageing has not been identified and is unlikely to 
be identified (Bonsall, 2006). It is more likely that a number of different contributors collectively 
determine the ageing process with input from various environmental factors (or lifestyle 
choices).  
To measure ageing and to understand how the ageing process can be altered, the survival or 
mortality of a population is commonly studied. Due to the difficulty in longitudinal ageing studies 
of humans, animal models are often used to understand which mechanisms are involved in 
the ageing process. In particular, mice, flies and worms are used to study survival and mortality 
(Mitchell et al., 2015). Survival under different conditions can then be analysed to identify how 
manipulation of the factors which contribute to the ageing process affects survival. 
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1.2 C. elegans as a model organism 
C. elegans is a non-parasitic free-living nematode first described in 1900 by Émile Maupas 
who discovered it in the soil in Algeria (Maupas, 1900, Blaxter, 2011). Since then it has been 
used as a model organism for a range of different research purposes from investigating 
molecular mechanisms to studying behaviour. Most notably it was established by Sydney 
Brenner since 1963 who used it to study development and neurobiology at a molecular level. 
It is also important in investigating the role and interactions of single proteins within a whole 
organism and allows for identification of phenotypic changes. (Corsi et al., 2015). 
C. elegans are normally found in the soil, in compost heaps or in other bacteria rich 
environments and are not specific to a single geographical location as they have been found 
globally (Felix and Braendle, 2010, Andersen et al., 2012). In the laboratory, they are cultured 
either on solid agar or in liquid culture. In both cases they feed upon a bacterial food source 
with the most common being the Escherichia coli (E. coli) OP50 strain (Corsi et al., 2015). 
They are transparent and grow up to approximately 1mm in length and so are easy to visualise 
under a stereo microscope. They can also be cheaply cultivated in the laboratory without 
requiring too much space or maintenance.  
1.2.1 C. elegans physiology 
C. elegans have 2 sexes: hermaphrodites and males. Males are a lot rarer than 
hermaphrodites, with 1 male for every 1000 hermaphrodites. Sex determination is based on 
the autosome to allosome ratio: hermaphrodites have 5 autosome pairs and a pair of the X 
allosome, whereas males have a single X allosome (Corsi et al., 2015, Hillier et al., 2005). 
Although males have one less chromosome, they have been found to have more somatic cells 
(1031) compared to the hermaphrodites (959). However, the adult hermaphrodites tend to 
grow to a larger size compared to the males (Corsi et al., 2015, Wood, 1988). The lineage of 
all cells in both hermaphrodites and males have been identified and shows that the worm is 
comprised of a few tissue types and organ systems such as the mouth, pharynx, intestine, 
cuticle, nervous system, musculature, and sex specific gonads. They do not have a circulatory 
or respiratory system but instead rely upon gas diffusion to the tissue and use their muscles 
23 
 
which run the length of the body to propel itself to crawl either forward or backwards. Males 
have a single testis, vas deferens, and a tail with spicules for mating, while hermaphrodites 
have two ovaries, an oviduct, a spermatheca, a vulva and a uterus (Corsi et al., 2015, Wood, 
1988, Sulston and Horvitz, 1977, Kimble and Hirsh, 1979). Hermaphrodites have 302 neurons 
and males have 385 neurons which control worm movement, the response to sensory 
(mechanical, chemical and thermal) stimuli, and also feeding, mating and egg laying (Corsi et 
al., 2015, Sammut et al., 2015). 
1.2.2 C. elegans life cycle 
C. elegans worms typically have a 3-day lifecycle (generation time) from being laid as an egg 
to becoming a fully developed egg laying adult (hermaphrodite). Development starts with 
fertilisation of the oocyte and continues after hatching as it progresses through the larval 
stages into adulthood (Figure 1.1). There are 4 larval stages, L1 through to L4, the L1 stage 
occurs when the egg hatches and is approximately 14 hours post fertilisation. The L1 stage 
worm then undergoes cell division and moults into the L2 stage. Moulting is the generation of 
a new cuticle under the old one, and occurs additionally three more times, once between each 
larval stage, until it becomes an adult. Somatic cell division comes to an end at the adult stage, 
and 12 hours after the final moult process hermaphrodites are capable of egg laying. Egg 
laying lasts for approximately 4 days in which 300 fertilised eggs are laid. At that point the 
sperm produced in the hermaphrodite becomes a limiting factor for fertilisation. However, if 
males also fertilise the hermaphrodite, up to 1000 fertilised eggs can be laid. If fertilised by 
males it increases the likelihood of male presence in the progeny with approximately 50% of 
the population becoming males (Anderson et al., 2010, Corsi et al., 2015). 
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Figure 1.1: Lifecycle of C. elegans 
 
In 1998, the C. elegans worm became the first multicellular organism to have its entire genome 
sequenced. It has a 100Mb genome sequence which is structured in to the 6 chromosome 
pairs (5 autosomes and 1 allosome), which is 30 times smaller than the human genome size. 
So far, 20,215 protein coding genes have been identified in the C. elegans from a total number 
of 48,447 genes (WS268, 2019), compared to the human genome which currently has an 
estimated 19,940 protein coding genes and 58,721 total genes (GENCODE Version 29, 2019). 
This indicates, that on a genetic level, worms are similar to humans, with an estimated 60-80% 
of genes in worms having a homologous gene in humans and approximately 40% of human 
disease genes have a homologue in C. elegans (Culetto and Sattelle, 2000, Kaletta and 
Hengartner, 2006).  
1.2.3 C. elegans lifespan 
The wild type (N2) worm has an average lifespan of 18 days at 20°C, which can be extended 
or shortened under different environmental conditions (Klass, 1977). Additionally, genetic 
mutations can alter its lifespan (Friedman and Johnson, 1988). C. elegans can also show other 
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ways of extending their lifespan, for example by diet. The most common change to diet is by 
calorie restriction, which has been shown to extend lifespan in many different organisms 
(Houthoofd et al., 2005, Weindruch et al., 1986). Additionally, in the absence of food, worms 
which are in the L1 stage are able to undergo developmental arrest until food is reintroduced 
(Johnson et al., 1984). Similarly, worms can enter an alternative lifecycle dependent on 
environmental conditions by developing into dauer larvae. Under optimal conditions, L1 and 
L2 larvae continue development into the L3 larval stage. However, under stress conditions, 
they develop into the alternative dauer larval stage. This is an arrested state which can be due 
to a number of factors but is often due to a change in environment such as starvation, crowding 
or high temperatures. Once worms enter the dauer stage, they have the potential to survive 
for many months. However, if returned to regular conditions, they continue into the L4 and 
adult stages with a normal lifespan (Riddle et al., 1997, Hu, 2007). As the dauer stage is able 
to indefinitely extend lifespan, it is important to understand how this occurs and if these 
mechanisms are interconnected with the adult worms’ ability to extend lifespan. Although larval 
arrest and dauer formation do extend the lifespan of C. elegans, it is important to note that the 
changes to lifespan are based on adult (post L4 stage) worms. 
1.3 Factors of ageing and their role in C. elegans 
C. elegans is an excellent model organism for many different research areas, but in particular 
it is well established for research into ageing. This is often conducted by the generation of a 
synchronous population of worms and measuring the changes in lifespan (or healthspan) 
under different experimental conditions. This provides understanding of the different factors 
influencing ageing by promoting a phenotype which changes lifespan and altering the level of 
ageing-related deterioration in the worm. Thus, many factors have been implicated in why 
ageing occurs and from this many theories of ageing have been developed and investigated 
in multiple organisms (Figure 1.2). 
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Figure 1.2: Factors involved in ageing 
1.3.1 Calorie restriction 
Calorie restriction is the act of restricting nutrients from dietary intake without malnutrition. It is 
one of the most common non-genetic interventions used to alter lifespan. It has a highly 
conserved effect as it has been replicated in many species including C. elegans, yeast, rodents 
and primates (Jiang et al., 2000, McCay et al., 1935, Weindruch et al., 1986, Bodkin et al., 
2003, Mattison et al., 2017). Calorie restriction was first identified in 1935 when it was 
demonstrated that a 40% reduction in calorie intake extended the lifespan of rats (McCay et 
al., 1935). 
Additionally, in C. elegans, bacterial food source is important in regulating lifespan. For 
example it has been shown that feeding worms different strains (OP50 vs HB101) of E. coli 
results in differences in lifespan (So et al., 2011). Furthermore, there are also differences 
between live or dead bacteria used for food as killing bacteria by UV treatment results in an 
increased lifespan (Gems and Riddle, 2000). 
The mechanism through which calorie restriction acts to extend lifespan is not yet completely 
understood, although a number of theories have been suggested. One of which proposes 
oxidative stress and redox imbalance which leads to the generation of reactive oxygen species 
27 
 
(ROS) resulting in DNA damage. The damage from oxidative stress by can be prevented by 
regenerating anti-oxidants (Ungvari et al., 2008, Sohal and Weindruch, 1996). Calorie 
restriction can also induce sirtuins, particularly SIRT1, which is known for its regulation of 
energy metabolism and endocrine signalling pathways as well as the stress response. Sirtuins 
are also linked to redox state as its activation is dependent upon the NAD+/NADH levels 
(Cohen et al., 2004, Ungvari et al., 2008). One such example of the beneficial effects of calorie 
restriction affecting redox state is found in the reduction of oxidative stress and additional 
inflammation protection by release of nitric oxide in the vasculature (Ungvari et al., 2008). 
Calorie restriction can also affect the insulin signalling pathway and may be one of the 
pathways by which lifespan is extended. The insulin signalling pathway is particularly important 
in regulation of lifespan of many different species, and in C. elegans is the prominent DAF-16 
pathway (Argentino et al., 2005, Kenyon, 2010). Additionally, calorie restriction has been 
shown to reduce core body temperature, which in turn may act to extend lifespan as seen in 
C. elegans and also in mice (Duffy et al., 1990, Redman et al., 2008). Hormesis may also 
explain the beneficial effects of calorie restriction as the moderate stress may elicit a protective 
response which in turn promotes improved health and lifespan. The effect of hormesis has 
also been shown to act upon mitochondrial redox balance by restriction of calories causing 
mitochondrial stress, which in turn induces stress defence mechanisms (Ristow and 
Schmeisser, 2011, Ristow and Schmeisser, 2014). It is likely that many of these mechanisms 
are interrelated and act together to extend lifespan during calorie restriction.  
1.3.2 DNA damage theory of ageing 
It is thought that the ageing process is a result of damage to cellular components and DNA. 
DNA holds the genetic code for life and disruption or damage to this genetic code has a number 
of consequences i.e. ageing. DNA can be mutated which results in a change in base pairs 
sequence or it can be damaged either chemically or physically leading to structural change of 
the DNA double helix (Gensler and Bernstein, 1981). Deficiencies in DNA damage repair 
pathways can lead to the accumulation of DNA damages leading to ageing by cellular 
senescence or apoptosis. This suggests that increased longevity/protection from ageing is 
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proportional to the DNA repair pathway activity; and this has been seen in C. elegans  as more 
damage or reduced capability to repair damage results in a shortened lifespan (Hyun et al., 
2008). This is supported by progeroid syndromes (e.g. Werner syndrome, Cockayne syndrome 
and trichothiodystrophy) which are due to mutations in DNA repair proteins and pathways e.g. 
ERCC8, WRN helicase, Transcription factor II Human subunits (Kulkarni and Wilson, 2008). 
DNA damage can be caused by either internal or external sources such as ROS or UV 
radiation. The theory suggests that when nuclear DNA is damaged by internal or external 
sources, it is unable to be repaired by the normal DNA repair mechanisms. This may lead to 
the accumulation of damaged DNA leading to further mutations, changes in transcription or 
gene expression and also apoptosis which inevitably leads to the disruption of cellular function 
or tissue homeostasis which affects functionality of the organism (Wang et al., 2016, Freitas 
and de Magalhaes, 2011).  
1.3.3 The free radical theory of ageing 
The free radical theory of ageing is based upon the idea that ageing is due to the production 
of free radicals during cellular metabolic process (Harman, 2006, Harman, 1956). The 
production of free radicals (ROS generated in the mitochondria) leads to accumulation of 
damage over time, particularly as the free radicals are able to react with DNA, proteins and 
lipid molecules leading them to cause damage to other molecules or to become dysfunctional 
and affect cellular processes (Wickens, 2001). This free radical production is due to 
dysfunctional mitochondria which generate more free radicals which leads to further 
deterioration of the mitochondria which then affects other cellular processes leading to an 
exacerbated ageing phenotype (López-Otín et al., 2013). 
The damage caused by free radicals can be prevented by enzymatic or non-enzymatic defence 
mechanisms such as anti-oxidants or enzymes like superoxide dismutases (e.g. SOD1). It is 
thought that these defensive mechanisms tend to show declining activity with age, which leads 
to a greater imbalance of ROS and antioxidants leading to increased damage, thus increasing 
oxidative stress (Wickens, 2001). 
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This theory is also linked with the rate of living theory which states that an organism’s metabolic 
rate and lifespan are inversely proportional. The free radical theory helps to explain this as a 
higher metabolic rate would mean more free radicals produced resulting in more damage and 
therefore an increased rate of ageing and a shorter lifespan (Harman, 1956). 
It has been shown that in C. elegans there is a correlation between oxidative stress and ageing 
which supports the idea that ageing is due to oxidative stress (Vanfleteren, 1993). Conversely 
studies have shown that increased levels of ROS can actually extend lifespan (Ewald et al., 
2017). 
1.3.4 Energy Maintenance Theory of Ageing 
More recently a novel theory of ageing based upon mitochondrial function has been proposed, 
linking multiple theories of ageing (Chaudhari and Kipreos, 2018). It is based upon the idea 
that survival in older animals is promoted by maintaining energy levels which is improved in 
long and fused mitochondria and suggested to generate fewer ROS. However, as the overall 
effect of ROS on lifespan is still unclear, more work is required to determine the mechanism of 
action. Additionally, it is suggested that during calorie restriction there is reduced insulin 
signalling which leads to DAF-16 promoting mitochondrial fusion and also an increase in 
glycolysis. This study concludes that the maintenance of ATP levels or higher ATP levels 
correlates with an increased lifespan (Chaudhari and Kipreos, 2018). 
1.3.5 Genetic control of ageing 
In C. elegans, a number of genes have been identified which regulate the lifespan of the worm. 
In 1988, the age-1 gene was the first to be identified as a regulator of ageing as the age-1 
(hx546) mutant leads to an average increase in lifespan of 40% suggesting that the normal 
function of this age-1 gene leads to promotion of the signals activating the ageing process 
(Friedman and Johnson, 1988). 
Following on, many more genes have been found to alter the ageing process. The most 
important from them is the FOXO family orthologue DAF-16, which is part of the evolutionarily 
conserved insulin and IGF-1 signalling (IIS) pathway and fits into the calorie restriction theory 
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of ageing. Normally IIS signalling occurs when insulin-like peptides activate the DAF-2 (IGF-
1) receptor resulting in a phosphorylation cascade leading to the phosphorylation and 
deactivation of DAF-16 which leads to a reduction in lifespan due to inactivation of cell 
protective factors. Further supporting this theory is that C. elegans daf-2 mutants have been 
shown to have an extended lifespan compared to wild type worms, due to the inability to 
deactivate DAF-16, thus promoting activity of cell protective factors such as anti-oxidants and 
heat-shock proteins (Sun et al., 2017). 
In addition to these genes, a number of other genes (for example hif-1 and trpa-1) have been 
identified to influence the lifespan and ageing of worms to varying degrees of change, which 
will later be discussed in their response to environmental change (Section 1.4 and 1.5). 
1.3.6 Hormesis 
Hormesis is the application of mild stressors to organisms to elicit long term beneficial effects. 
It has therefore become an important area in the ageing field as these mild stressors have 
been shown to lead to improved biological function and possibly anti-ageing properties. The 
most common methods of hormesis used in ageing are calorie restriction and heat shock. 
However, the mechanisms by which hormesis extends lifespan are not believed to be universal 
but rather act by mechanisms dependent on the stressor. It has also been shown that the IIS 
pathway plays a major role in hormetic lifespan extension (Cypser et al., 2006). Linked to this 
is the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress. It activates 
cellular mechanisms to alleviate stress in the ER. It has been shown that activation of the UPR 
(ER) has a reduced function with age. It is also seen that in C. elegans the lifespan extension 
via the reduction in IIS signalling requires components which make up the UPR. Additionally 
the decline in function of the UPR contributes to the ageing process, yet it is not clear how the 
UPR and ER exactly change with age (Taylor, 2016). 
1.3.7 Other nutrient sensors 
The ability to detect nutrients and the rate of living theory are linked by another major protein; 
AMP-activated protein kinase (AMPK). In the ageing process AMPK acts to regulate energy 
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metabolism and cellular homeostasis (Onken and Driscoll, 2010). AMPK is of interest due to 
its highly diverse and central role being a part of many key signalling pathways such as 
rapamycin (mTOR), sirtuins, and the IIS pathway (Salminen and Kaarniranta, 2012). AMPK is 
thought to be linked with the ageing process due to its activation by metformin resulting in 
extended lifespan in multiple organisms (Onken and Driscoll, 2010, Salminen and Kaarniranta, 
2012). Additionally, it is thought that AMPK function is impaired with age as it loses its ability 
to detect AMP and leads to a reduction in mitochondrial biogenesis and function, again linked 
to ageing (Reznick et al., 2007). Additionally, the mTOR pathway is also linked to AMPK which 
is important as mTOR activity decreases with increased lifespan. AMPK is also linked to 
sirtuins whereby increased expression/activation of sirtuins/Sir2.1 has been shown to extend 
lifespan, possibly by DNA repair to improve the ageing phenotype (Salminen and Kaarniranta, 
2012). 
1.3.8 Telomere length and loss 
Telomeres have been suggested to act as biomarkers of ageing as it is thought that they 
shorten with age. Although DNA damage accumulates with age it is well known that specifically 
the telomeres which cap chromosomes are shortened with age. It is thought that this is due to 
oxidative stress resulting in DNA damage (Mather et al., 2011). Correlation has been shown 
between telomere length and age as people who live longer tend to have longer telomeres 
than those who have a shorter lifespan. However it is unknown whether the shortening of 
telomeres is a cause or effect of ageing (Shammas, 2011). In C. elegans, it has been shown 
that this may not be the case as telomere length in C. elegans was independent of longevity 
(Raices et al., 2005). 
1.4 Temperature and Lifespan 
1.4.1 Rate of living theory 
Temperature is a known regulator of lifespan, and it has been well documented that reducing 
temperature extends lifespan in many different homeothermic and poikilothermic organisms. 
Further to this raising the temperature results in a reduction in lifespan (Conti, 2008). In flies 
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the temperature is a direct regulator of lifespan and in mice, changes to core body temperature 
also influences lifespan (Conti, 2008, Loeb and Northrop, 1916). 
In C. elegans, as in other organisms, the physiological mechanism of how changing the 
temperature affects lifespan is not yet completely understood. One distinguished theory is that 
at lower temperatures there is a reduction in rates of chemical reactions, this is known as the 
rate of living theory (Pearl, 1928, Shaw and Bercaw, 1962)  
This also links with Arrhenius’s theory, where the temperature is proposed to determine rates 
of reactions which can be calculated alongside activation energies (Arrhenius, 1889). The 
Arrhenius equation has been applied to testing of equipment where temperature is used to 
stress equipment to see how long it will last, (i.e. time to failure tests). Arrhenius’s law states 
that for every 10C increase in temperature, the rate of reaction doubles (Shaw and Bercaw, 
1962, Arrhenius, 1889). 
1.4.2 Genetic thermoregulation, AFD neuron and Heatshock proteins  
As it is not entirely understood how temperature changes leads to a physiological mechanism 
which reduces lifespan a genetic approach has become the common method to investigate 
the potential pathways that are involved in temperature-based lifespan modifications. It has 
been seen that genetics play an active role in controlling lifespan, however this is still not well 
understood as different studies suggest a plethora of different factors which differentially 
regulate lifespan (Miller et al., 2017). 
Miller reviewed the impact of different culture temperatures on a number of mutant worms and 
found that there are a substantial number of genes which play a role in temperature dependent 
lifespan extension. She then suggested that lifespan extension simply cannot be explained by 
changes in thermodynamic reaction kinetics (Miller et al., 2017). This study went on to suggest 
a few genes which are affected by temperature, such as cep-1 and rsks-1 which has a varying 
lifespan at lower and higher temperatures indicating temperature dependent activation (Miller 
et al., 2017). 
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Another mechanism which has been investigated is the thermosensory AFD neuron which 
responds thermotaxically to temperatures within a normal range (15C-25C). Inactivation of 
the AFD neuron via ablation or mutation leads to loss of this thermotaxic ability (Lee and 
Kenyon, 2009). Although it is still not fully understood how AFD acts to increase lifespan, it is 
thought that this thermotaxis ability involves cyclic guanosine monophosphate (cGMP) -gated 
ion channels TAX-2 and TAX-4 and guanylate cyclases GCY-8, GCY-18 and GCY-23. 
Temperature changes lead to a Ca2+ current which signals to PKC-2 resulting in a 
phosphorylation cascade signalling to the DAF-9 transcription factor and the steroid signalling 
pathway which ultimately leads to inhibition of DAF-12 resulting in anti-ageing properties. 
However once ablated, this instead leads to DAF-12 activation and ageing. DAF-12 is the 
thyroid hormone receptor beta orthologue which normally is involved in lipid oxidation to 
support reproduction and growth (Lee and Kenyon, 2009, Land and Rubin, 2017, Mori and 
Sasakura, 2009, Ramot et al., 2008, Wang et al., 2015). The effect this thermosensory neuron 
has on lifespan is only effective at higher (25C) temperatures  as there is no consequence of 
ablation at lower (15C) temperatures (Lee and Kenyon, 2009). Heat shock proteins are also 
important in the lifespan of C. elegans, with an increase during transient exposure to high 
temperatures at a young age leading to longevity (Morley and Morimoto, 2004). Heat shock 
proteins act as molecular chaperones responding to heat shock and other stressors. They 
ensure proteostasis by assisting protein folding and assembly to prevent damage and 
aggregation of proteins which occurs due to high temperatures. In C. elegans temperatures 
above 26°C enable a heat shock response whereby the hsp16-1 reporter expression increases 
with small increases in temperature (Zevian and Yanowitz, 2014, Dawe et al., 2006). 
1.4.3 TRPA-1 and thermoregulation of lifespan 
Another prominent protein which has been suggested to be required for cold dependent 
lifespan extension is the cold/pain sensor transient receptor potential ankyrin 1 (TRPA-1, also 
known as ANKTM1) (Xiao et al., 2013). This somatosensory voltage dependent TRPA-1 non-
selective Ca2+ cation channel is the only TRPA protein expressed in humans, worms, flies and 
other mammals (Figure 1.3). However, in C. elegans there is also an uncharacterised TRPA-
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2 protein, which does not have sequence homology related to TRPA channels in humans, 
rodents or flies (Kindt et al., 2007). 
 
Figure 1.3: The TRPA-1 ion channel which allows Ca2+ entry into the cell. 
 
TRPA-1 in C. elegans is expressed in many different tissues types including sensory neurons, 
epithelial cells, muscle tissue and tissue which makes up the excretory system (Kindt et al., 
2007, Xiao et al., 2013). Temperature-regulated activation of TRPA-1 is contested as to 
whether it is activated by heat or cold. Additionally, differences between species and if indeed 
cold is the activator of the TRPA-1 channel is disputed (Chen et al., 2013, Chen, 2015). 
The lifespan regulatory function of TRPA-1 requires downstream regulators and it is 
unsurprising that it acts via the master lifespan regulator DAF-16. TRPA-1 allows Ca2+ ions 
into the cell which is thought to activate the calcium-sensitive kinase PKC-2 which then 
phosphorylates the kinase SGK-1 (amongst other effectors and transcription factors) found 
upstream of DAF-16 and promotes nuclear DAF-16 localisation (Figure 1.4; (Xiao et al., 2013). 
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Figure 1.4: Cold dependent temperature activation of TRPA-1 signalling to DAF-16 and 
other transcription factors resulting in longevity. 
 
Additionally, it has been found that temperature differentially regulates lifespan of adult and 
larval worms, as the cold stimuli in larval worms reduces overall lifespan but in adult worms it 
increases lifespan (Xiao et al., 2013). The opposite is also seen at higher temperatures as 
larval worms which have been grown at higher temperatures have a longer lifespan but once 
they reach adulthood if they are continually grown at the high temperature then it results in a 
reduced lifespan. However, if they are shifted to a lower temperature upon reaching adulthood 
then an increase in lifespan is seen (Xiao et al., 2013, Henderson et al., 2018). 
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In addition to cold activation and cold-regulated lifespan extension in C. elegans, the TRPA-1 
channel has a mechanosensory role in foraging and nocioception (Kindt et al., 2007). It also 
has a role in oxygen sensing as it is regulated by oxygen-sensitive prolyl hydroxylases (PHDs). 
During the inflammatory response it is controlled by HIF-1 which binds to the TRPA1 gene 
therefore controlling cytokine release from inflammatory synoviocytes (Hatano et al., 2012).  
Finally, TRPA-1 can be activated by many different chemical compounds such as electrophilic 
compounds like hydrogen peroxide or allyl-isothiocynate (AITC) and also non-electrophilic 
compounds such as the essential oil carvacrol found in oregano and thyme plants or 
cannabidiol, suggesting links to the cannabinoid signalling pathways (Skerratt, 2017). 
1.4.4 DAF-16 and longevity  
DAF-16 is a transcription factor which has been comprehensively implicated with ageing and 
longevity in C. elegans. It is the single orthologue of the Forkhead Box O (FOXO) family of 
proteins, therefore acting as a central mediator in many signalling pathways (Lin et al., 1997, 
Sun et al., 2017). The most common pathway which has been associated with the DAF-16 
pathway is the IIS pathway which as previously mentioned (section 1.3.5) is involved in glucose 
uptake providing energy to cells for growth and reproduction. The IIS pathway also plays a 
major role in longevity via calorie restriction. Other than this the DAF-16 pathway is involved 
in many other cellular stress signalling pathways. The mTOR pathway, AMPK pathway, JNK 
pathway, sirtuin signalling pathway and also germline signalling pathway are all dependent on 
DAF-16 activity to function. Additionally DAF-16 regulation occurs by a plethora of alternative 
mechanisms, such as co-factors, (Heat shock factor 1 (HSF-1), HCF-1 SMK-1) as well as post 
translational regulators such as acetylases, phosphatases and ubiquitinases which play roles 
in dauer formation, apoptosis, lipogenesis, reproduction and development, anabolism and 
catabolism and cell cycle signalling and arrest, as well as signalling to protect from stress 
factors such as oxidative stress, heat stress and stress from food deprivation (Sun et al., 2017, 
Yen et al., 2011). Many of these pathways contribute to longevity and healthy ageing. 
Overall DAF-16 has approximately 3000 gene targets, making its role very complex (Tepper 
et al., 2013). Further complicating its role are the different isoforms of the daf-16 gene with 8 
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in total varying, from daf-16a to daf-16h. These different isoforms share sequence similarity 
but may have varying importance depending on their role for instance in longevity or in dauer 
formation (Sun et al., 2017, Kwon et al., 2010, Yen et al., 2011, Lin et al., 2001). DAF-16 
shuttles between the cytoplasm and nucleus of the cell where it binds to the DAF-16 binding 
element (5’-TTGTTTAC-‘3). It is expressed in tissue including, muscle, neurons intestines and 
pharynx and is expressed during all phases of developmental lifecycle stages and adulthood 
throughout the C. elegans lifespan (Lin et al., 2001, Sun et al., 2017). 
It is proposed that temperature can influence DAF-16 signalling, via the temperature sensitive 
TRPA-1 cation channel which allows Ca2+ entry into the cell activating a signalling cascade 
which activates DAF-16. 
The other major players which respond to temperature with DAF-16 are the heat shock 
proteins. HSF-1 is a transcription factor which regulates heat shock protein transcription which 
go on to interact with DAF-16 and it is thought that together they extend lifespan. A reduction 
in HSF-1 activity promotes onset of the ageing phenotype whereas over expression of HSF-1 
leads to DAF-16 dependent lifespan extension. It is thought that HSF-1 and DAF-16 act 
together to target 4 genes of the small heat shock proteins (shsps) (Hesp et al., 2015). 
However, further details on this mechanism is still under investigation (Yen et al., 2011). 
Overall it is still not widely understood how temperature mechanistically acts to alter lifespan. 
Although a number of viable mechanisms have been identified, it is likely that these 
mechanisms all act to alter lifespan, but function complementarily to one another or under 
different conditions for example, under varying temperature conditions, or at different time 
points during the worm’s lifespan. Therefore, it is important to further characterise how the 
signal to and from DAF-16 is transduced and what specific gene targets are activated to alter 
lifespan, with perhaps each mechanism providing a small synergistic contribution to lifespan 
extension. 
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1.5 Oxygen and ageing 
1.5.1 Oxygen and organisms 
Oxygen plays a major role in regulating the lifespan and ageing process of all organisms. 
Without oxygen we would be unable to survive and yet it is also responsible for cellular damage 
which leads to the ageing phenotype according to the free radical ageing theory (Harman, 
1956). All multicellular organisms (except Loricifera) require oxygen for survival as none are 
able to survive in anoxia (Danovaro et al., 2010). 
Many lifespan studies have been conducted in varying oxygen levels in a range of organisms. 
Mammals (including rodents) and drosophila which have been exposed to hyperoxia have a 
reduced lifespan but in C. elegans there is no negative effect of this high oxygen exposure 
(Rascón and Harrison, 2010, Jamieson, 1989). Conversely, low oxygen levels or 
(physiological) hypoxia have been shown to have varying effects. For example, in drosophila 
some studies report that hypoxia results in lifespan extension while in others, a reduction is 
reported (Rascón and Harrison, 2010, Vigne and Frelin, 2006).  
Human cell culture studies have shown that culturing fibroblasts (human diploid WI-38) at low 
oxygen levels (10%) leads to an increase in replicative lifespan as opposed to the higher 
concentration of oxygen which led to damage of cells and loss of viability (Packer and Fuehr, 
1977). 
1.5.2 Hypoxia in C. elegans 
Since 1993, it has been reported that hypoxia extends the lifespan of C. elegans although 
there is some variability in this finding, particularly due to the varied methodology of the studies 
(Honda et al., 1993). Many studies do not maintain worms in hypoxia throughout the entirety 
of their lifespan, as some studies remove them from hypoxic conditions daily in order to 
measure lifespan. Some pass gas over the culture plates contained within a small chamber 
and one study even uses a plastic bag containing an oxygen scavenger to sequester oxygen, 
although measuring how much oxygen is remaining is difficult to assess. Additionally, studies 
in hypoxia are also dependent on their definition of hypoxia, as some define hypoxia as 1% 
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oxygen, whereas others define it as 0.5% or even as low as 0.1% (Leiser et al., 2013, Honda 
et al., 1993, Mehta et al., 2009, Kitazume et al., 2018, Fawcett et al., 2012, Liu and Cai, 2013). 
Regardless of methodologies, it is generally reported that a reduction in oxygen levels normally 
results in an increase in lifespan (Honda et al., 1993, Leiser et al., 2013, Mehta et al., 2009, 
Liu and Cai, 2013).  
1.5.3 Neuronal response to oxygen 
C. elegans respond to changing oxygen levels by the BAG and URX, AQR and PQR sensory 
neurons. High oxygen levels are detected by the URX, AQR and PQR neurons and low oxygen 
levels are detected by BAG neurons (Liu and Cai, 2013). At the molecular level, soluble 
guanylyl cyclases (sGCs) expressed on the neurons act to sense gas by binding to the 
gaseous ligand such as oxygen. The sGCs are differentially expressed in the different neurons. 
In BAG neurons, the sGCs expressed are GCY-31 and GCY-33 which detect a decrease in 
oxygen and signal via cGMP/Ca2+ signalling resulting in TAX-2 depolarisation and play a role 
in regulating lifespan. GCY-33 is also expressed in URX, AQR and PQR neurons in addition 
to GCY-35 and GCY-36 which detect increases in oxygen levels and again signal via cGMP 
(Liu and Cai, 2013, Zimmer et al., 2009, Gray et al., 2004, Chang et al., 2006, Cheung et al., 
2004, Rogers et al., 2006). These sGCs in the BAG and URX neurons play a complementary 
role in balancing the action of one another in lifespan regulation. BAG neurons play an 
inhibitory role which acts to prevent the pro-longevity effect of low oxygen conditions and the 
URX neuron also plays an inhibitory role to prevent the anti-longevity effect of high oxygen 
levels. Additionally it is believed that the action of BAG and URX neurons with sGCs is 
independent to other pathways which respond to oxygen changes (Liu and Cai, 2013, Coates 
and de Bono, 2002). 
1.5.4 HIF-1 signalling in hypoxia 
Another important signalling pathway involved in oxygen sensing is the HIF-1 signalling 
pathway. Hypoxia inducible factor (HIF) is a highly conserved transcription factor which 
responds to low oxygen levels. In humans, HIF is a heterodimer which is made up of an   and 
a  subunit (Wang et al., 1995).  Three HIF- subunits have currently been identified, (HIF-1, 
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HIF-2 and HIF-3) which when translocated to the nucleus form heterodimers with HIF- 
(Aryl hydrocarbon receptor nuclear translocator) which is constitutively expressed in the 
nucleus. HIF-1 is expressed in most tissue types although it has greater expression in the 
heart and kidneys. The three HIF- subunits have different functions (Tian et al., 1997, Wang 
et al., 1995, Gu et al., 2018). HIF-1 has been studied extensively and when active generally 
acts to target metabolic processes to adapt to hypoxia and increase oxygen delivery. This 
occurs when the HIF-1 heterodimer binds to the DNA sequence known as the HIF-1 response 
element (HRE; 5’-TACGTG-‘3) which is on the promoter of a number of genes such as vascular 
endothelial growth factor (VEGF),  glucose transporters and erythropoietin (Shen et al., 2005, 
Semenza, 2009). Additionally, it plays a role in cancer and embryo development where it acts 
to promote tumour angiogenesis and placental vascularisation (Semenza, 2009). Similarly, 
HIF-1 is known to play a protective role in ischemia reperfusion disease (Howell and Tennant, 
2014). 
HIF-2 has been shown to have a similar mechanism of action to HIF-1 and acts to promote 
genes expression such as VEGF (Ratcliffe, 2007). Additional studies have found a protective 
role in heart failure and in embryonic development by maintaining catecholamine homeostasis 
(Brown et al., 2009, Giaccia, 2013). 
HIF-3 function is not as well understood as the other two subunits. Studies suggests that HIF-
3 has more of a regulatory role and targets a number of genes, some of which overlap with 
HIF-1 targets (Zhang et al., 2014). One known function is that it acts to repress angiogenic 
factors (Kobayashi et al., 2015). 
HIF is regulated by oxygen. In the presence of oxygen HIF is hydroxylated by PHDs on proline 
residues. This in turn leads to ubiquitination by the Von-Hippel-Lindau protein (pVHL) E3 
ubiquitin ligase which targets it for proteasomal degradation. In low oxygen conditions HIF is 
stabilised as oxygen inhibits the PHDs which in turn allows HIF to be translocated to the 
nucleus to regulate gene expression (Tanimoto et al., 2000). 
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1.5.5 HIF in C. elegans 
In C. elegans, there is only one single HIF- orthologue (HIF-1) and one single HIF- 
orthologue (AHA-1) which dimerise to control gene expression. Just as in humans the HIF-1 
regulatory pathway is evolutionarily conserved as HIF-1 is degraded in the presence of 
oxygen by action from the prolyl hydroxylase (EGL-9) and the E3 ligase VHL-1 (Figure 1.5; 
(Pitt et al., 2014, Jiang et al., 2001). It is located on chromosome V and has a number of 
gene targets in response to hypoxia. These gene targets affect cellular metabolism, dauer 
formation and apoptosis. HIF-1 is also involved in regulating a number of signalling 
pathways: for example HIF-1 regulates the mRNA levels of EGL-9, thus leading potentially to 
a negative feedback loop (Shen et al., 2005, Jiang et al., 2001). 
 
Figure 1.5: Hypoxia prevents EGL-9 mediated HIF-1 degradation which can act to promote 
lifespan signalling factors. 
 
O2
Normoxia
EGL-9 EGL-9
HIF-1 HIF-1
Hypoxia
VHL-1 
mediated 
degradation
Longevity
Environment
Sensors
Transcription
Factor
Outcomes
42 
 
1.5.6 Lifespan and HIF-1 
Another major role of HIF-1 in C. elegans is its role in lifespan and ageing. As mentioned 
previously (section 1.5.2), hypoxia acts to extend lifespan. HIF-1 has been extensively 
investigated to identify its role in lifespan changes. Stabilisation of HIF-1 via knockdown of 
VHL-1 or EGL-9 results in an increase in lifespan. Loss of VHL-1 protein also results in 
improvements in other biomarkers of ageing including reduction of autofluorescence. The 
same study concluded that the VHL-EGL-HIF pathway acts distinctly from the IIS pathway to 
extend lifespan. Mutation to vhl-1 and egl-9 show similar lifespan extensions whereas hif-1 
deletion shows no difference in lifespan (Mehta et al., 2009). Conversely, further studies 
showed that hif-1 deletion in C. elegans increases lifespan although the methodology in this 
study was different (Zhang et al., 2009). HIF-1 also shows temperature sensitivity as at higher 
temperatures loss of hif-1 extends lifespan but this is not observed at low temperatures (Leiser 
et al., 2011). Additionally, hif-1 overexpression has been shown to extend lifespan however 
this is dose dependent (Zhang et al., 2009). Furthermore, it has been reported that HIF-1 is 
required for lifespan extension in response to hypoxia and that DAF-16 is also required for this 
lifespan extension (Leiser et al., 2013). It is not yet clear whether the two pathways are linked 
but other studies have shown that in mammalian cells, the DAF-16 orthologue FOXO3a is a 
target of HIF-1 (Bakker et al., 2007). 
DAF-16/FOXO is a shared target of both TRPA-1 and HIF-1, however in addition to this, TRPA-
1 and HIF-1 show many different links to one another in multiple different organisms. 
Chemically induced hypoxia i.e. treatment with desferroxamine or dimethyloxalylglycine leads 
to HIF-1 activation and also results in increased TRPA1 mRNA levels. Additionally, in the 
same study HIF-1 has been shown to bind to a number of HRE motif sites on the TRPA1 
gene resulting in increased expression and induction of TRPA-1 ion channels, which in turn 
leads to increases in cellular Ca2+ (Hatano et al., 2012). Further linking these two pathways is 
the proposal that TRPA-1 is a sensor for oxygen and is sensitised (to pain) in hypoxic 
conditions and is also regulated by PHDs in a similar manner to how HIF is regulated (So et 
al., 2016). As previously mentioned HIF-1 responds to temperature changes, indicating that 
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both of these temperature and hypoxia signalling pathways are tightly linked. Therefore, these 
oxygen and temperature signalling pathways would be ideal to further investigate lifespan 
changes in C. elegans as a measure of ageing in response to environmental changes including 
both temperature and oxygen. 
1.6 Measures of ageing 
1.6.1 Lifespan and chronological age as a measure of ageing 
Lifespan or chronological age has commonly been used as a surrogate measurement for the 
ageing process (Klass, 1977). This is due to the correlation between the ageing phenotype 
and increased age even though the two are in fact distinct (Bansal et al., 2015). Lifespan is 
clearly defined as a measurement of an organism’s survival as time passes. This simple 
definition makes it easy to measure and conduct by simple survival assays and can be 
conducted on a range of organisms so relative comparisons can be made. Although extremely 
easy to conduct, there are positive and negative qualities of lifespan in its ability to act as a 
measure of ageing. The chronological age of an individual is an accurate measurement of its 
lifespan. However, its ability to act as a measure of the ageing process is less accurate 
primarily due to the many variations between individuals. Population studies and measuring 
the average lifespan of a population to generate survival curves are generally considered to 
be more useful and more accurate measures of ageing. However, the methodology of 
conducting lifespan assays is also important as differences in methodology can yield different 
results. Factors to consider is population size, frequency of measurement and number of 
replicates. 
1.6.2 Biological age as an alternative measure of ageing 
An alternative measure of the ageing process is biological age. Unlike chronological age which 
measures the time passed since birth, biological age is calculated from measurements of 
multiple different parameters which act as biomarkers of how an organism’s body (tissues, 
organs and systems) is functioning. Changes in the characteristic biomarkers are measured 
as bodily function deteriorates over time. Higher levels of biomarkers which characterise 
greater deterioration of bodily function result in a higher biological age. Therefore, biological 
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age as a whole is a closer measure of the health or wellness of an individual which normally 
deteriorates in the ageing process. As there is no single direct measurement of biological age 
but a range of substitute measurements, it is difficult to get consistent and comparable 
measure of biological age. Example of biomarkers can be either lifestyle factors (such as 
weight, blood pressure, breathing tests, amount of exercise and food intake) or biomedical 
factors (such as genetic makeup, immunoglobulin G structure or telomere length or DNA 
methylation). These biomarkers can be investigated individually or collectively in a population 
to give a measure of biological age. However, in different organisms there are different 
biomarkers of biological age and also multiple different markers for the same bodily functions 
making it difficult to draw comparisons. Additionally, these single tests show high levels of 
inter- and intra- individual variability, making it difficult to extrapolate from a population, 
particularly when investigating treatments or interventions (Levine et al., 2018, Kato et al., 
2006).  
1.6.3 Healthspan 
Linked to biological age is healthspan which does not have a single universally accepted 
definition. Many studies measure a few biomarkers which correspond to good health but then 
conclude that it affects healthspan as a whole (Bansal et al., 2015). One definition is that 
healthspan is a measure of the disease free or healthy time period of an individual’s lifespan, 
although another definition is the average length of healthy life (Kaeberlein, 2018, Crimmins, 
2015). Therefore, before healthspan can be widely used as a surrogate measure of ageing, 
standardised measures must be implemented. Like biological age, healthspan is characterised 
by a number of measures which identify whether an individual is in a healthy state. Similarly, 
many studies measure different biomarkers of healthspan as it is difficult to measure all of 
them given that there is no finite number of biomarkers. This also makes it difficult to 
standardise a measurement of healthspan (Bansal et al., 2015). As previously mentioned, the 
average lifespan and (life expectancy) in humans has increased over time, but healthspan has 
not increased at the same rate (Olshansky, 2018). In particular during later lifespan, a number 
of chronic late onset diseases have become prevalent in the elderly. These include diseases 
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such as dementia, diabetes or cancer. Additionally, healthspan can be affected by a number 
of diseases and even though one measure shows a positive health outcome others may not. 
Thus overall healthspan is currently more difficult to improve than lifespan. Many studies have 
initiated setting out parameters which are used to measure healthspan and which are relevant 
to humans (Bansal et al., 2015, Xia et al., 2017, Lara et al., 2015, Burkle et al., 2015). In C. 
elegans, conflicting results have been reported as it has been shown that healthspan and 
lifespan are not proportional to one another yet coincidentally (or not) improvements to 
healthspan result in an increase in lifespan (Richardson et al., 2016, Rollins et al., 2017). 
1.6.4 Frailty Index 
Another alternative measure of ageing linked to healthspan is the frailty index which 
determines the health status of an individual from an index of health biomarkers (Searle et al., 
2008). Specifically, for each biomarker, the number of individuals in a health deficit are 
calculated and thus healthy and frail proportions of a population are generated. Therefore, in 
many studies, the frailty index is used as a measure for biological age. Similarly, the whole 
population rather than an individual can be investigated and, by conducting lifespan studies, a 
frailty measurement can be made (Rockwood et al., 2017, Goggins et al., 2005). Mouse 
models to study frailty have become more widespread, with many studies investigating a range 
of parameters and physiological changes in relation to frailty, which in turn provides the 
opportunity to translate applicable findings to humans (Kane et al., 2016). 
1.6.5 Applying frailty index to mortality 
Lifespan studies are able to provide data at various time points in which there is a proportion 
of the population that is in deficit (dead) and the remaining population which is alive and not in 
deficit. Multiple groups have studied this assumption, with all groups concluding that the frailty 
index in humans and mice is predictive of mortality (Rockwood et al., 2017, Kojima et al., 
2018). Although it is a simple assumption, it can be assumed from lifespan data that at lower 
survival proportions the population is frailer and therefore has a higher biological age.  
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1.7 Measurement of lifespan 
1.7.1 Traditional lifespan assay methods 
Lifespan assays are a key method for studying biological and physiological processes such as 
ageing and stress resistance which affect longevity in organisms including flies, mice or worms. 
Although ageing and lifespan are separate concepts they are linked to one another. Due to the 
short lifespan, genetic simplicity and straightforward methodology C. elegans lifespan assays 
are an ideal method to measure ageing. Lifespan measurement is a property of an ageing 
population which is done by the documentation of each worms’ lifespan in the studied 
population.  
Lifespan assays involve measurement of the consequence of ageing which uses death as an 
endpoint. In a population a start point is needed, often birth or first day of adulthood, and the 
number of individuals which are alive, and dead are measured at regular intervals. This is 
commonly shown as proportions of alive vs dead over time. 
C. elegans lifespan can be measured in many different ways which further complicates the 
comparison of results among different studies. The most common difference is conducting 
lifespan assays on either solid medium or in a liquid culture. 
Lifespan assays on solid medium use Nematode Growth Media (NGM) agar plates typically 
seeded with bacteria (e.g. E. coli OP50) as a food source. Other food sources can be used 
such as E. coli HB101 or HT115, which are often used to introduce RNAi for gene knockdown 
in C. elegans (Amrit et al., 2014).  
Conventionally, these survival assays are conducted manually, using a microscope and a 
worm pick to count and record alive, dead and censored worms manually. A synchronised 
young adult (L4) population is selected, which is then counted at regular intervals, typically 
daily or every other day. 
1.7.2 Digital lifespan assays 
Additionally, worm lifespan can be measured digitally using flatbed scanners. In this thesis the 
term “digital” lifespan measurement includes both automated and semi-automated lifespan 
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measurement systems. There are many setups that have been produced for digital lifespan 
measurement. The C. elegans ‘lifespan machine’ is a well characterised system which uses a 
Linux server and a custom-built image analysis software to automate lifespan measurement 
by taking scans at regular intervals (~15 minutes) and compares differences between images 
(Stroustrup et al., 2013).  
Another automated system is the ‘Wormscan’ system which requires the user to take 
subsequent images which are analysed for differences by the image processing software Fiji 
(Mathew et al., 2012). 
Both manual lifespan assays and digital lifespan assays have their benefits and drawbacks. 
For example, the automated systems require less user contact and can be higher throughput 
on a larger scale compared to manual counting. However, as dead worm detection is based 
on image parameters the exact time of death may be difficult to determine. Thus, it may result 
in less accurate survival curves compared to manual counting which can accurately determine 
whether a worm is dead or alive. However, frequency of counting also affects the determination 
of death; most manual counting assays record worms on a daily basis with some studies using 
a less frequent measurement time points, whereas the automated counting can record lifespan 
at up to 15-minute intervals giving a much higher resolution of the generated survival curve. In 
automated systems there is also minimal user contact resulting in less extraneous variables 
which may affect worm lifespan and potential biases from the user. However, other factors 
such as the heat and light from the scanners are known factors which may affect lifespan and 
must be taken into consideration (De Magalhaes Filho et al., 2018). 
Liquid cultures of C. elegans is an alternative method for growth and to conduct lifespan 
assays. The worms are grown in a S-Basal medium and are placed on a platform shaker which 
provides sufficient oxygenation to the worms for proper growth (Amrit et al., 2014). In the 
lifespan measurement in liquid culture, worms which do not respond to shaking are classified 
as dead. Additionally, there is a ‘wormfarm’ automated lifespan system which is able to 
measure lifespan of worms in a liquid culture (Xian et al., 2013). 
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1.8 Lifespan analysis 
1.8.1 Kaplan-Meier estimator and other non-parametric models 
The most common method for analysis of population survival is the non-parametric Kaplan-
Meier estimator (Goel et al., 2010). Also known as the product limit estimator, it is defined as 
the probability of survival in a given length of time at specific measured time points (Kaplan 
and Meier, 1958, Goel et al., 2010). Not only can the Kaplan-Meier estimator be used to 
calculate lifespan but it has a number of applications which require measurement of time to an 
event, for example disease onset in patients or drug treatment comparisons (Collett, 2015). 
From the Kaplan-Meier estimator a number of useful quantities can be obtained. Thus it 
calculates the probability of an event (death) occurring at given time points and can also take 
into account censored individuals. Additionally a median survival time is calculated, which is 
the time point when 50% death of the original population occurs (Goel et al., 2010). From the 
Kaplan-Meier estimator it is also possible to calculate a survival function and from this, the 
hazard function, which is the probability that an individual will survive beyond a given time point 
and the probability that an individual will die at a given time point (Collett, 2015). The most 
common method for comparison of Kaplan-Meier curves is the log-rank test which statistically 
tests the null hypothesis that there is no statistically significant difference between the two 
populations in the probability of death at a given time point (Goel et al., 2010). However, by 
using the Kaplan-Meier estimator to measure lifespan data, the different experimental 
realisations cannot be collated with one another, and as a result differences between 
realisations are often overlooked particularly as each curve can only be compared with a single 
other curve. Additionally, by coupling it with the log-rank test the only output obtained is 
whether there is a difference between the two curves but there is no indication as to when 
differences in lifespan may occur. Thus, the Kaplan-Meier coupled to the log-rank test is an 
insufficient methodology for examining lifespan data in detail.   
Another non-parametric test is the Kolmogorov-Smirnov test. It is able to quantify differences 
between two samples by comparing the two distributions against the null hypothesis that the 
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two samples come from the same distribution. It does this by comparing empirical cumulative 
distributions, in this case observed lifespan distributions (Massey, 1951). 
Other models which can be used to fit survival data can be semi-parametric or parametric, 
which assume a distribution of the experimental data. One example of a semi-parametric 
model is the Cox proportional hazards model which estimates the effect of a known covariate 
(continuous variable) upon a hazard which is relative to the baseline hazard (hazard function 
when all covariates are set to 0). The Cox model allows relative comparison of multiple 
covariates and is commonly used in clinical investigations as its use is restrictive in situations 
where hazards are not proportional. This model is a semi-parametric as the baseline hazard 
function is not assumed but remains unspecified (Cox, 1972, Bradburn et al., 2003, Bugnard 
et al., 1994).  
The accelerated failure time model is an alternative parametric model to the proportional 
hazards model and uses a Weibull or exponential distribution to compare two populations. It 
defines the difference between the curves by a multiplicative parameter as the curves are 
either shifted to the left or right from one another (Bradburn et al., 2003, Swindell, 2009). 
1.8.2 Parametric modelling 
As an alternative to the non-parametric and semi-parametric models, parametric models can 
be used to fit lifespan curves. Unlike non-parametric and semi-parametric models, the 
parametric models have finite parameter values expressed by mathematical equations. A 
number of parametric models of cumulative distribution functions have been developed which 
allow fitting to lifespan curves and other time series data. The majority of survival models are 
sigmoidal in shape with an exponential decrease. The parametric models are useful for 
modelling lifespan as the number of parameters can be adjusted depending on the type of 
survival data. However, the chosen parametric model must fit data sets as they assume a 
baseline hazard to estimate parameters. It is therefore important that parametric functions are 
accurate so to gain reliable conclusions, as inappropriate models would not yield reliable 
results (Dätwyler and Stucki, 2011). The most renowned model is the Gompertz model which 
was originally applied to the law of mortality itself based upon the hazard (of death) which 
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increases exponentially as time passes (Gompertz, 1825). Life tables of mortality is commonly 
used to investigate the number of deaths in populations over time and are often attributed to 
specific causes. The Gompertz model was originally developed to approximate life tables and 
has been further developed by the addition of an extra parameter into the Gompertz-Makeham 
function (Makeham, 1860). 
Another popular model is the Weibull model, which has the mortality/failure rate proportional 
to the power function of time (Weibull, 1951). The Weibull model is used as the baseline hazard 
of the proportional Cox model and accelerated failure time models (Bradburn et al., 2003, Cox, 
1972). Variation of these models have since been developed with varied fitting powers. The 
majority of models which are used to fit survival data have two parameters which follow a 
monophasic decrease. A number of other models with a varied number of parameters have 
since been developed and applied to many biological time-to-event data sets in survival of 
animals, bacterial cultures of growth or inactivation and tumour growth. (Vanfleteren et al., 
1998, Xiong et al., 1999, Marusic, 1996, Wilson, 1994). Additionally, these sigmoidal curves 
are applied in engineering to failure rates of components to investigate for how long they will 
function as intended. 
1.9 Two phases of C. elegans lifespan 
C. elegans is a model organism in which their survival is modelled. Its lifespan is commonly 
modelled by Gompertz or Weibull models. However, recent studies have shown that even 
isogenic populations of C. elegans grown in similar conditions have variations in lifespan which 
can be due to a number of intrinsic factors including mutations, modifications and random 
changes to processes which may have cumulative effects upon lifespan of individuals 
(Kirkwood et al., 2005). For example Hsp16-2 shows a large variation in expression levels 
which has been linked with variations in survival (Rea et al., 2005). Another study has also 
introduced the idea of subpopulations of short-lived and long-lived individuals, with 
physiological differences in movement, autofluorescence and tissue integrity. Compared to 
long-lived worms, short-lived worms have greater autofluorescence, lower tissue integrity and 
move less. Additionally, a correlation is seen between longer lifespan and smaller body size 
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and fewer eggs laid. The study concludes that short-lived individuals die earlier but still appear 
to be healthy while  the longer lived individuals undergo physiological decline early on but 
continue to spend the rest of their long lifespan with reduced function (Zhang et al., 2016). 
Another study uses post mortem analysis and identify two causes of death. Thus the 
population is split into two subpopulations based on differences in pharyngeal pathologies and 
are termed big ’P’ and small ‘p’ which correspond to early deaths and late deaths. They 
conclude that the ‘P’ deaths are due to a pharyngeal infection and subsequently damaged due 
to high pharyngeal pumping rates (Zhao et al., 2017). Finally, an additional study which 
investigates maximal movement velocity of worms as a measure of healthspan indicate that 
worms can be split into two subpopulations; those with a high movement velocity and those 
with a low movement velocity and the study shows that there is a distinct differences in lifespan 
between these two groups (Hahm et al., 2015). These studies provide compelling evidence 
that there are two phases of lifespan in C. elegans and therefore modelling lifespan data with 
the commonly used monophasic parametric models is unsuitable for lifespan analysis. 
1.10 Thesis justification, hypothesis and aims 
Lifespan in C. elegans is observed to occur in two phases with the early phase death of short-
lived individuals and the late phase death of long-lived individuals. Current parametric models 
used to analyse lifespan follow monophasic survival and therefore would be unable to reliably 
model two phase (biphasic) lifespan. Temperature and oxygen changes are important 
environmental modifiers which control lifespan of C. elegans signalling via TRPA-1 and HIF-1 
signalling pathways respectively. Mathematical modelling of lifespan of TRPA-1 and HIF-1 
signalling pathway factors allows further investigation of the role played by the two signalling 
pathways and will provide insight into the interaction between the two pathways.  
We hypothesise that a parametric biphasic lifespan model would be a more accurate model 
for fitting lifespan data of C. elegans compared to commonly used existing models. Using this 
model would allow further investigation to changes in lifespan under different temperatures 
and oxygen conditions and by using mutant animals to identify the specific roles played by 
these factors in influencing lifespan. This will also lead to better understanding of signalling 
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between HIF-1 and TRPA-1 and how it affects lifespan. Furthermore, using this model will 
allow different data realisations to be collated with one another providing a more 
comprehensive method of analysis. 
The aim of this thesis is to use mathematical modelling techniques to investigate how TRPA-
1 and HIF-1 signalling regulate lifespan. More specific objectives are: 
 To generate a novel mathematical model capable of modelling biphasic lifespan data 
and to confirm that C. elegans lifespan can be biphasic. To compare this model with 
existing models using goodness of fit testing. To identify the versatility of this model by 
applying it to a range of conditions and species to identify lifespan differences. 
 To generate predictive models which can predict the effect of intervention on lifespan. 
Verify the accuracy of the predictive models by comparing predictions to experimental 
lifespan data. To identify critical intervention time points at which lifespan has 
significantly changed or can no longer be changed. 
 To use the parametric model to determine the relationship between TRPA-1 and HIF-
1 signalling in relation to temperature and oxygen changes and to determine the effects 
upon lifespan in C. elegans. To identify signalling between the TRPA-1 and HIF-1 
pathways in mammalian cells and to identify if signalling is consistent in C. elegans. 
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2.1 Materials 
All materials were purchased from Sigma-Aldrich Company (Dorset, UK)  unless otherwise 
stated. Plasticware for cell and worm culture was purchased from Thermo Fisher Scientific 
(Loughborough, UK) and VWR International (Lutterworth, UK). 
2.2 C. elegans experiments 
2.2.1 Strains growth and maintenance 
The C. elegans strains N2 (wild isolate), and daf-16(mu86) (10980 bp deletion), hif-1(ia4) 
(1231 bp deletion), trpa-1(ok999) (1334 bp deletion), egl-9(sa307) (243 bp deletion) and egl-
9(n586) (base substitution) were acquired from the Caenorhabditis Genetics Center (CGC), 
University of Minnesota.  All strains were cultured on solid nematode growth media (NGM) 
agar (Table 2.1).  
Table 2.1: Recipe for making NGM agar. 
Reagents For 100ml of dH2O 
Agar 1.7g 
NaCl 0.3g 
Peptone 0.25g 
Autoclave 
1M CaCl2 100l 
1M MgSO4 100l 
1M KPO4 2.5ml 
Cholesterol (5mg/ml in Ethanol) 100l 
Nystatin (10mg/ml in DMSO) (N6261) 100l 
FuDR (150mM)  33l (lifespan assay plates only) 
 
10ml of NGM agar was poured into each 55mm plate and allowed to solidify and dry at room 
temperature overnight. Once dry, NGM plates were seeded with 200l of Escherichia Coli (E. 
coli) OP50 strain (CGC) and E. coli was allowed to dry on the plate at room temperature. OP50 
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cultures were seeded from a single colony grown in LB broth overnight at 37°C in a shaking 
incubator. C. elegans strains were maintained in an incubator (RLSD01502; LabCold) at 20°C 
unless stated otherwise. Strains were viewed using a stereomicroscope (Motic SMZ-171T) 
and were handled using a flame sterilised platinum worm pick (#59-AWP; WormStuff, Genesee 
Scientific). 
2.2.2 C. elegans lifespan assays 
NGM plates used for lifespan assays were additionally supplemented with 50M (33l of 
150mM in 100ml of NGM agar) of 5-Fluoro-2’-deoxyuridine (FuDR; F10705-1.0; Melford 
Laboratories) to prevent growth of unwanted offspring. Lifespan assays were conducted on a 
population of synchronised worms.  Adult worms (containing eggs) were placed into a drop 
(~10l) of alkaline hypochlorite solution (250l of dH2O, 230l of sodium hypochlorite and 30l 
of 10M NaOH) on the NGM plate. The solution killed the worms, causing eggs to be released. 
Hatching occurs simultaneously resulting in a synchronised population. Offspring were grown 
and at least 50 L4 stage worms were transferred onto new NGM plates containing FuDR for 
lifespan assays. Worms were transferred onto new plates weekly but more frequently if the 
seeded OP50 had become depleted, if plates had any unwanted bacterial or fungal 
contamination or showed desiccation. Day 0 is considered as the first day of adulthood and 
time points for events (death or censorship) were marked almost daily (Figure 2.1). Total 
number of dead and censored worms and total number of trials for all experiments in chapters 
3.0, 4.0 and 5.0 is shown in Appendix 8.1 (Table 8.1a, 8.1b and 8.1c respectively). 
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Figure 2.1: Workflow for setting up a lifespan assay, (a) NGM agar plates are made and (b) 
seeded with E. coli. (c) Droplets of alkaline hypochlorite solution is spotted onto the plate and 
adult worms containing eggs are placed in the solution to release the eggs. (d) This generates 
a synchronised population which can then be (e) transferred onto an experimental (treatment) 
plate and lifespan can be (f) measured as alive, dead or censored. 
 
Worms were classified into 3 categories at each measured time point: alive, dead or censored. 
They were classified as alive if any movement is observed. If no movement is observed the 
agar surrounding the worm is tapped with the sterile worm pick. If still no movement is 
observed, then the head of the worm is gently tapped with the worm pick to elicit a physical 
response. If after this there is still no response the worms are classified as dead and are 
removed from the plate. Worms can also be classified as censored from the experiment if a 
final time of death is unable to be determined. Censorship of worms occurs if worms do not 
naturally die from old age. Some examples where censorship would occur are internal hatching 
of eggs (bagging), bacterial or fungal contamination, vulval protrusion and rupturing or death 
57 
 
due to worms crawling off of the agar. Although worms are censored from lifespan experiments 
they are still included for statistical analyses. 
2.2.3 C. elegans lifespan assays from digital recording 
Flatbed photo scanners were used for some lifespan assays where manual counting assays 
could not be conducted (for example in hypoxic environments). Use of flatbed scanners to 
conduct automated lifespan measurements such as with the ‘automated wormscan’ (Mathew 
et al., 2012) and ‘the C. elegans lifespan machine’ (Stroustrup et al., 2013) inspired the use of 
flatbed photo scanners for acquisition of photos. The Epson Perfection V800 Photo Scanner 
was used to scan the agar plates (up to 12 at a time) at least twice daily to generate high 
resolution images of all plates (Figure 2.2). Once images were acquired the individual plates 
were analysed manually by comparing images taken. If worms had moved position then they 
were classified as alive, had they not moved they were classified as dead. Additionally, missing 
worms (crawled off the plate) were classified as censored along with worms which were seen 
to have had internal hatching of eggs (bagging), bacterial or fungal contamination, vulval 
protrusion and rupturing. 
 
Figure 2.2: Digital lifespan recording. (a) Loading plates onto scanners. (b) Representative 
scan of 12 plates. (c) Representative scan of a single plate zoomed in. 
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2.2.4 C. elegans treatments 
2.2.4.1 Temperature Intervention 
In temperature intervention studies, C. elegans (L4 stage) were incubated at an initial 
temperature (either 15°C or 25°C) for a certain time period of their lifetime and then incubated 
at the alternative temperature (25°C or 15°C) for the remaining length of their lifetime. C. 
elegans N2 and trpa-1(ok999) strains were used in switching experiments. Temperature 
switching was conducted by transferring worms between incubators pre-set at either 15C or 
25C. 
2.2.4.2 Pharmacological Intervention 
Pharmacological intervention was used to influence lifespan of C. elegans to identify how drugs 
affect the lifespan of worms, specific populations and parameters. In these studies, the 
pharmacological intervention occurred from day 0 (synchronised worms at L4 stage) for the 
entire adult lifetime, until death. 
2.2.4.2.1 Carvacrol 
Carvacrol (Figure 2.3; 282197) is a monoterpene phenol found in Oregano and other aromatic 
plants and is known to have antibacterial properties (Xu et al., 2006). However, it also acts as 
an activator of human TRPA1 and TRPV3 ion channels. It has previously been shown to allow 
Ca2+ ion entry into cells. Carvacrol (0mM, 50mM, 200mM and 500mM; Solvent: DMSO; 
Control) was added to melted NGM agar before pouring into 55mm plates culture plate. 
 
Figure 2.3:  Molecular structure of carvacrol 
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2.2.4.3 Hypoxia 
C. elegans (L4) were exposed to hypoxia (1% O2, 99% N2) by placing them inside the hypoxia 
O2 Control InVitro Glove Box (Coy Laboratories). Temperature was regulated using a climate 
control system in the room to an average temperature of 20C. As previously mentioned 
(section 2.2.3), a flatbed photo scanner (EPSON V800) was used to take images of worms in 
the hypoxia chamber to generate survival curves. 
2.3 Drosophila lifespan assay 
Control wDah was derived by backcrossing w1118 into the outbred wild type Dahomey 
background. The dfoxoΔ flies were previously described (Slack et al., 2011). Flies were raised 
and maintained on standard sugar/yeast medium (Bass et al., 2007). Lifespan experiments 
were conducted at 25°C on a 12:12 hours light/dark cycle at constant humidity. Flies were 
reared at standard density, allowed to mate for 24 h, sorted by sex, and then transferred to 
experimental vials at a density of ten flies per vial. Approximately 100 flies were used per 
experimental replicate. Flies were transferred to fresh vials three times a week, and deaths 
were scored during transferral. Drosophila experiments were conducted by Cathy Slack at 
Aston University, UK. 
2.4 Honey bee lifespan assay 
Lifespan data of caged and hived (free flying) bees originated from two independent studies 
(Woyciechowski and Moron, 2009, Kuszewska et al., In preparation). One part of newly 
emerged workers from each colony was placed in a wood-frame cage (51-100 bees) kept in 
an incubator (34-36°C). The bees were provided with a small piece of honeycomb and 50% 
sucrose solution and water ad libitum. The cages were checked every day and dead bees 
were counted. The second part of newly emerged workers (59 - 100 bees) were marked 
individually on the thorax and returned to their native colonies. The colonies were checked 
daily  (depending on weather conditions) and the alive bees were counted every 3-4 days 
(Kuszewska et al., In preparation). Honey bee experiments were conducted by Karolina 
Kuszewska and Michał Woyciechowski at Jagiellonian University, Poland. 
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2.5 Rapamycin effect on mouse lifespan 
Published data for rapamycin intervention in the mouse was kindly provided by the National 
Institute on Aging (NIA) Interventions Testing Program (ITP) (Miller et al., 2014). Rapamycin 
concentration used was 42ppm (42mg rapamycin per kg of food).  
2.6 Survival curve analysis 
From the survival data generated by measuring alive, dead and censored worms Kaplan-Meier 
survival curves were constructed by inputting events at measured time points into GraphPad 
Prism 7.0 (GraphPad Software). Time points were inputted as days and events are encoded 
as per the software’s input requirements with death encoded as 1 and censorship as 0. Survival 
proportions at each time point was calculated by the software. A log-rank (Mantel-Cox) test 
was conducted to statistically compare differences between two curves. 
2.6.1 Average lifespan and Median Survival 
Average lifespan was calculated by finding the average time of death for a population (sum of 
when worms die divided by the total number of worms that die). Average lifespan can be 
calculated for a whole population for their entire lifespan or for the worms remaining post 
treatment. This is equal to the integral of the survival curve. The median survival of a population 
is the time point at which 50% of a population is remaining. 
2.6.2 Curve fitting 
Non-linear regression models which were based on logistic functions were used to fit curves 
to the survival proportions. The MATLAB (MathWorks) Curve fitting toolbox (R2016a, 
v9.0.0.370719) and sfit objects were used to fit data using a non-linear least squared fit method 
(Trust-Region algorithm) to estimate parameters.  When fitting the survival data, other settings 
were kept to default: Robust=Off, DiffMinChange=0.00000001, DiffMaxChange=0.1, 
MaxFunEvals=600, MaxIter=400, TolFun=0.000001, TolX=0.000001. 
2.6.3 Novel 5-parameter Bilogistic model and reduced versions 
A number of models were used to fit survival data. A novel 5-parameter Bilogistic model was 
constructed to be able to fit both biphasic and monophasic data (Equation 1). The f parameter 
61 
 
splits the curve into two phases giving a weighting to each phase. The two phases correspond 
to an early phase and late phase of death. There are two death rates (deaths per day), k1 and 
k2 (one for each phase), and two time parameters, t1 and t2, representing the median survival 
for each phase (Figure 2.4). 3 variants of the Bilogistic model were also constructed to reduce 
the model to 4 parameters: 1) the two death rates were the same (k1 = k2); 2) the two phases 
had equal weight (f = 0.5); 3) only one phase existed (f = 0). Additionally, the model was further 
reduced to 3 parameters with there being 2 variants: 1) where the two phases had equal 
weighting and the two death rates were the same (f = 0.5 & k1 = k2); 2) where the weighting 
between the two phases was fixed to an average of previously calculated f’s for the realisations 
used and the two death rates were the same (f = average & k1 = k2). The terms in the numerator 
ensure that for t = 0 the pre-factor of the function is N0, which is typically rescaled in each 
experiment to be 100%. 
The first derivative of the 5-parameter model is proportional to the hazard for each population 
over time (Equation 2).  
 
𝑁(𝑡) = 𝑁0 [𝑓
1 + 𝑒−𝑘1𝑡1
1 + 𝑒𝑘1(𝑡−𝑡1)
+ (1 − 𝑓)
1 + 𝑒−𝑘2𝑡2
1 + 𝑒𝑘2(𝑡−𝑡2)
] 
Equation 1: Bilogistic 5-parameter model. 
 
𝑑𝑁
𝑑𝑡
= 𝑁0 [
𝑓𝑘1(𝑒
−𝑘1𝑡1 + 1)𝑒𝑘1(𝑡−𝑡1)
(1 + 𝑒𝑘1(𝑡−𝑡1))2
+
(1 − 𝑓)𝑘2(𝑒
−𝑘2𝑡2 + 1)𝑒𝑘2(𝑡−𝑡2)
(1 + 𝑒𝑘2(𝑡−𝑡2))2
] 
Equation 2: First derivative of the Bilogistic model. 
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Figure 2.4: Example of curve fitting and parameter (f, k1, k2, t1, t2) estimation for a survival 
curve using our Bilogistic model 
 
2.6.4 Other sigmoidal models 
The six other models which have been previously been used to characterise survival data 
were: Whiting-Buchanan Model (Equation 3; (Whiting and Buchanan, 1993)), Gompertz-
Makeham (Equation 4; (Makeham, 1860, Gompertz, 1825) Logistic Model (Equation 5; 
(Pletcher et al., 2000)), Wilson’s 2-parameter Model (Equation 6; (Wilson, 1994)), Weibull 
Model (Equation 7; (Weibull, 1951)) and Gompertz Model (Equation 8; (Gompertz, 1825)). For 
all models containing an f parameter it is bound between 0 and 1. Additionally, both death 
rates (ki) and time parameters (ti) were bound to being positive values and the t1 value was 
always lower than t2. 
𝑁(𝑡) = 𝑁0 [𝑓
1 + 𝑒−𝑘1𝑡𝑙𝑎𝑔
1 + 𝑒𝑘1(𝑡−𝑡𝑙𝑎𝑔)
+ (1 − 𝑓)
1 + 𝑒−𝑘2𝑡𝑙𝑎𝑔
1 + 𝑒𝑘2(𝑡−𝑡𝑙𝑎𝑔)
] 
Equation 3: Whiting-Buchanan Model 
𝑁(𝑡) = 𝑁0(𝑒
−𝑐𝑡−
𝑎
𝑏
(𝑒(𝑏𝑡)−1) 
Equation 4: Gompertz-Makeham Model 
𝑁(𝑡) =
𝑁0
1 + 𝑒
𝑡−𝑡𝑙𝑎𝑔
𝑘
 
Equation 5: Logistic Model 
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𝑁(𝑡) =
𝑁0
1 + (
𝑡
𝑡𝑙𝑎𝑔
)
𝑘 
Equation 6: Wilson Model 
𝑁(𝑡) = 𝑁0 (𝑒
−(𝑎𝑡)𝑏) 
Equation 7: Weibull Model 
𝑁(𝑡) = 𝑁0 (𝑒
−
𝑎
𝑏
(𝑒(𝑏𝑡)−1)) 
Equation 8: Gompertz Model 
 
2.6.5 Curve fitting statistical analysis 
After parameters were obtained statistical analysis was conducted. GraphPad Prism was used 
to perform an ordinary two-way Analysis of Variance (ANOVA), with all groups compared to 
one another (non-repeated measure). After average lifetime values were obtained statistical 
analysis was conducted. GraphPad Prism was used to perform an ordinary one-way Analysis 
of Variance (ANOVA), with all groups compared to one another (non-repeated measure).   In 
conjunction to this ANOVA, Tukey’s multiple comparison test was also conducted. Statistical 
p-values p<0.05, p<0.01, p<0.001 and p<0.0001 shows a statistically significant difference 
between groups and is indicated in the figures. 
2.7 Goodness of Fit and model comparison 
2.7.1 Root Mean Square Error 
The root mean square error (RMSE) was used for the goodness of fit statistical analysis of the 
different models using MATLAB (MathWorks, R2016a, v9.0.0.370719). It represents the model 
performance accuracy taking in to account the number of data points and parameters and 
applying a penalty to models with higher parameters so that simplest model with the best fit is 
shown. Fitted models with lower RMSE values indicate a better fit. The statistical significance 
between two groups was examined using two-way analysis of variance (ANOVA) followed by 
Tukey’s multiple comparison tests using GraphPad Prism. Statistical p-values p<0.05, p<0.01, 
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p<0.001 and p<0.0001 shows a statistically significant difference between groups and is 
indicated in the figures. 
2.7.2 Residual Analysis 
Another method used to analyse goodness of fit of the models was to look at residuals. 
Residual differences between experimental lifespan data points and fitted model curves were 
calculated for each data set. Residual differences for each experimental realisation in a single 
data set was collated into one set which then underwent a data binning procedure to smooth 
the data. Data bin sizes were considered and grouped based upon the species, number of 
experimental realisations, number of residual data points per day and total length of lifespan; 
in C. elegans, the data bin sizes were 2, 3 and 4 days. Residual plots which show the smallest 
residual error without universal deviations throughout the lifespan indicate best overall fit.  
2.8 Cell culture 
Mammalian cell culture experiments were conducted to support whole organism experiments 
to investigate specific mechanisms of signalling between hypoxia and temperature pathways.  
Using in vitro studies in conjunction with in vivo studies, allows for comparison and 
identification of pathways which are organism specific and those which are conserved. 
2.8.1 Plasmid cloning 
Plasmid constructs used are pHRE-MP-GLuc HIF responsive plasmid DNA (Cavadas and 
Cheong, 2014) and pcDNA3.1/neo(+)-human TRPA1 plasmid DNA kindly provided as a gift 
from Katsuhiko Muraki at Aichi Gakuin University, Japan (Hatano et al., 2012). Plasmid 
constructs were transformed into α-Select Bronze Competent Cells (BIO-85025; Bioline 
Reagents) using the heat shock method. 1ng of plasmid construct was mixed with 50l α-
Select Bronze Competent Cells and stored on ice for 30 minutes. This was then transferred to 
42°C for 50 seconds and placed on ice for 2 minutes. 100l of LB was added to the plasmid-
cell mix and incubated at 37°C for one hour with shaking. The culture was spread onto a LB 
agar plate supplemented with 100g/ml of Ampicillin (A9518) and incubated at 37°C overnight. 
The following day single colonies were identified and selected. Selected colonies were used 
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to inoculate LB (w/ 100g Ampicillin) and incubated overnight at 37°C with shaking. Plasmid 
DNA was purified using the Pureyield Plasmid Midiprep System (A2492; Promega) using 
vacuum DNA purification and elution by centrifugation as per the standard protocol. DNA 
concentration was quantified using the NanoDrop spectrophotometer (Thermo Fisher 
Scientific). 
2.8.2 Mammalian Cell Growth and Maintenance 
All cell culture methods were carried out in a Microflow class II advanced biological safety 
cabinet (Bioquell) with aseptic technique to ensure sterile conditions. 
2.8.2.1 HEK-293 cell culture 
Human embryonic kidney cells (HEK-293) are a human cell line derived from an aborted foetus 
in 1977 containing a transformed sheared adenovirus 5 (Graham et al., 1977). It is widely used 
due to its ease of growth and transfection capability. 
HEK-293 cells were cultured in 75cm2 flasks with Dulbecco’s modified Eagle Medium (1x 
DMEM) with 4.5g/l of D-Glucose, 4mM L-glutamine and 1mM Pyruvate (41966-029; Gibco Life 
Technologies). It was additionally supplemented with 10% Foetal Bovine Serum (FBS; 10500-
064; Gibco Life Technologies) and 5% Penicillin-Streptomycin (P4333).  
When adherent HEK-293 cells reached 70-80% confluence they were passaged using Trypsin-
EDTA 10x solution (T4174) and re-seeded into new flasks at the desired concentration. Growth 
media was replaced every 72 hours until cells required further passage. Cells were maintained 
in a CO2 incubator at 37°C in an atmosphere of 5% CO2/ 95% air. 
2.8.2.2 HepG2 cell culture 
HepG2 is a human liver hepatocellular carcinoma isolated from a 15 year old Caucasian male 
(Aden et al., 1980). 
HepG2 cells were cultured in 75cm2 flasks with RPMI-1640 with 1mM (0.3g/l) L-glutamine and 
Sodium Bicarbonate (2g/L) (R8758). It was additionally supplemented with 10% Foetal Bovine 
Serum (FBS) and 5% Penicillin-Streptomycin. When adherent HepG2 cells reached 70-80% 
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confluence they were passaged using Trypsin-EDTA 10x solution and re-seeded into new 
flasks at the desired concentration. Growth media was replaced every 72 hours until cells 
required further passage. Cell were maintained in a CO2 incubator at 37°C in an atmosphere 
of 5% CO2/ 95% air. 
2.8.3 Seeding of mammalian cells 
Cells were detached from the flask using Trypsin-EDTA 10x solution and suspended in DMEM 
and then counted using a haemocytometer. 50, 000 cells were seeded in a 24 well plate with 
500l of media. Cells were incubated at 37°C in 5% CO2/ 95% air for 24 hours to allow for cell 
adherence to the well and proliferation.  
2.8.4 Transient Transfection 
A calcium phosphate co-precipitation methodology (Chen, 2012) was used for transient 
transfection of cells. 
Two solutions were prepared prior to the transfection, solution A and solution B (Table 2.2). 
 
Table 2.2: Recipe for Calcium Phosphate Co-precipitation solutions A and B. 
Solution Description  Typical volume 
for 24 well plate 
Solution A 2M CaCl2 (12.2l per 1-5g of plasmid DNA; filter 
sterilised) 
Plasmid DNA (200ng per well) 
dH2O  
 12.2l  
2400ng 
Make up to 120l 
Solution B 2X HEPES buffered Saline (HBS) (50mM HEPES (H-
3375), 280mM NaCl, 1.5mM Na2HPO4 dissolved in H2O; 
pH 7.0, filter sterilised) 
 
120 l 
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Solution A was added to solution B whilst mixing and was incubated for 10 minutes at room 
temperature. After incubation 10l of the total solution was added to cells in each well. Cells 
were incubated at 37°C in 5% CO2/95% air for 48 hours. 
2.8.5 Treatments 
24 hours post transfection, the 500l of growth media was replaced with fresh media and then 
treated using a number of different conditions. Treatment of cells usually lasted 24 hours.  
2.8.5.1 Hypoxia 
Cells were exposed to hypoxic conditions (1% O2, 94% N2, 5% CO2) in a hypoxia O2 Control 
InVitro Glove Box (Coy laboratories) and growth media used in treatments was pre-exposed 
to hypoxia for at least 16 hours before application to cells. 
2.8.5.2 Carvacrol 
A dose response treatment with carvacrol was also conducted to show the effect of increasing 
carvacrol concentration on HIF using doses at 5M, 20M, 50M, 200M and 500M. 
2.9 Gaussia Luciferase assay  
Gaussia luciferase acts as a secreted bioluminescent reporter which is then able to quantify 
the genetic plasmid construct (Figure 2.5) (Cavadas and Cheong, 2014). The pHRE-MP-GLuc 
HIF plasmid construct was used by which HIF activity was measured. 10l of conditioned 
media was collected 24 hours post-treatment and transferred into an opaque 96-well plate. 
2.5mM coelenterazine (#303; Nanolight) was diluted in PBS to 100M. 50l of 100M 
coelenterazine was added to aliquoted media in each well and was read on a SpectraMax 
Gemini EM Microplate Reader (Molecular Devices) at the ambient temperature. The SoftMax 
Pro Software (v5.0) was used to configure the plate reading settings: Top read, Luminescence, 
Emission: Lm1 461nm, Reads/Well: 6. 
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Figure 2.5: Mechanism by Gaussia Luciferase acts as a reporter for HIF activity. The 
luciferase enzyme is encoded and secreted after HIF binds the HRE promoter. Coelenterazine 
acts as a substrate which the luciferase enzyme catalyses to produce luminescence. 
 
 
 
Figure 2.6: Workflow of the Gaussia Luciferase assay. (a) Mammalian cells are seeded, (b) 
transfected and (c) treated (d) media is collected and (e) the substrate coelenterazine is added 
to a 96-well plate and (f) luminescence was measured on a plate reader.   
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2.9.1 Statistical Analysis 
Average (relative) luminescence for individual treatments in the Gaussia Luciferase assay was 
calculated (±SEM) using GraphPad. An Ordinary One-Way ANOVA with Tukey’s multiple 
comparisons test was used to compare individual treatments in the Gaussia Luciferase assay. 
Statistical p-values p<0.05, p<0.01, p<0.001 and p<0.0001 shows a statistically significant 
difference between groups and is indicated in the figures. 
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Chapter 3.0: Biphasic lifespan 
dynamics in multiple organisms 
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3.1 Preface 
Ageing research has focused on identifying lifespan modifiers, but a major challenge lies in 
understanding and appropriately interpreting their effects. The shape of the survival curve 
reveals crucial information on the mechanism of action. In this chapter, a novel Bilogistic model 
is introduced to describe and quantify lifespan data which can be applied to a range of standard 
animal models. The novel Bilogistic model provides a better fit to the experimental data than 
existing models such as the Gompertz-Makeham model and reveals the existence of two 
distinct sub-populations corresponding to two phases in the survival pattern in worms, flies, 
bees and mice. The model parameters account for the death rates for short-lived and long-
lived subpopulations, enabling statistical analysis of intra- and inter-group variance. Thus, the 
Bilogistic model can provide a rational statistical analysis of lifespan modifiers such as 
temperature, daf-16/FOXO mutation and rapamycin, on each phase, and establishes that 
biphasic survival dynamics is widespread across different organisms. 
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3.2 Introduction 
Today, many societies face the challenge of a rapidly ageing population with associated health 
problems and an increase in healthcare expenses. A crucial step towards our understanding 
of ageing is the identification and characterisation of lifespan modifiers in animal models such 
as worms, flies or mice. Common lifespan modifiers which have been investigated are 
temperature (Klass, 1977), diet (Colman et al., 2014), pharmacological interventions (Miller et 
al., 2014) and genetic pathways (Kenyon et al., 1993).  
The most common method for testing a potential lifespan modifier is to carry out lifespan 
assays and use the non-parametric Kaplan-Meier estimator to determine lifespan and 
probability of survival in a given length of time (Goel et al., 2010). The Kaplan-Meier estimator 
is often coupled with  the log-rank statistical test, which tests the null hypothesis that there is 
no statistically significant difference between the control and test group (Goel et al., 2010). 
This allows qualitative comparison between the two groups (i.e. tests if the two groups are 
different), but it is not possible to statistically compare experimental or biological replicates. 
Crucially, as it is only a significance test comparing two curves, it is unable to identify where 
differences may occur. Survival curves can be one of three types (Type 1, 2 and 3). Type-1 
curves have lower mortality early on and greater mortality in later life. Type-2 curves show a 
consistent mortality throughout the lifespan. Type-3 curves show greater mortality early in life 
and lower mortality later on in life (Deevey, 1947). 
An alternative is to perform parametric modelling of the data by fitting a mathematical function 
to the survival curve. Common distributions for lifespan data are the logistic and exponential 
distributions (Lawless, 2014). Two-parameter sigmoidal functions such as the logistic (Pletcher 
et al., 2000), Weibull (Weibull, 1951) or Gompertz (Gompertz, 1825) models fit lifespan data. 
Simple logistic functions often have a death rate and time lag parameters, or parameters which 
define the shape and scale of the curve. With these logistic functions it is possible to fit data 
points which follow a typical sigmoidal shape where there is a shoulder, an exponential but 
monotonic decrease and then a tailing (Lawless, 2014, Xiong et al., 1999).  However, these 
models often do not adequately fit all experimental data, as it has been previously shown that 
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not all lifespan curves show a simple monotonic decrease. For example, in C. elegans lifespan, 
it has recently been shown that there are short lived and long-lived worms which make up the 
population therefore reinforcing the fact that lifespan curves are likely to show small differences 
in death rates and time points within the survival curve resulting in shapes which are different 
to the standard monotonic decrease. (Zhang et al., 2016, Zhao et al., 2017). As is often done 
in parametric modelling by fitting the common logistic curves such as Gompertz and Weibull, 
there is an over-smoothing of the curves which leads to unintentionally discarding features 
which make up the lifespan curve. Therefore, to prevent this over-smoothing of experimental 
data, a novel parametric model is required, which is able to better model many different 
variations of survival curves whether they show a monotonic or biphasic decrease in lifespan 
and whether the rate of change is high or low or time lags are different at different points in the 
survival curve. 
3.2.1 Aims and Objectives 
This chapter aims to: 
1) Introduce a novel parametric model which describes and distinguishes two phases 
within the survival curve of a population, each with its own death rate and median 
survival. 
2) Examine differences between existing models and how well they fit experimental data 
and show that this novel model provides a significantly better fit of experimental data 
compared to the other existing models.  
3) Show that this novel model can be applied to fit a variety of different animal models, 
suggesting that a biphasic dynamism in the lifespan can be a general property of 
ageing populations.  
4) Explore how this model can statistically compare experimental data and replicates to 
quantitatively measure the effects of lifespan modifiers from experimental replicates to 
reveal new features in the survival curve.  
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3.3 Materials and Methods 
3.3.1 C. elegans lifespan assay 
The C. elegans strains N2 (wild isolate), and daf-16(mu86) were acquired from the 
Caenorhabditis Genetics Center (CGC), University of Minnesota.  All strains were maintained 
on solid nematode growth media (NGM) plates at 20°C unless stated otherwise and 
supplemented with nystatin (10 µg/ml) and seeded with E. coli OP50 strain. 
NGM plates used for lifespan assays were supplemented with 5-fluoro-2’-deoxyuridine (FuDR) 
(50µM) to prevent growth of unwanted offspring. Lifespan assays were conducted on a 
population of worms synchronised by alkaline hypocholorite treatment. Once synchronised, 50 
L4 stage worms were transferred onto fresh NGM FuDR plates for the start of the experiment. 
Worms were transferred onto fresh plates weekly, but more frequently if the seeded OP50 was 
depleted or in cases of unwanted bacterial or fungal contamination. Day 0 is considered as the 
first day of adulthood and time points for events (death or censorship) were marked almost 
daily. Worms were classified into 3 categories at each time point: alive, dead or censored.DR 
3.3.2 Drosophila lifespan assay 
Control wDah was derived by backcrossing w1118 into the outbred wild type Dahomey 
background. The dfoxoΔ flies were previously described (Slack et al., 2011). Flies were raised 
and maintained on standard sugar/yeast medium (Bass et al., 2007). Lifespan experiments 
were conducted at 25°C on a 12:12 hours light/dark cycle at constant humidity. Flies were 
reared at standard density, allowed to mate for 24 h, sorted by sex, and then transferred to 
experimental vials at a density of ten flies per vial. Approximately 100 flies were used per 
experimental replicate. Flies were transferred to fresh vials three times a week, and deaths 
were scored during transferral.  
3.3.4 Honey bee lifespan assay 
Lifespan data of caged and hived (free flying) bees originated from two independent studies 
(Woyciechowski and Moron, 2009, Kuszewska et al., In preparation). One part of newly 
emerged workers from each colony was placed in a wood-frame cage (51-100 bees) kept in 
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an incubator (34 - 36°C). The bees were provided with a small piece of honeycomb and 50% 
sucrose solution and water ad libitum. The cages were checked every day and dead bees 
were counted. The second part of newly emerged workers (59-100 bees) were marked 
individually on the thorax and returned to their native colonies. The colonies were checked 
every day or every 3-4 day  (depending on weather conditions) and the alive bees were 
counted (Kuszewska et al., In preparation).  
3.3.5 Rapamycin effect on mouse lifespan 
Data from the rapamycin intervention in the mouse was kindly provided by the National Institute 
on Ageing (NIA) Interventions Testing Program (ITP) (Miller et al., 2014). Rapamycin 
concentration used was 42ppm (42mg rapamycin per kg of food).  
3.3.6 Survival curve analysis 
Kaplan-Meier survival curves were constructed by inputting events occurring at given time 
points into GraphPad Prism 7. Survival proportions at each time point were calculated and a 
log-rank (Mantel-Cox) test was conducted to statistically compare differences between two 
curves. 
3.3.7 Lifespan models  
A novel Bilogistic model with 5 parameters capable of fitting biphasic data was constructed 
(Equation 1). The f parameter splits the curve into two phases giving a weighting to each 
phase. There are two death rates k1 and k2 and two time parameters t1 and t2, representing the 
median survival for each phase. Simpler variants of this model with fewer parameters were 
also constructed where the two death rates were the same (k1 = k2), the two phases had equal 
weight (f = 0.5), or there existed only one phase (f = 0). The terms in the numerator make sure 
that for t = 0 the pre-factor of the function is N0, which is typically rescaled in each experiment 
to be 100%. The first derivative of the Bilogistic 5-parameter model is proportional to the hazard 
for each subpopulation over time (Equation 2). 
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𝑁(𝑡) = 𝑁0 [𝑓
1 + 𝑒−𝑘1𝑡1
1 + 𝑒𝑘1(𝑡−𝑡1)
+ (1 − 𝑓)
1 + 𝑒−𝑘2𝑡2
1 + 𝑒𝑘2(𝑡−𝑡2)
] 
Equation 1: Bilogistic 5-parameter model 
𝑑𝑁
𝑑𝑡
= 𝑁0 [
𝑓𝑘1(𝑒
−𝑘1𝑡1 + 1)𝑒𝑘1(𝑡−𝑡1)
(1 + 𝑒𝑘1(𝑡−𝑡1))2
+
(1 − 𝑓)𝑘2(𝑒
−𝑘2𝑡2 + 1)𝑒𝑘2(𝑡−𝑡2)
(1 + 𝑒𝑘2(𝑡−𝑡2))2
] 
Equation 2: First derivative of the Bilogistic model 
The six other models which have been previously been used to characterise survival data 
were: Whiting-Buchanan Model (Equation 3; (Whiting and Buchanan, 1993)), Gompertz-
Makeham (Equation 4; (Makeham, 1860, Gompertz, 1825) Logistic Model (Equation 5; 
(Pletcher et al., 2000)), Wilsons’ 2-parameter Model (Equation 6; (Wilson, 1994)), Weibull 
Model (Equation 7; (Weibull, 1951)) and Gompertz Model (Equation 8; (Gompertz, 1825)).  
𝑁(𝑡) = 𝑁0 [𝑓
1 + 𝑒−𝑘1𝑡𝑙𝑎𝑔
1 + 𝑒𝑘1(𝑡−𝑡𝑙𝑎𝑔)
+ (1 − 𝑓)
1 + 𝑒−𝑘2𝑡𝑙𝑎𝑔
1 + 𝑒𝑘2(𝑡−𝑡𝑙𝑎𝑔)
] 
Equation 3: Whiting-Buchanan Model 
𝑁(𝑡) = 𝑁0(𝑒
−𝑐𝑡−
𝑎
𝑏
(𝑒(𝑏𝑡)−1) 
Equation 4: Gompertz-Makeham Model 
𝑁(𝑡) =
𝑁0
1 + 𝑒
𝑡−𝑡𝑙𝑎𝑔
𝑘
 
Equation 5: Logistic Model 
𝑁(𝑡) =
𝑁0
1 + (
𝑡
𝑡𝑙𝑎𝑔
)
𝑘 
Equation 6: Wilson Model 
𝑁(𝑡) = 𝑁0(𝑒
−(𝑎𝑡)𝑏) 
Equation 7: Weibull Model 
𝑁(𝑡) = 𝑁0 (𝑒
−
𝑎
𝑏
(𝑒(𝑏𝑡)−1)) 
Equation 8: Gompertz Model 
The MATLAB (MathWorks) curve fitting toolbox (R2016a, v9.0.0.370719) was used to fit data 
using a non-linear least squared fit method (Trust-Region algorithm) to estimate parameters. 
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All models can be used in common statistical analysis packages, such as GraphPad Prism 7 
for curve fitting (nonlinear regression), parameter estimation and goodness-of-fit tests 
including residual analysis and RMSE. 
3.3.8 Residual analysis 
Residual analysis was conducted to identify how well each model fits experimental data points 
for each data set. This method is an indicator of goodness of fit and allows for the comparison 
of the different models. Residual differences for each experimental realisation in a single data 
set was collated into a single set. This data was smoothed by a data binning procedure. Data 
bin sizes was dependent on the species, number of experimental realisations, number of 
residual data points per day and total length of lifespan. Residual plots which show the smallest 
errors or deviations throughout the lifespan indicate the best overall fit. 
3.3.9 Root mean square error 
The root mean square error (RMSE) was used for the goodness of fit statistical analysis of the 
different models using MATLAB (MathWorks, R2016a, v9.0.0.370719). It represents the model 
performance and lower values of RMSE indicate better fit. The statistical significance between 
two groups was examined using two-way analysis of variance (ANOVA) followed by Tukey’s 
multiple comparison tests using GraphPad Prism 7. Statistical p-values p<0.05, p<0.01, 
p<0.001 and p<0.0001 shows a statistically significant difference between groups and is 
indicated in the figures. 
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3.4 Results 
3.4.1 Modelling the effect of temperature on C. elegans 
The nematode worm C. elegans is a commonly used organism for studying lifespan. As 
previously described (section 1.4), cooler temperatures extend the lifespan of the worm and 
hotter temperatures shorten it (Klass, 1977). In this study, the lifespan curves in response to 
four temperatures (15C - 30C; Figure 3.1a) were used to model the effect of temperature on 
C. elegans survival. A novel Bilogistic model (Equation 1) was constructed to fit biphasic 
lifespan curves which was observed from the experimental data (Figure 3.1a). The parameters 
of this Bilogistic model are as follows: the f value (which denotes the weighting or proportion 
of the two phases), the death rates k1 and k2 and median survival times t1 and t2 for each of 
the phases (Figure 2.4). The Bilogistic model was used to fit the lifespan data points (Figure 
3.1b) and visually, it was able to capture both monophasic and biphasic dynamics of all of the 
lifespan curves.  
The first derivative of the fitted curves is proportional to the hazard of death for each of the 
phases over time (Equation 2). The phases represent a short-lived (1st phase) and a long-lived 
subpopulation (2nd phase). Increasing the temperature increased the hazard of both phases 
(Figure 3.1c, d). Changes to parameters due to temperatures were also investigated. 
Increasing temperature did not affect the proportion of each phase (the f value; Figure 3.1e) 
but showed a significantly reduced the median survival of both phases (t1 and t2; Figure 3.1f). 
Furthermore, the significant difference between t1 and t2 at 15°C and 20°C revealed the two 
distinct phases. With higher temperatures an increase in the rate of death in the 2nd phase 
although not statistically significant was seen, i.e. the long-lived subgroup died faster (k2; 
Figure 3.1g) and the larger number of deaths in the 1st phase masked the 2nd phase, resulting 
in overlapping phases (Figure 3.1c, d, f, g). In such cases the separation of phases has to be 
interpreted with caution. 
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Figure 3.1: C. elegans lifespan displays biphasic dynamics. (a) Representative lifespan of 
control N2 worms maintained at different temperatures (15C, 20C, 25C and 30C). (b) 
Curves fitted to the data shown in a. (c, d) Comparison of 1st (c) and 2nd (d) phases of lifespan 
curves of N2 worms maintained at different temperatures. The phases were obtained from 1st 
order differentiation of fitted lifespan curves. (e-g) Quantification of parameters estimated for 
lifespan curves of N2 worms maintained at 15°C (n=20), 20°C (n=15), 25°C (n=14) and 30°C 
(n=3). Data is shown as mean ± SEM. **** p<0.0001. 
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Taken together, these data showed that the Bilogistic model is able to fit lifespan data and 
distinguish the biphasic properties of the data. Unlike other models which assumed 
monophasic dynamics (Stroustrup et al., 2016, Petrascheck and Miller, 2017, Pletcher et al., 
2000, Weibull, 1951, Gompertz, 1825), this model separated lifespan into 2 subpopulations 
(short- or long-lived) and calculated the effect of temperature on both the death rates and the 
median survival of each groups. 
3.4.2 Analysis of lifespan models by goodness of fit test 
As the 5-parameter Bilogistic model is able to fit biphasic lifespan data it was then compared 
to other published models and the number of parameters were reduced to test whether it was 
possible to simplify the model. Many existing lifespan models contain 2 to 4 parameters 
(Gompertz, 1825, Weibull, 1951, Wilson, 1994, Whiting and Buchanan, 1993, Makeham, 
1860), but other proposed models can have up to 10 parameters (de Beer et al., 2017, Siler, 
1979). The following simplifications were considered to reduce the model to 4 parameters: a 
single death rate (where k1 is equal to k2), a fixed f to be either 0.5 (equal weight of phases) or 
0 (a single phase). Further simplifications were made to reduce the parameters to 3: a fixed f 
to 0.5 and k1 equal to k2 so phases had equal weighting and a single death rate, or a fixed f to 
an average of previously calculated f’s and k1 equal to k2. The Bilogistic model and an 
assortment of commonly used lifespan models (see Methods, Equations 3-8) were fitted to the 
data from C. elegans maintained at 20C (the standard culture temperature; Figures 3.2a-i). 
Visual inspection of representative experimental data indicates that the full model is able to 
accurately fit the data points well and clearly suggests the existence of two phases. In many 
of the other models there were systematic deviations in the fittings and therefore many did not 
capture the biphasic nature of the survival curve (see Figure 3.2d-i).  
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Figure 3.2: Fitting of a representative lifespan curve by different models. (a-i) Representative 
lifespan curve of N2 worms maintained at 20°C was fitted with a panel of lifespan models. 
Reducing the number of parameters in our Bilogistic model results in poorer fit of the data. 
 
In order to confirm or reject this observation and to compare the goodness of fit of the 
parametric models, the residual differences between actual experimental lifespan data points 
and fitted model curves for each data set were calculated. Residual differences for each 
realisation in a data set was collated and underwent a data binning procedure by days to 
smooth data. In the C. elegans data, residuals were grouped into bins of 2, 3 or 4 days and 
plotted (Figures 3.3a-i). The Bilogistic model shows the smallest residual error with minimal 
systematic deviations in all bins (Figure 3.3a-i) when compared to the other models (Figure 
3.4), indicating that it is the most complete fit fully able to capture biphasic lifespan data. The 
two 3 parameter variants of the Bilogistic model was also fitted to lifespan data (Figure 3.5 a, 
b) and residuals were collated and binned into groups of 2, 3 or 4 days to smooth data (Figure 
3.5 c, d). These two simplified variants were compared to the 5-parameter Bilogistic model and 
show a greater residual error (bin 3) indicating that the simplified models are unable to capture 
biphasic lifespan data (Figure 3.5 e, f). Similar residual analysis was conducted at 15°C, 25°C 
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and 30°C which all show similar findings that the 5-parameter Bilogistic model shows the 
smallest residual error (Figures 3.6, 3.7, 3.8).  
 
 
Figure 3.3: Analysis of lifespan models by residual difference analysis. (a-i) The residual 
differences between the experimental data and the fitted curve from individual models were 
calculated (grey dots) and data was grouped into bins of 2, 3, or 4 days (red, blue and purple 
lines respectively). Smaller residual differences indicate better fit. Data is from 15 replicate 
experiments. 
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Figure 3.4: Comparison of Bilogistic model against other lifespan models. (a-h) Residual 
difference analysis of the Bilogistic model (red) against either simplified variants or other 
lifespan models (black). Binning was set to 3 days. Smaller residual differences indicate better 
fit. Data is from 15 replicate experiments. 
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Figure 3.5: Analysis of variants of Bilogistic model. (a, b) Representative lifespan of C. elegans 
worms maintained at 20oC were fitted with the Bilogistic model where either k1=k2 and f=0.5 
(a) or k1=k2 and f=Avg (b). (c, d) Residual differences between the experimental data and the 
fitted curve from each model were calculated (grey dots) and data was grouped into bins of 2, 
3, or 4 days (red, blue and purple lines respectively). (e, f) Comparison of the residual 
differences from Bilogistic model (red) against either simplified variants (black). Binning was 
set to 3 days. Smaller residual differences indicate better fit. Data is from 15 replicate 
experiments. 
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Figure 3.6: Analysis of lifespan models by residual difference analysis in C. elegans 
maintained at 15°C. The residual differences between the experimental data and the fitted 
curve from individual models were calculated (grey dots) and data was grouped into bins of 2, 
3, or 4 days (red, blue and purple lines respectively). Smaller residual differences indicate 
better fit. Data is from 20 replicate experiments. 
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Figure 3.7: Analysis of lifespan models by residual difference analysis in C. elegans 
maintained at 25°C. The residual differences between the experimental data and the fitted 
curve from individual models were calculated (grey dots) and data was grouped into bins of 2, 
3, or 4 days (red, blue and purple lines respectively). Smaller residual differences indicate 
better fit. Data is from 14 replicate experiments. 
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Figure 3.8: Analysis of lifespan models by residual difference analysis in C. elegans 
maintained at 30 °C. The residual differences between the experimental data and the fitted 
curve from individual models were calculated (grey dots) and data was grouped into bins of 2, 
3, or 4 days (red, blue and purple lines respectively). Smaller residual differences indicate 
better fit. Data is from 3 replicate experiments. 
 
 
For a more quantitative measure, the RMSE was also calculated for each model fitted curve. 
This type of analysis took into account the varying number of parameters present in each 
model (by applying greater penalties to models with more parameters) and therefore  
represented an unbiased model performance (Chai and Draxler, 2014). Using the lifespan data 
of C. elegans maintained at 20°C, the Bilogistic model showed significantly lower RMSE values 
compared to existing models (Figure 3.9). Similarly, significantly lower RMSE values using 
data from worms maintained at 15°C, 25°C and 30°C (Figure 3.10) were observed. Thus, the 
unbiased analysis of RMSE showed that the Bilogistic model is significantly better at fitting 
lifespan curves of C. elegans across different temperatures. 
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Figure 3.9: Analysis of goodness of fit by root mean square error (RMSE). The RMSE for each 
lifespan models was compared to either the Bilogistic model (a) or to variants where k1=k2 (b) 
or f=0 (c). Lower values of RMSE indicate better fit. (d) Significance comparison for the 
Bilogistic model and variants against other lifespan models. The scale represents the p-value 
statistical significance (from no significance (0) to **** (4)).  Data is shown as RMSE ± SEM, 
n=15.  * p<0.05, ** p<0.01***, p<0.001, and **** p<0.0001. 
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Figure 3.10: Goodness of fit testing for C. elegans at 15oC and 25oC. The root mean square 
error (RMSE) was calculated from model fitting of lifespan data of C. elegans maintained at 
either 15oC (a, c, e, f; n=20) or 25oC (b, d, f, h; n=14), and compared to either the Bilogistic 
model (a) or to variants where k1=k2 (b) or f=0 (c). Smaller values of RMSE indicate better fit. 
(g, h) Significance comparison for the Bilogistic model and variants against other lifespan 
models. The scale represents the p-value statistical significance (from no significance (0) to 
**** (4)). Data is shown as RMSE ± SEM.* p<0.05, ** p<0.01, ***p<0.001, and ****p<0.0001. 
 
 
3.4.3 Conserved effects of daf-16/FOXO deletion on lifespan 
As the model had only been tested on wild type (N2 worms) alternative conditions were 
investigated. As genetics play a major role in lifespan it was tested whether the model could 
be applied to measure the effects of genetic manipulations on lifespan. The daf-16(mu86) 
mutation where worms are lacking DAF-16 (FOXO ortholog in nematodes) which is known to 
play a critical role in regulating lifespan (Kenyon et al., 1993) was considered. As expected, 
this resulted in a significantly shorter lifespan (Figure 3.11a), which could be fitted with the 
Bilogistic model (Figure 3.11b). The hazard showed that the loss of DAF-16 affected both 
phases of the survival curve (Figure 3.11c, d), primarily due the convergence of both phases 
(t2; Figure 3.11e) which is the result of an increased rate of death of the 2nd subpopulation (k2; 
Figure 3.11f). As sharp drops in a lifespan curve correspond to many death events in a short 
time and hence few data points, all parameter values derived from fitting procedures have to 
be assessed individually and with caution. 
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Figure 3.11: daf-16(mu86) deletion in C. elegans shortens lifespan by increasing rate of death 
in second phase. (a) Representative lifespan curves of N2 and daf-16(mu86) worms 
maintained at 20°C and (b) fitted with the Bilogistic model. The strong dip for the mutants 
corresponds to only few data points and the fitting has to be interpreted with caution. (c, d) 
Comparison of 1st (c) and 2nd (d) phases of lifespan curves of N2 and daf-16(mu86) worms, 
obtained from 1st order differentiation of fitted curves. (e, f) Quantification of parameters 
estimated for lifespan curves of N2 (n=9) and daf-16(mu86) (n=5) mutant worms. Data is 
shown as mean ± SEM. *p<0.05 and ****p<0.0001.  
 
It was hypothesised that the effects of FOXO loss-of-function on lifespan are conserved in 
other organisms. To test this, the lifespans of Drosophila melanogaster lacking FOXO 
(dfoxoΔ), which also have a shorter lifespan than their control (wDah) (Slack et al., 2011) (Figure 
3.12a) was analysed (Figures 3.12b). The effects of dfoxo deletion in Drosophila mirrored the 
findings from the daf-16(mu86) worms as a higher hazard in both 1st and 2nd phases in dfoxoΔ 
flies (Figure 3.12c, d), with an earlier median survival for the 2nd phase (Figure 3.12e) due to 
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the observed increased 2nd phase death rate (k2, Figure 3.12f). Additionally the fitted data and 
residuals from drosophila were analysed indicating that the Bilogistic model has the lowest 
residual error indicating a better fit in both wDah and dfoxoΔ mutants Figure (3.13 and 3.14).  
Taken together, the Bilogistic model is able to fit and detect the effects of nematode daf-
16(mu86) and Drosophila dfoxoΔ mutation on lifespan. Importantly, the Bilogistic model found 
that daf-16/FOXO mutations resulted in similar changes in the lifespan curves in both 
organisms; The longer-lived subgroup in the mutant population started dying earlier and faster.  
 
Figure 3.12: Mutation of dFOXO in D. melanogaster shortens lifespan by increasing rate of 
death in second phase. (a) Representative lifespan curves of wild type (wDah) and FOXO 
mutant (dfoxoΔ) flies and (b) fitted with the Bilogistic model. (c, d) Comparison of 1st (c) and 
2nd (d) phases of lifespan curves of wDah and dfoxoΔ flies, obtained from 1st order differentiation 
of fitted curves. (e, f) Quantification of parameters estimated for lifespan curves of wDah and 
dfoxoΔ flies. Experimental data shown (a) was collected by Cathy Slack. Data is shown as 
mean ± SEM, n=10. *p<0.05, **p< 0.01, ***p< 0.001, and **** p<0.0001.  
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Figure 3.13: Analysis of lifespan models by residual difference analysis in wDah drosophila. 
Residual differences between the experimental data and the fitted curve from each model were 
calculated (grey dots) and data was grouped into bins of 5 days (red line). Smaller residual 
differences indicate better fit. Data for wDah drosophila (a-g) is from 10 replicate experiments. 
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Figure 3.14: Analysis of lifespan models by residual difference analysis in dFOXOΔ 
drosophila. Residual differences between the experimental data and the fitted curve from each 
model were calculated (grey dots) and data was grouped into bins of 5 days (red line). Smaller 
residual differences indicate better fit. Data for dFOXOΔ drosophila (a-g) is from 10 replicate 
experiments. 
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3.4.4 Modelling type-2 survivorship in honey bees 
Having modelled type-1 survival curves for the worms and flies, type-2 survivorship pattern 
(Demetrius, 1978) as observed in hived bees were tested to see if they could be modelled by 
analysing the lifespan of honey bees (Apis mellifera carnica) maintained in either hived or 
caged colonies (Figure 3.15a) (Sakagami and Fukuda, 1968, Woyciechowski and Moron, 
2009). Additionally hived and caged bees show differences in survival and were investigated 
to see if the Bilogistic model is capable of identifying differences between the two. The log-
rank test could not reliably distinguish differences in the survival of the two populations. Of the 
4 replicates, 2 did not show significantly differences, the 3rd dataset showed significant 
differences between the two conditions at p<0.05, and the final dataset at p<0.001. However, 
by using the Bilogistic model to fit the data for both hived and caged bees, statistical 
comparison using all 4 replicates can be made (Figures 3.15b). A higher hazard for hived bees 
in the 1st phase was observed (Figure 3.15c) whilst most caged bees died in the 2nd phase 
(Figure 3.15d). Analysis of the model parameters between hived and caged bees showed a 
delayed median survival for the 1st phase (t1) for caged bees (Figure 3.15e) and a reversal of 
the 1st and 2nd phase death rates (k1 v k2; Figure 3.15f) presumably due to absence of external 
hazards such as predators and weather conditions (Woyciechowski and Moron, 2009). Once 
again the Bilogistic model shows a superior fitting to lifespan data compared to other models 
in both hived and caged bees (Figure 3.16, 3.17).  
These results therefore showed that the Bilogistic model detected biphasic behaviour in type-
2 survivorship data from hived bees, and caging the bees reduced the numbers in the short-
lived group. 
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Figure 3.15: Caged carniolan honeybees (A. mellifera carnica) display increased lifespan 
compared to hived bees due to increased 1st phase survival. (a) Representative lifespan curves 
of caged and hived honeybees and (b) fitted with the Bilogistic model. (c, d) Comparison of 1st 
(c) and 2nd (d) phases of lifespan curves of caged and hived honeybees, obtained from 1st 
order differentiation of fitted curves. (e, f) Quantification of parameters estimated for lifespan 
curves of caged and hived honeybees. Experimental data shown (a) was collected by Karolina 
Kuszewska and Michał Woyciechowski. Data is shown as mean ± SEM, n=4. *p<0.05, **p< 
0.01, and ****p< 0.0001.  
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Figure 3.16: Analysis of lifespan models by residual difference analysis in hived bees. 
Residual differences between the experimental data and the fitted curve from each model were 
calculated (grey dots) and data was grouped into bins of 4 days (red line). Smaller residual 
differences indicate better fit. Data for hived bees (a-g) is from 4 replicate experiments. 
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Figure 3.17: Analysis of lifespan models by residual difference analysis in caged bees. 
Residual differences between the experimental data and the fitted curve from each model were 
calculated (grey dots) and data was grouped into bins of 4 days (red line). Smaller residual 
differences indicate better fit. Data for caged bees (a-g) is from 4 replicate experiments. 
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3.4.5 Application to mammalian lifespan 
Importantly it was assessed whether the model could be used for investigating mammalian 
lifespan data. In particular, survival data from one of the most common animal models, the 
mouse, kindly provided by the National Institute for Aging (NIA) Interventions Testing 
Program (ITP) was examined (Miller et al., 2014). Rapamycin treatment was shown to result 
in a significant extension of lifespan in both male and female UM-HET3 mice (Miller et al., 
2014) (Figure 3.18a). The Bilogistic model could fit the data well (Figures 3.18b) and could 
allow for statistical comparison of all the replicates to be conducted. The Bilogistic model 
revealed that the onset of the 1st phase is sexually dimorphic, as in males but not in females, 
rapamycin delayed the onset of the 1st phase (Figure 3.18c, compare blue control and green 
rapamycin lines, Figure 3.18e). In both sexes, rapamycin delayed the onset of the 2nd phase 
(Figure 3.18d, e). Thus, in females, rapamycin emphasised the biphasic nature of their 
survival data (Figure 3.18e). Additionally, there is an earlier 1st phase median survival in 
control males than control female mice a further indication of sexual dimorphism (Figure 
3.18e). Rapamycin therefore appeared to exert its effects on lifespan via alterations to the 
time-lag phases rather than through changes to the death rates (Figure 3.18f). In agreement 
with fitting of lifespan data from other model organisms once again the Bilogistic model is 
able to fit lifespan data better than other model as the residual error in all four groups is 
lowest with the Bilogistic model (Figure 3.19, 3.20, 3.21, 3.22).  
The Bilogistic model was thus able to fit mouse lifespan data as biphasic dynamics and is likely 
to fit other mammalian lifespan data. The parameter analysis suggests that rapamycin delays 
the onset of the death but not the rate of death 
 
100 
 
 
Figure 3.18: Rapamycin differentially increases lifespan in male and female UM-HET3 mice 
(M. musculus). (a) Representative lifespan curves of male and female UM-HET3 mice treated 
with and without rapamycin (42ppm; mg/kg) and (b) fitted with the Bilogistic model. (c, d) 
Comparison of 1st (c) and 2nd (d) phases of lifespan curves of male and female mice treated 
with and without rapamycin, obtained from 1st order differentiation of fitted curves. (e-f) 
Quantification of parameters estimated for lifespan curves of male and female mice treated 
with and without rapamycin. (MC= Male control, FC= Female control, MR= Male rapamycin 
treated, FR= Female rapamycin treated). Experimental data shown (a) was provided by the 
National Institute on Aging (NIA) Interventions Testing Program (ITP). Data is shown as mean 
± SEM, n=3. *p< 0.05, **p< 0.01, and ****p< 0.0001. 
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Figure 3.19: Analysis of lifespan models by residual difference analysis in male mice. Residual 
differences between the experimental data and the fitted curve from each model were 
calculated (grey dots) and data was grouped into bins of 100 days (red line). Smaller residual 
differences indicate better fit. Data for male mice (a-g) is from 3 replicate experiments. 
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Figure 3.20: Analysis of lifespan models by residual difference analysis in female mice. 
Residual differences between the experimental data and the fitted curve from each model were 
calculated (grey dots) and data was grouped into bins of 100 days (red line). Smaller residual 
differences indicate better fit. Data for female mice (a-g) is from 3 replicate experiments. 
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Figure 3.21: Analysis of lifespan models by residual difference analysis in rapamycin treated 
male mice. Residual differences between the experimental data and the fitted curve from each 
model were calculated (grey dots) and data was grouped into bins of 100 days (red line). 
Smaller residual differences indicate better fit. Data for male mice (a-g) is from 3 replicate 
experiments. 
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Figure 3.22: Analysis of lifespan models by residual difference analysis in rapamycin treated 
female mice. Residual differences between the experimental data and the fitted curve from 
each model were calculated (grey dots) and data was grouped into bins of 100 days (red line). 
Smaller residual differences indicate better fit. Data for female mice (a-g) is from 3 replicate 
experiments. 
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3.5 Discussion 
This chapter has focused on introducing a novel 5-parameter Bilogistic model which is capable 
of fitting biphasic lifespan data. Additionally, this Bilogistic model was compared against a 
number of existing models and reduced versions of the Bilogistic model with fewer parameters. 
Furthermore, the Bilogistic model was used to model lifespan in a number of different animal 
models. In these animal models, lifespan modifiers such as genetic, pharmacological and 
environmental factors were quantitatively measured whilst taking into account multiple 
replicates.  
Lifespan and survival are the results of a wide range of complex interactions within and 
amongst individual organisms, which makes discerning the effects of lifespan modifiers a 
challenging task. The log-rank test coupled to the Kaplan-Meier estimator works as a basic 
statistical test (Kaplan and Meier, 1958), comparing two curves and indicating whether they 
are statistically significantly different. With this testing methodology, there are two principal 
problems. The first lies in testing biological replicates as they often do not consistently show 
the same magnitude of effects. It is good experimental practice to observe similar results 
before reaching a conclusion and it is also good practice to compare the average of a control 
group to the average of a test group. Unfortunately, it is not possible to average different 
(Kaplan-Meier) lifespan curves due to differences in time of death. The second problem is due 
to the log-rank test not providing any further insight into where the difference lies i.e. the rate 
of death or the time of death. 
Parametric models such as Gompertz and Weibull have previously been used to analyse and 
interpret such data (Lawless, 2014). By nature of using only two parameters, these models 
propose that lifespan follows a monophasic gradient (Vaupel et al., 1994) or shifts the lifespan 
curves along the time axis (Stroustrup et al., 2016). However, this assumes a monophasic 
lifespan with a uniform distribution throughout the lifespan, which is clearly not the case in 
many instances, furthermore biphasic dynamics can be more pronounced depending on 
experimental conditions or animal strains (Lucanic et al., 2017, Zhang et al., 2016). Note that 
the asymmetric shape of the Gompertz (and Gompertz-Makeham) curves can be referred to 
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as a biphasic, but this does not capture the dynamics described here as there is not an explicit 
exponential age-dependent component. These models also lack flexibility on the timing of 
biphasic dynamics and therefore fail to capture biphasic dynamics which are expressed during 
earlier or midway through the lifespan curves. 
The experimental data clearly displays biphasic dynamics in certain conditions (e.g. C. elegans 
wild type (N2 strain) at 20C, daf-16(mu86)). Furthermore, it has recently been reported that 
analysis of the pharynx of C. elegans corpses revealed two distinct death types which could 
be separated as occurring at an early and late phase (Zhang et al., 2016, Zhao et al., 2017). 
Thus, the timing of these phases seems to correlate well with this death phases shown by the 
Bilogistic model. Clearly the shape of the lifespan curve can reveal important clues to the action 
of lifespan modifiers. For example, both high temperature and loss of daf-16/dfoxoΔ increase 
the death rate in the 2nd phase in both worms and flies, suggesting that, in both organisms, the 
initiating events for death occur in the 1st phase. Rapamycin acts via delaying the onset of 
death in male but not female mice and has no effect on the rate of death. However, the death 
rate of bees is dependent on the level of external hazards, which is quite different for free flying 
and caged bees. The safe environment of the cages decreases the 1st phase death rate but at 
the same time it increases the 2nd phase death rate, most likely due to the fact that the bees 
are unable to leave the cage to carry out their dangerous foraging. Although the experimental 
organisms are isogenic, lifespan analysis shows that sub-populations of short- and long-lived 
individuals exist. The present analysis does not reveal the mechanisms behind the observed 
biphasic dynamics, although the wide range of lifespan modifiers may suggest a poly-
mechanistic explanation. As the animal models are not closely related phylogenetically, this 
points towards a general mechanism operating on populations rather than on a specific 
conserved trait. It can only be speculated that the first phase corresponds to the growth and 
maturation of the organism (c.f. adolescence and adulthood) and the second phase to the 
post-maturation and the start of senescence.  
As the shape of survival distribution is important (Wrycza et al., 2015), it is therefore crucial 
that parametric models capture the data as accurately as possible without smoothing important 
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aspects. Building on current parametric analysis, this study proposes a novel biphasic model 
which is able to model lifespan data in a variety of organisms commonly used for ageing 
research. The experimental data and residual differences for the Bilogistic model, its variants 
and several previously characterised parametric models have been carefully analysed. For 
each animal model used, i.e. worms, flies, bees and mice, the Bilogistic model performs better 
in fitting lifespan data compared to other models. By comparing it to simplified variants of the 
Bilogistic model it assesses the possibility that by using 5 parameters the model is overfitting 
the data. In some cases, lifespan modifiers do not significantly affect the weighting between 
the two phases (f; Table 3.1), suggesting one parameter can be removed by fixing f to 0.5. 
However, at least for the data sets studied, taking less than 5 parameters still weakens the 
general model’s ability to fit the experimental data, particularly in individual cases. The model 
can be interpreted as an extension of a simple logistic model and a modification of the Whiting-
Buchanan model (Whiting and Buchanan, 1993) with two instead of one time lag phase. A 
generalization to a triphasic model would be straightforward but is beyond the scope of this 
thesis.  
As typical for survival models using logistic functions, it has not been derived from first 
principles, but is justified a posteriori due to its high predictive capacity. The results here agree 
with previous findings that logistic fittings provide better results than Gompertz-Makeham or 
Weibull fittings (Vanfleteren et al., 1998, Yashin et al., 2000), although the differences become 
clearly significant only for the full Bilogistic model. While five parameters might seem two too 
many, equations with up to 8 and 10 parameters have also been suggested (Siler, 1983, 
Heligman and Pollard, 2012). Based on goodness of fit testing and residual analysis, it is 
proposed that the full 5-parameter Bilogistic model is the preferred model to fit the majority of 
experimental lifespan data, although a reduced variant may be sufficient to fit other 
experimental data. 
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Furthermore, the Bilogistic model is preferred to traditional methods as it allows statistical 
comparison of experimental replicates, an important analytical step which is lacking in many 
lifespan experiments. Unfortunately, in an increasing number of studies lifespan assays are 
only conducted in duplicate, with no statistical analysis of the replicates therefore resulting in 
weaker evidence which leads to the possibility of mistaken conclusions. In this study, a 
relatively large number of replicates has been used for each animal model. Backed up with 
the ability of this model allowing for a statistical analysis of the parameters, it provides 
confidence in the survival curves thus opening up the possibility to get insights into the 
mechanisms of action of the lifespan modifiers. Additionally, this model can be used to fit 
experimental lifespan data by easily inserting it in to commonly used statistical analysis 
programs such as GraphPad Prism and XLfit and programming languages such as MATLAB 
and R. Parameters from the curve fitting can then be grouped and statistically analysed. While 
other parametric and non-parametric models beyond Kaplan-Meier exist, their uptake by life 
scientists has been poor.  
3.5.1 Future work 
It is thought that this study will compel other researchers to use parametric modelling on their 
lifespan data making it a more prevalent approach. In addition to this this novel Bilogistic 
model has the potential to be useful in other fields of study. Many areas of research collect 
time to event data for example investigating bacterial or tumour growths and this model may 
provide an insight into the dynamics over time. Furthermore, application of this Bilogistic 
model to the lifespan of other model organisms will ascertain the possibility of universal 
lifespan properties across different species. 
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3.6 Conclusions 
In conclusion, this chapter proposes a new parametric model for analysing lifespan assays. 
Having shown it is able to fit experimental data from a variety of animal models such as 
worms, flies, bees and mice, all of which exhibit biphasic dynamics and having carefully 
considered the danger of overfitting the experimental data residual difference analysis and 
goodness of fit tests show that the Bilogistic model offers a better fit than existing models. 
Finally, analysis of the parameters from curve fitting enables comparison of lifespan assays 
both within similar groups and among different experimental conditions and clearly offers an 
improvement on detecting the timing and magnitude to which lifespan modifiers are affecting 
survival. This novel Bilogistic model is therefore expected to facilitate the rational analysis of 
lifespan modifiers, e.g. through genetic analysis of long vs short lived sub-populations 
(Tissenbaum, 2012, Zhao et al., 2017), and improve understanding of their mechanisms of 
action. 
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Chapter 4.0: Modelling thermal 
intervention in C. elegans 
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4.1 Preface 
Ageing research has focused on identifying lifespan modifiers and the extent to which they 
modify lifespan. A bigger challenge lies in investigating the dynamic effect of interventions 
which act to modify lifespan, such as genetic switches, environmental conditions and 
pharmacological treatment. In this section, the effects of switching temperatures (thermal 
intervention) from low to high and vice-versa on lifespan are investigated. Two predictive 
models, (which use the novel 5-parameter Bilogistic model) are proposed to model the effects 
of thermal intervention and are based upon either chronological age or biological age. Using 
average lifespan as a measure, the biological model is observed to better represent the 
experimental data from C. elegans subjected to thermal intervention. Additionally, the models 
predict critical time points for intervention such as the last possible time point for thermal 
intervention to affect lifespan and also time points at which it is too late for intervention to 
affect lifespan. Finally, further investigation is conducted into the temperature sensitive TRPA-
1 channel protein in thermal determination of lifespan and lifespan intervention. 
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4.2 Introduction 
4.2.1 The ageing complexity 
Over the last few centuries, the lifespan of humans has increased resulting in a greater 
number of elderly people in the population. This is due to the sharp increase in improved 
standards of living, improved healthcare systems, advancement in biomedical and 
biotechnologies and lifestyle changes leading to a healthier lifestyle and genetic differences 
which collectively play a role to extend lifespan. This results in an increased prevalence of a 
number of ageing-related diseases which is plaguing the elderly and is driving up the cost of 
healthcare (Bansal et al., 2015). 
4.2.2 Chronological age as a measure of ageing 
Over the past few decades, lifespan or chronological age has been used as a surrogate 
measurement for the ageing process (Klass, 1977). Lifespan is clearly defined as a 
measurement of an organism’s survival over time. This definition allows for easy 
measurement which is conducted by simple survival assays. Although extremely easy to 
conduct, there are positive and negative qualities in its ability to act as a measure of ageing. 
The chronological age of an individual is a measurement of lifespan. However, as a measure 
of ageing it is less meaningful due to intra individual variation. Population studies and the 
measurement of average lifespan of a population to generate survival curves are more useful 
and accurate measures of ageing. 
4.2.3 Biological age as an alternative measure of ageing 
Biological age is an alternative measure of the ageing process. Unlike chronological age 
which measures the time passed since birth, biological age is calculated from multiple 
different parameters which act as biomarkers of an organism’s bodily function and its 
deterioration over time. Greater deterioration of the bodily functions which these biomarkers 
characterise result in a higher biological age. However, measurement of biological age is 
difficult because there is not a single direct measure. Biomarkers can be either lifestyle factors 
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or biomedical factors which can be investigated individually or collectively as a population to 
give a measure of biological age. However, these single tests of biomarkers show high inter- 
and intra- individual variability, making it difficult to extrapolate from a population, particularly 
when investigating treatments or intervention (Levine et al., 2018, Kato et al., 2006).  
4.2.3.1 Healthspan 
Healthspan is a measure linked to biological age but does not have a single universally 
accepted definition. Therefore, a standardised measure must be implemented before it can 
be widely used to act as a surrogate measure of ageing. One definition is that healthspan is 
a measure of the disease free or healthy time period of an individual’s lifespan (Kaeberlein, 
2018). Healthspan is characterised by a number of measures which identify if an individual is 
in a healthy state. Different studies measure a number of different parameters making it 
difficult to measure all of them and also difficult to standardise the measurements (Bansal et 
al., 2015). Coincidentally (or not) improvements to healthspan result in an increase in lifespan 
(Richardson et al., 2016). 
4.2.3.2 Frailty Index and lifespan 
Frailty index is another measure which determines the health status of an individual by looking 
at an index of health biomarkers and calculating healthy and frail (in deficit) proportions 
(Searle et al., 2008). Lifespan studies are able to provide data at various time points in which 
there is a proportion of the population that is in deficit (dead) and the remaining population 
which is alive and not in deficit. This assumption has been studied and found that the frailty 
index in humans and mice is a predictor of mortality (Rockwood et al., 2017, Goggins et al., 
2005). 
4.2.4 Importance of timing of intervention 
Lifestyle change or pharmacological interventions are often implemented to prevent diseases 
so that individuals age more resiliently and healthily resulting in an improved healthspan (or 
reduced frailty) and a ‘younger’ biological age. The timing of these interventions is also 
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extremely important and it is reasonable to assume that the success of the intervention will 
only occur within a time window in which the internal mechanism is susceptible to change. 
When investigating the effects of intervention both biological age and chronological age are 
important factors. However, as chronological age measurements have a single measure and 
can be conducted more easily than biological age they should be used first as a basic 
measure of intervention testing. Then, they should be verified and further analysed 
mathematically by parametric analysis to gain maximum information on the effects of 
intervention on a population (see chapter 3). Similarly, investigations can also be carried out 
to identify and understand the effect of different interventions on lifespan and also how the 
timing of the intervention affects the lifespan of the population. 
4.2.5 The role of temperature on lifespan 
There are many external environmental stimuli which can act as an intervention to extend 
lifespan such as diet, environment and pharmacological agents (Harrison et al., 2009, Wu et 
al., 2009). Environmental temperature is another main factor which influences lifespan, 
particularly in C. elegans. 
The inverse relationship between lifespan and temperatures is well known and preserved 
across many organisms. It has been shown that a reduction in temperature results in an 
increased lifespan of many poikilotherms such as worms, flies and fish (Klass, 1977, Loeb 
and Northrop, 1916, Liu and Walford, 1966). Similarly, in the homeothermic mouse, it has 
been shown that a reduction in core body temperature results in an increased lifespan (Conti, 
2008).  
It has previously been hypothesised that the increase in lifespan is due to a reduction in 
chemical thermodynamic reaction rates (Shaw and Bercaw, 1962). This suggests a passive 
mechanism by which lifespan is extended and is in agreement with the rate of living theory 
(Pearl, 1928). However, it is highly unlikely to be the only mechanism by which lifespan 
extension occurs. It has been proposed that a more active physiological mechanism must 
exist which acts to control lifespan changes that is seen by altering the temperature (Conti, 
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2008). Naturally a genetic approach has been taken to investigate the mechanism by which 
temperature regulated lifespan extension occurs (Lee and Kenyon, 2009, Xiao et al., 2013, 
Miller et al., 2017). 
One such proposed mechanism of temperature regulated lifespan extension is the 
somatosensory voltage dependent non-selective cation channel TRPA-1 (Transient Receptor 
potential ankyrin 1) which is expressed in many organisms including C. elegans and humans. 
TRPA-1 channels open in response to cool temperatures and act to target the master 
regulator of lifespan DAF-16 (the FOXO3 analogue) (Xiao et al., 2013). Daf-16 is a 
transcription factor with over 3000 gene targets which act to extend lifespan, and 
investigations on its targets and mechanism of action is ongoing by many groups (Tepper et 
al., 2013). This role TRPA-1 has on regulating DAF-16 makes it an attractive target for 
investigating temperature-based lifespan extension. 
4.2.6 Thermal intervention 
One simple methodology of investigating temperature intervention is to look at differences 
between high and low temperature which act as a proxy for ‘detrimental’ and ‘favourable’ 
growth conditions. Worms can be grown and switched between these conditions at different 
time points in their life to see effects of intervention upon their lifespan and to identify critical 
time points at which intervention provides a beneficial effect on lifespan. Thermal intervention 
has been studied to an extent previously. One study (Zhang et al., 2015) exposed worms to 
normal growth temperatures (20C) from eggs and switched the worms to either a high (25C) 
or low (15C) temperature at each larval stage and then back to the normal growth 
temperature (20C) at adulthood. They found that growth at a low (15C) temperature during 
developmental stages and transferring worms to normal temperature (20C) at adulthood 
results in a reduction in lifespan, but developmental growth at a high temperature (25C) and 
then switching to normal temperatures (20C) at adulthood leads to an increase in lifespan. 
They also found L1 and L2 stages were critical for the worm in determining longevity and also 
that trpa-1 was important in cold dependent lifespan extension (Zhang et al., 2015, Xiao et 
al., 2013).  
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Another study (Henderson et al., 2018) found similar results having conducted similar 
experiments whereby they exposed worms to high (25C) or low (15C) temperatures during 
development stages and switched to the opposite temperature at adulthood. They conclude 
that lifespan changes are dependent on redox levels with longer lived worms having fewer 
oxidants and short-lived worms having higher oxidant levels. Additionally they suggest this 
lifespan extension is due to increased prdx-2 expression levels and the reduction in lifespan 
is due to reduced prdx-2 levels (Henderson et al., 2018).  
Another study (Wu et al., 2009) conducted similar experiments but focused on how lowering 
temperature or calorie restriction changes mortality. Mortality was analysed by using the 
Gompertz equation and investigating the differences in parameters  (Initial mortality) and  
(rate of increase in mortality). They found there to be a delay of one day before changes in 
temperature changed mortality trajectory. Additionally, a change in mortality was seen when 
going from a high (25C) temperature to a low temperature (16C) when compared to 25C 
but not 16C. When switching from a low (16C) temperature to a high (25C) temperature 
an increase in mortality compared to 16C is seen, but there is no difference in the increase 
in rate of mortality. They conclude by saying prior conditions are important in determining 
initial mortality rates but the current conditions determine future mortality rates (Wu et al., 
2009). 
These experiments show the importance of early developmental conditions which appear to 
play a role in determining the lifespan of worms. Therefore, the timing of the intervention is 
extremely important in determining the lifespan of these worms. Further to this, it would be 
useful to determine critical time points post-development as once adulthood has been 
reached conditions can change and influence lifespan.  
Conducting these experiments to accurately identify critical time points is time consuming due 
to the number of lifespan assays and intervention times at which experiments can be 
conducted. Therefore, it would be beneficial to create a model which would accurately 
replicate the effects of intervention, which can then be tested against select experimental data 
for accuracy. 
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4.2.7 Aims and Objectives 
This chapter aims to: 
1) Develop predictive models which are able to use two initial survival curves from 
different conditions and combine them at different intervention times to generate 
theoretical curves representative of the different intervention times.  
a. Develop a predictive model based on chronological switching time. 
b. Develop a predictive model based on chronological switching time and survival 
proportions. 
2) Compare the theoretical data from the two predictive models to experimental lifespan 
data from C. elegans. 
3) Identify critical time points from theoretical and experimental data, at which predictions 
can be made regarding: 
a.  The minimum time required to be spent in the favourable condition to gain full 
benefits of this condition. 
b. The minimum time required to be spent in the favourable condition to get any 
benefit from this compared to those who spend all their life in the detrimental 
condition.  
c. The maximum time spent in the detrimental condition before it is too late to 
gain any benefit from the favourable condition. 
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4.3 Materials and Methods 
4.3.1 C. elegans lifespan assay 
The C. elegans strains N2 (wild isolate), and trpa-1(ok999) were maintained on solid 
nematode growth media (NGM) plates supplemented with nystatin (10 µg/ml; Sigma) and 
seeded with E. coli OP50 strain at 20°C unless stated otherwise. 
NGM plates used for lifespan assays were additionally supplemented with FuDR (50µM). 
Lifespan assays were conducted on a synchronised population of 50 L4 stage worms on fresh 
NGM FuDR plates as previously mentioned (section 2.2). 
4.3.1.1 Temperature Intervention 
In temperature intervention studies, C. elegans (L4 stage) were incubated at either at an initial 
temperature of either 15°C (favourable) or 25°C (detrimental) for a period of their lifetime and 
then incubated at the alternative temperature (25°C or 15°C) for the remaining length of their 
lifetime. N2 and trpa-1(ok999) strains were used in intervention experiments as multiple 
different time points were selected as intervention times at which the worms are switched 
between the two temperatures. Switching from 15°C to 25°C took place on days 5, 10, 13, 16 
and 20, and switching from 25°C to 15°C took place on days 1, 3, 5, 8 and 12. Additionally 
switches which took place on day 0 was classified as being at the second temperature for 
their entire adult lifetime. Switches which took place on days 35 and 16 for 15°C and 25°C 
respectively are those which have not been switched and remained at the initial temperature 
for their entire adult lifetime (until death) (Figure 4.1). 
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Figure 4.1: Temperature intervention timeline: Worms are synchronised and grown at 20°C 
until L4 stage and then transferred to 15°C or 25°C. At a given time t they are then switched 
to the opposite temperature (25°C or 15°C) until death. 
 
4.3.2 Survival curve analysis 
Kaplan-Meier survival curves were constructed by inputting events occurring at given time 
points into GraphPad Prism 7. Survival proportions at each time point were calculated and 
the novel 5-parameter Bilogistic model was used for fitting lifespan data (Equation 1). The f 
parameter splits the curve into two phases giving a weighting to each phase. There are two 
death rates (k1 and k2) and two time parameters t1 and t2, representing the median survival 
for each phase.  
𝑁(𝑡) = 𝑁0 [𝑓
1 + 𝑒−𝑘1𝑡1
1 + 𝑒𝑘1(𝑡−𝑡1)
+ (1 − 𝑓)
1 + 𝑒−𝑘2𝑡2
1 + 𝑒𝑘2(𝑡−𝑡2)
] 
Equation 1: The 5-parameter Bilogistic model 
4.3.3 Average lifetime and Median Survival 
Average lifetime was calculated by finding the average time of death for a population (Sum 
of when worms die divided by the total number of worms that die). Average lifetime can be 
calculated for a whole population for their entire lifespan or for the worms remaining post 
intervention. This is equal to the integral of the survival curve. The median survival of a 
population is the time point at which 50% of a population is remaining. 
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4.3.4 Curve fitting 
Non-linear regression models which were based on logistic functions were used to fit curves 
to the survival proportions. The MATLAB (MathWorks) Curve fitting toolbox (R2016a, 
v9.0.0.370719) and sfit objects were used to fit data using a non-linear least squared fit 
method (Trust-Region algorithm) to estimate parameters.  When fitting the survival data, other 
settings were kept to default: Robust=Off, DiffMinChange=0.00000001, DiffMaxChange=0.1, 
MaxFunEvals=600, MaxIter=400, TolFun=0.000001, TolX=0.000001. 
4.3.4.1 Average lifetime statistical analysis 
After average lifetime values were obtained statistical analysis was conducted. GraphPad 
Prism was used to perform an ordinary one-way Analysis of Variance (ANOVA), with all 
groups compared to one another (non-repeated measure). In conjunction to this ANOVA, 
Tukey’s multiple comparison test was also conducted. Statistical p-values p<0.05, p<0.01, 
p<0.001 and p<0.0001 shows a statistically significant difference between groups and is 
indicated in the figures. 
4.3.5 Lifespan predictions from 2 models 
MATLAB was used to create scripts (Appendix 8.2-8.5) which allowed the generation of 
switched survival curves for temperature switches from 15C to 25C and 25C to 15C for 
any time point based upon an initial data set of worms grown throughout their lifetime at either 
15C or 25C. Generated survival curves follow the path of worms in the first condition (either 
15C or 25C) and at the switch time follows the survival curve path of worms in the second 
condition. This can be done in two ways. The first is the chronological model (Appendix 8.2 
& 8.3) which is able to make predictions based upon chronological age which refers to the 
time in days that the worm has been an adult (since day 0). The second is the biological 
model which is based upon biological age (Appendix 8.4 & 8.5) and the percentage alive and 
therefore assumes that at a given percentage alive from a population, worms have the same 
biological age.  
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Chronological age follows the path of the initial temperature and at any time point is able to 
switch to the other temperature but to account for the difference in survival proportions 
(percent alive) at the given switch time the second survival curve is rescaled so that the 
survival curve becomes continuous. To rescale the second temperature survival curve, a ratio 
of the survival proportions (percent alive) of the first condition over the survival proportions 
(percent alive) of the second condition is taken and incorporated to scale down the survival 
curve of the second condition so that the curve is continuous from pre-switch to post-switch 
(Figure 4.3a).  
Biological age is based upon the survival proportion of a population which follows the path of 
the initial temperature and then switches to the second temperature but takes into account 
the survival proportions (percent alive) of the first condition. The post switch curves start at 
the survival proportion at the point where the first condition survival curve ends at the switch 
time point and continues onwards from the point at which the survival proportions is equal 
(rather than from the start of the curve). The post switch survival curve is shifted so that the 
survival proportions match at the same switch time point (Figure 4.4a).  
Computer generated switched survival curves from either model can then be compared to 
experimental data and differences can be identified. This can be done by calculating the 
integral (which equates to the average lifetime of the survival curves) and compare the 
computer generated and experimental data sets. 
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4.4 Results 
A temperature-based effect upon lifespan of C. elegans is observed in both wild type (N2) 
and trpa-1(ok999) mutant worms. The lower temperature and more favourable condition of 
15C results in a longer lifespan compared to the higher temperature and unfavourable 
condition of 25C which results in a shorter lifespan. In wild type worms, the average lifespan 
is ~20 days at 15C but ~10 days at 25C (Figure 4.2).  
 
Figure 4.2: Fitted survival curves of wild type (N2) C. elegans at 15C and 25C. Data for 
15C (n=27 trials), data for 25C (n=20 trials). 
 
4.4.1 Predictive modelling of lifespan 
Two models have been developed to predict the effect of lifespan intervention. In this study, 
2 temperatures (15C and 25C) are investigated by switching wild type and mutant worms 
between the temperatures at different time points.  
4.4.1.1 Chronological Model 
Firstly, a chronological model is considered, which only takes into account the time the 
temperature switch occurred (Figure 4.3a).  
The chronological model predicts that switching from a favourable condition of 15C to a less 
favourable condition of 25C leads to a reduction in lifespan. Additionally, the time at which 
this switching occurs is important. i.e. the earlier the switch from 15C to 25C the shorter the 
lifespan (Figure 4.3b).  
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Switching from the less favourable temperature of 25C to the more favourable condition of 
15C extends the lifespan. Again, the timing of the switch is important in determining the 
lifespan of worms: earlier switches from 25C to 15C predicts longer lifespans due to the 
greater proportion of time spent at 15C than 25C (Figure 4.3c).  
 
Figure 4.3: The chronological model (a) Chronological model showing the 25C (red) curve 
scaled down (curve in grey box scaled down to yellow box) at the switch time to match the 
survival proportions of the 15C (blue) curve. The switched curve is shown in purple. (b) 
Predictions for the chronological model when switching from 15C to 25C. (c) Predictions of 
the chronological model when switching from 25C to 15C Colours indicate stepwise change 
in intervention time (day by day). 
 
4.4.1.2 Biological Model 
An alternative model to predict the effect of intervention on survival curves is a model that 
takes into account both the chronological time point of switching and the survival proportion 
of the worms which are undergoing the switch (Figure 4.4a). When switching from 15C to 
25C, the biological model shows similar predictions to the chronological model, although, 
the predicted lifespans more closely resemble the initial condition (Figure 4.4b). Additionally, 
the relationship between lifespan and the time of switching is predicted to be more linear 
compared to the chronological model. When switching from 25C to 15C, the biological 
model shows that the relationship between lifespan and switch time is not linear as many 
different switch times overlap (Figure 4.4c). 
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Figure 4.4: The biological model (a) Biological model showing the 25C (red) curve shifted 
across (curve in grey box shifted across to yellow box) at the switch time to match survival 
proportions of the 15C (blue) curve. The switched curve is shown in purple. (b) Predictions 
for the biological model when switching from 15C to 25C. (c) Predictions of the biological 
model when switching from 25C to 15C. Colours indicate stepwise change in intervention 
time (day by day) 
 
4.4.1.3 The effect of thermal intervention on average lifespan 
Having conducted thermal intervention experiments on C. elegans at 5 different time points, 
a relationship curve to show the experimental effect of thermal intervention upon average 
lifespan was generated. Initially the experimental data supports the theory that worms which 
have undergone thermal intervention generate hybrid survival curves of the two conditions 
which they are in.  
Comparing the experimental survival curves with the chronological model computer 
generated curves for both 15C to 25C (Figure 4.5a-e) and 25C to 15C (Figure 4.6a-e) and 
also the biological model computer generated curves for both 15C to 25C (Figure 4.7a-e) 
and 25C to 15C (Figure 4.8a-e) show that, in more cases the biological model is closer at 
modelling the experimental curves more accurately than the chronological model. 
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Figure 4.5: Chronological model predictions and experimental data for 15C to 25C. Switch 
days (a) 5, (b) 10, (c) 13, (d) 16 and (e) 20. Experimental data for switch day 5 (n=3), 10 
(n=3), 13 (n=3), 16 (n=4), 20 (n=3) 
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Figure 4.6: Chronological model predictions and experimental data for 25C to 15C. Switch 
days (a) 1, (b) 3, (c) 5, (d) 8 and (e) 12. Experimental data for switch day 1 (n=3), 3 (n=3), 5 
(n=3), 8 (n=4), 12 (n=3) 
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Figure 4.7: Biological model predictions and experimental data for 15C to 25C. Switch days 
(a) 5, (b) 10, (c) 13, (d) 16 and (e) 20. Experimental data for switch day 5 (n=3), 10 (n=3), 13 
(n=3), 16 (n=4), 20 (n=3) 
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Figure 4.8: Biological model predictions and experimental data for 25C to 15C. Switch days 
(a) 1, (b) 3, (c) 5, (d) 8 and (e) 12. Experimental data for switch day 1 (n=3), 3 (n=3), 5 (n=3), 
8 (n=4), 12 (n=3) 
 
Additionally, the relationship between average lifespan and thermal intervention times of the 
two predicted relationships from the models shows that the biological model prediction is a 
more accurate model of thermal intervention compared to the chronological model (Figure 
4.9).  
Experimentally, the thermal intervention from 15C to 25C results in an increase in lifespan 
with later intervention times. From this a critical time point of 13 days can be identified, as 
spending a minimum of 13 days is required to gain a benefit from the favourable conditions 
of 15C, to spend any longer than this is not detrimental to the lifespan of the worm but also 
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does not provide any significant extra benefit. Similarly, if only 10 days (or less) are spent at 
the favourable condition than a significant reduction in average lifespan is seen (Figure 4.9a). 
This is important as it shows that there is an irreversible time point beyond which the 
intervention is unable to make a difference. Additionally, it shows that before this time, lifespan 
can be altered to an extent but the later the intervention occurs the less impact it has. 
Investigating interventions from 25C to 15C uncovers several critical time points. A critical 
time point of 3 days is identified as spending longer than 3 days at the unfavourable condition 
of 25C shows an irreversible reduction in average lifespan compared to those not 
experiencing the unfavourable condition at 15C. Additionally, spending longer than 8 days 
in the unfavourable conditions will result in an irreversible reduction in lifespan to the point 
where there is no significant difference to those that have spent their entire lifespan in the 
unfavourable condition (Figure 4.9b). This means that, after 8 days it is too late for any chance 
of recovery by intervention (switching to the favourable condition of 15C). Again, this 
indicates that the timing of the intervention is extremely important and that leaving a beneficial 
intervention too late will have no effect.  
For the 15C to 25C thermal intervention, the biological model is much more accurate in 
predicting the effect of the temporal thermal intervention compared to the chronological 
model. The biological model has a similar average lifespan at most time points of switching 
with few deviations at the extreme ends (when switching occurs very early or very late in the 
lifespan of the worm; Figure 4.9a). Overall however, it is a good predictor unlike the 
chronological model which appears to be consistently underestimating the average lifespan 
of the worms undergoing thermal intervention, with an average difference between 
experimental results and predicted data from the chronological model of 4 days and biological 
model is within a 1-day difference (Figure 4.9a).  
With the opposite thermal intervention (from 25C to 15C), similar results are seen. The 
biological model is observed to be a more accurate predictor of thermal intervention 
compared to the chronological model and can differ slightly by a few days compared to the 
experimental data. Once again, the chronological model overestimates average lifespan, 
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although in this case it is less clear due to greater variations depending on the intervention 
time. The biological model is closer although it initially overestimates the average lifespan 
and at later intervention times it underestimates the average lifespan by a 2 day margin 
(Figure 4.9b).  
 
Figure 4.9: Comparison of predicted average lifespan of wild type C. elegans by 
chronological model and biological model with experimental data. (a)15C to 25C. (b) 25C 
to 15C. One-way ANOVA with Tukey’s multiple comparison test. *shows statistical 
comparison to 15°C, # shows statistical comparison to 25°C. ****p<0.0001, ***p<0.001, 
*p<0.05, ####p<0.0001, #p<0.05.  
 
4.4.2 The role of TRPA-1 in temperature regulation of lifespan 
The trpa-1(ok999) mutant shows varying results when the same methodology is applied.  
The temperature dependent lifespan reduction due to the trpa-1 mutation is not seen in this 
investigation as a similar lifespan to wild type is seen in both cases. The average lifespan 
for trpa-1 mutants is ~21 days at 15C and ~11 days at 25C (Figure 4.10). However, there 
are varied effects the intervention has on lifespan. Neither the chronological model (Figure 
4.11a, b), nor biological model (Figure 4.11c, d) are entirely suitable models to predict how 
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intervention affects the survival of trpa-1(ok999) mutants (Figure 4.12, 4.13, 4.14, 4.15). 
However, a general increase in average lifespan of trpa-1(ok999) mutants is observed 
compared to wild type worms but it is not significant to suggest that TRPA-1 may play a part 
in temperature-based regulation of lifespan (Figure 4.9a, b and 4.16a, b).  
 
Figure 4.10: Fitted survival curves of trpa-1(ok999) C. elegans at 15C (dark blue) and 
25C (dark red) compared to N2 at 15C (light blue) and 25C (light red). Data for trpa-1 
15C (n=12 trials), data for trpa-1 25C (n=7 trials). Data for N2 15C (n=27 trials), data for 
N2 25C (n=20 trials). 
 
Figure 4.11: trpa-1(ok999) survival predictions (a) Predictions for the chronological model 
when switching from 15C to 25C. (b) Predictions of the chronological model when switching 
from 25C to 15C. (c) Predictions for the biological model when switching from 15C to 25C. 
(d) Predictions of the biological model when switching from 25C to 15C. 
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Figure 4.12: trpa-1(ok999) chronological model predictions and experimental data for 15C 
to 25C. Switch days (a) 5, (b) 10, (c) 13, (d) 16 and (e) 20. Experimental data for switch day 
5 (n=3), 10 (n=3), 13 (n=3), 16 (n=3), 20 (n=3) 
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Figure 4.13: trpa-1(ok999) chronological model predictions and experimental data for 25C 
to 15C. Switch days (a) 1, (b) 3, (c) 5, (d) 8 and (e) 12. Experimental data for switch day 1 
(n=3), 3 (n=3), 5 (n=3), 8 (n=3), 12 (n=3) 
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Figure 4.14: trpa-1(ok999) biological model predictions and experimental data for 15C to 
25C. Switch days (a) 5, (b) 10, (c) 13, (d) 16 and (e) 20. Experimental data for switch day 5 
(n=3), 10 (n=3), 13 (n=3), 16 (n=3), 20 (n=3) 
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Figure 4.15: trpa-1(ok999) biological model predictions and experimental data for 25C to 
15C. Switch days (a) 1, (b) 3, (c) 5, (d) 8 and (e) 12. Experimental data for switch day 1 
(n=3), 3 (n=3), 5 (n=3), 8 (n=3), 12 (n=3) 
 
The trpa-1(ok999) mutant has an impaired overall ability to adapt from both 15°C to 25°C or 
from 25°C to 15°C as the average lifespan is closer to the 25°C worms compared to wild type 
(Figure 4.9a, b and 4.16a, b). However, trpa-1(ok999) mutants switching from 25°C to 15°C 
in the early switch stages (days 1 and 3) show a slight but not significant increase in average 
lifespan compared to those which have spent their entire lifespan at 15°C. 
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Neither the chronological or biological models are able to predict this effect but instead 
demonstrate that the average lifespan remains constant for most of the lifespan intervention 
times and does not change until later lifespan intervention times (Figure 4.11).  
As for the switch from 15C to 25C similar trends between the actual data and the 
experimental model are observed although there can be differences in the average lifespan. 
The biological model shows fairly accurate average lifespan predictions with improved 
accuracy to experimental data in later switch times. During the early stages of lifespan 
intervention, the biological model overestimates the average lifespan (Figure 4.16b).  
 
Figure 4.16: Comparison of predicted average lifespan of trpa-1(ok999) mutants by 
chronological model and biological model with experimental data. (a) 25C to 15C. (b)15C 
to 25C. One-way ANOVA with Tukey’s multiple comparison test. *shows statistical 
comparison to 15°C, # shows statistical comparison to 25°C. **p<0.01, *p<0.05, ###p<0.001, 
#p<0.05. 
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4.5 Discussion 
Overall, this study shows that the lifespan of wild type worms which have undergone thermal 
intervention can be predicted with two different models. The first is a chronological model 
based on the time which has passed from the start of the experiment and the second is a 
biological model which is based on the survival proportions of worms at the given switch time. 
Between the two models developed, the biological model is a better predictor of lifespan 
intervention compared to the chronological model. This suggests that when investigating 
lifespan, it is not only important to analyse lifespan based upon their chronological age but to 
also take in to account the survival proportion of worms throughout their lifespan as it is an 
important indicator of how the worms are ageing. Both models show that the predictions more 
closely resemble the condition at which a longer time is spent. Additionally, our findings show 
that the early lifespan is crucial and that changes at the early stage can have lasting 
consequences later on in life, which is in agreement with previous studies (Zhang et al., 2015, 
Henderson et al., 2018). Both the chronological and biological models are unable to 
accurately model intervention of trpa-1 mutants. This is likely due to the loss TRPA-1 affecting 
normal lifespan dynamics and impairing the worms ability to adapt to changing temperature. 
In wild type worms the ability to adapt is not impaired and so normal lifespan dynamics can 
be accurately predicted.  
This model can be applied to many other intervention types such as genetic, dietary, 
pharmacological and environmental. For example, when investigating the role of a gene, the 
gene can be active or inactive, and the activation of this gene may occur differentially 
throughout the lifespan of the organism. Therefore, this methodology can be used to 
investigate how genetic activity or intervention can alter lifespan over time by comparing 
different intervention times throughout the organism lifespan. 
Dietary intervention is another commonly studied area and can be investigated fairly easily 
by looking at different diets (e.g. high fat diet vs calorie restriction) and predicting the effect 
dietary intervention at different time points has on lifespan. 
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In this study the effect of thermal intervention on lifespan was investigated but further to this, 
other environmental factors such as oxygen levels (normoxia vs hypoxia vs hyperoxia) or 
other stress causing factors can be investigated.  
Pharmacological intervention is currently a major area of research and these models are 
extremely beneficial to investigators (for example those in the interventions testing 
programme) looking to screen the effect of drugs on lifespan. It would allow predictions of 
when is the best time for a drug to be given to extend lifespan. Furthermore, this can be 
potentially extrapolated to other species too, importantly those which have a much longer 
lifespan such as flies, rodents and even fish. Also, in higher order species in which surgical 
operations are conducted, these can be classed as an intervention. 
Although useful, the models predictions for different interventions must be interpreted with 
caution as in some cases where normal lifespan dynamics are severely affected the ability to 
predict lifespan is impaired. The different intervention types must be conducted to identify the 
universality of the models. What is also understood from this methodology is that it is of utmost 
importance that the original data sets are of high quality and are accurate, and therefore this 
stresses the importance of replication and reproducibility of data. 
4.5.1 Critical time points 
Another important output of this methodology is the critical time points. In this study, the 
critical time points show that the later the intervention occurs the less impact it has upon 
lifespan. This is in agreement with existing advice on intervention (for example early diagnosis 
result in a better prognosis). Additionally, the effect of intervention is highly dependent on the 
initial conditions. As such poor initial conditions would result in an increased death rate and 
a faster reduction in survival proportions, resulting in a smaller possibility of the intervention 
having an effect. 
Specifically, in poor initial conditions (e.g. high temperatures), the effect of intervention is 
biphasic as lifespan increases then decreases with later switch time. This is likely due to the 
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worm developing a tolerance or stress resistance factors at a young age therefore making 
the worm more resilient with an improved ability to adapt in changing conditions. 
This effect is not seen in interventions which begin in beneficial initial conditions and later 
switches to the detrimental conditions. This is probably because there is minimal stress in 
early development due to the condition and therefore minimal development of resistance. 
Furthermore, switching to detrimental conditions later on in life has greater consequences as 
the worms are more aged and also have a reduced capability to adapt to the detrimental 
condition and therefore the detrimental switching has a greater impact upon lifespan. 
Therefore, our results indicate that being in detrimental conditions later in life with no previous 
exposure results in a shorter average lifetime compared to spending the same amount of time 
early on in the lifetime. This further signifies the importance of not only the duration of the 
intervention but also the timing of it. 
4.5.2 The role of TRPA-1 in C. elegans lifespan 
The role of TRPA-1 as a temperature regulator in C. elegans has previously been investigated 
with data showing that TRPA-1 acts to extend lifespan in cooler temperature but not at warmer 
temperatures. This result was unable to be replicated as a similar lifespan to wild type is seen 
at both 15C and 25C. Although differences in lifespan between wild type and trpa-1(ok999) 
mutants is not expected at 25C, differences are expected to be seen at 15C. Although the 
data is not statistically significant it does show a temperature sensitive role. However this 
does not replicate what has previously been reported but in fact shows the opposite effect as 
at low temperatures the trpa-1(ok999) mutants have an extended lifespan meaning TRPA-1 
acts to reduce lifespan. At high temperatures a similar effect is seen although at an even 
lesser magnitude. This is unexpected, particularly as it has previously been suggested that 
trpa-1 is a cold temperature sensor which is activated in a noxious cold environment (i.e. 
15C) and normally functions to extend lifespan.  
However, our results are in agreement with another study which suggest TRPA-1 may not 
necessarily be a noxious cold sensitive regulator in C. elegans. The temperature range by 
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which TRPA-1 sensitivity occurs could be different to what has previously been suggested 
(Xiao et al., 2013, Miller et al., 2017). It is proposed that although it is temperature sensitive, 
TRPA-1 functionality in C. elegans is still to be explored and its effect upon lifespan is still to 
be determined.  
The increase in average lifespan of trpa-1(ok999) worms which have spent early lifespan in 
detrimental conditions is in agreement with previous studies which shows that the growth 
temperature at developmental stages is important (Xiao et al., 2013, Henderson et al., 2018). 
These results show that this idea can be extended from the developmental stages to the first 
3 days of lifespan which are important for development and lifespan regulation later on in life. 
Additionally, this shows that the TRPA-1 ion channel plays an important role particularly early 
on in the lifespan of worms which have grown at 25C and switched to 15C as trpa-1(ok999) 
mutant worms have a significantly higher average lifespan at day 3 compared to wild type 
worms, suggesting that exposure to high temperatures early on may act to reduce lifespan 
by signalling via TRPA-1. 
The trpa-1(ok999) mutants were not able to be modelled by either of the two predictive models 
as the lifespan predictions for interventions from 25°C to 15°C were shown to be constant in 
many cases. This is likely due to the effect of intervention on lifespan changes predicted by 
the model, amounting to the lifespan reduction that is due to the additional time in the 
detrimental temperature, therefore counteracting one another resulting in an average lifespan 
which does not change over the most part of the lifespan. Another explanation is that the 
intervention survival curve predictions by the models is heavily dependent on (and can be 
skewed by) the shape of the curve for the initial data of the worms grown in a single condition 
(15C or 25C). Indeed, the intervention from 25C to 15C is not well described by either 
model due to the relatively long period early on in the lifespan where worms do not die and 
so the survival proportions remain at 100% leading to an overestimation of lifespan. When 
they do die, there is an initial sudden decrease in survival proportions followed by a secondary 
shallower decrease in which both the 15C and 25C curves have a similar gradient. Thus, 
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this results in a clustering of predicted survival curves, leading to similar average lifespans 
regardless of the theoretical switch time (Figure 4.11d).  
4.5.3 Future work 
Having shown that temperature intervention has a dynamic affect upon lifespan of C. elegans 
and that many factors are involved, much is still left to be investigated beyond this chapter. It 
is still important to fully determine the role of TRPA-1 in C. elegans and the extent to which 
this ion channel influences nociception and thermoception. Further to this, it is important to 
see whether and to what extent this channel acts to alter lifespan. Additionally, other factors 
must be considered, for example the AFD neurons involvement with cyclic GMP ion channels 
activity in thermoregulation (Lee and Kenyon, 2009, Land and Rubin, 2017). It is also possible 
for there to be crosstalk between multiple different factors which react to variations in 
temperature. 
Although important, temperature is not the only intervention which has life changing 
consequences. Other interventions play an equally critical role and it is important to 
understand how these interventions act to alter lifespan with time. Here two models are 
proposed which can be used as an initial point for investigating the effect of these 
interventions. With minimal data input required, a substantial amount of data can be obtained 
which provides insight into lifespan effects of different interventions. 
4.6 Conclusion 
This study proposes a chronological and a biological model for predicting lifespan 
interventions and the timing of the intervention. Also identified are critical time points in the 
C. elegans lifespan, these include time points at which lifespan is pre-determined and time 
points at which interventions are too late and so result in minimal effects. Additionally, this 
study shows that TRPA-1 does play a small role in temperature-based lifespan regulation, 
although not to the extent by which it has previously been reported and that TRPA-1 activity 
is differentially regulated with time. 
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HIF-1 and TRPA-1 signalling 
pathways and its effect on C. 
elegans lifespan 
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5.1 Preface 
The purpose of this chapter is to use the Bilogistic model to investigate signalling between 
the hypoxia inducible factor 1 (HIF-1) (hypoxia) signalling pathway and the transient receptor 
potential ankyrin 1 (TRPA-1) (temperature) signalling pathway and the roles they play in 
regulating lifespan. Previous studies have implied some interaction between HIF-1 and 
TRPA-1. To investigate this, the C. elegans lifespan was explored under different 
temperatures and oxygen concentrations to identify the interaction between the HIF-1 hypoxia 
and TRPA-1 temperature signalling pathways. Additionally, the effect of TRPA-1 activation 
by the agonist carvacrol on HIF-1 activity was measured in mammalian cells. Furthermore, 
worms were treated with carvacrol to investigate whether the effect observed in mammalian 
cells were conserved in worms and could be applied to a whole model organism and to further 
provide insight into how this affects lifespan. 
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5.2 Introduction 
5.2.1 Environment and lifespan 
The lifespan of an organism is influenced by a number of internal and external factors. Internal 
factors include control by genetic regulators and external factors include environment and 
lifestyle choices. Temperature and oxygen concentrations are two key environmental factors 
which are known to influence lifespan.  
5.2.1.1 Temperature and TRPA-1 
In many organisms, temperature plays a conserved role in regulating lifespan. At high 
temperatures lifespan is reduced and vice-versa (Conti, 2008). Passive and active 
mechanisms of action which alter the lifespan have previously been described (section 1.4) 
(Keil et al., 2015). A number of active mechanisms involving temperature controlled genetic 
regulation of lifespan have been proposed. One such mechanism is the TRPA-1 signalling 
pathway previously identified to be stimulated by noxious cold stimuli and which extends 
lifespan in C. elegans (Xiao et al., 2013). TRPA-1 is thought to target DAF-16 (FOXO 
ortholog) via the calcium-sensitive PKC-2 and the kinase SGK-1 in C. elegans which is a 
known pathway involved in lifespan regulation. This indicates the TRPA-1 signalling pathway 
as an attractive target to investigate how temperature affects lifespan. In addition to noxious 
cold stimulation, the TRPA-1 cation channel can also be activated by pain stimulations or 
pharmacological agents such as the monoterpene carvacrol (Hasan et al., 2017). 
5.2.1.2 Hypoxia and HIF-1 
Oxygen is another important environmental factor which has a more varied effect upon 
lifespan and is also reported to be species dependent. High levels of oxygen are not known 
to have an effect on C. elegans lifespan but has been reported to negatively affect rodents 
and drosophila (Pitt et al., 2014). Low oxygen levels have varied effects upon lifespan and as 
previously described signal via the HIF-1 pathway (section 1.5.4). In flies some studies have 
shown that hypoxia extends lifespan whereas others report a reduction instead (Rascón and 
Harrison, 2010, Vigne et al., 2009). In C. elegans, hypoxia has been found to extend lifespan 
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and is also reported to act via the HIF-1 signalling pathway (Leiser et al., 2013). However, 
there is some variation in these studies due to differences in the methodology and individual 
definitions of hypoxia used. Most studies define hypoxia to be in a range of 0.5-2% oxygen 
concentration but other studies have a more extreme definition of hypoxia which is closer to 
anoxia (<0.1%) and can result in a lifespan reduction (Schieber and Chandel, 2014, Kitazume 
et al., 2018, Leiser et al., 2013, Fawcett et al., 2012, Mehta et al., 2009, Honda et al., 1993). 
This study defines hypoxia as 1% oxygen concentration. 
Hypoxia leads to a number of cellular changes which are controlled by different signalling 
pathways. The primary signalling pathway which responds to hypoxia is the HIF-1 signalling 
pathway. In a normoxic environment HIF-1 is hydroxylated by the prolyl hydroxylase EGL-9 
which is then targeted by von Hippel-Lindau 1 (VHL-1) for ubiquitination. Once ubiquitinated 
HIF-1 is targeted for degradation. Hypoxia prevents this degradation and allows HIF-1 to 
stabilise and function as a transcription factor. Therefore EGL-9 and VHL-1 act as regulators 
of HIF-1 function and signalling and prevent HIF-1 from binding to hypoxia response elements 
(HRE) which controls transcriptional activity of target genes (Epstein et al., 2001, Shen et al., 
2005).  
The function of HIF-1 as a transcription factor has been previously investigated, more so in 
mammalian systems (as the orthologue HIF-1) compared to model organisms. HIF-1 has 
been reported to have a role in many different physiological mechanisms such as 
angiogenesis, erythropoiesis, cell proliferation, cell survival, proteolysis glucose metabolism 
and pH regulation. In C. elegans, it has been speculated to act as a key factor in the 
mechanism behind lifespan control (Dengler et al., 2014, Pitt et al., 2014). A deletion of hif-1 
extends the lifespan of C. elegans, suggesting that HIF-1 normally acts to shorten lifespan. 
However, overexpression of hif-1 also leads to lifespan extension, suggesting a different 
pathway (Pitt et al., 2014, Mehta et al., 2009, Leiser and Kaeberlein, 2010, Zhang et al., 
2009). Due to the uncertainty of the HIF-1 regulation of C. elegans longevity, it is important 
that further investigations are conducted to determine its role. 
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5.2.2 Interaction between HIF-1 hypoxia and TRPA-1 temperature 
signalling pathways 
Oxygen concentration and temperature are two distinct environmental influencers which have 
been reported to act via their distinct pathways. However, a number of studies have shown 
that these pathways could be linked. The main physiological function linking these pathways 
is in inflammatory signalling where TRPA1 acts to signal pain and HIF-1 acts to induce 
immune functions. (Hatano et al., 2012, Nagarajan et al., 2017). Lifespan control in C. elegans 
also links these two pathways albeit by different stimuli (Leiser and Kaeberlein, 2010, Xiao et 
al., 2013). It is therefore reasonable to assume that there is some interaction between the 
TRPA-1 pathway and the HIF-1 pathway. Indeed, previous studies have shown that in 
mammalian cells HIF-1 is required for the signalling from NF-b to induce TRPA1. This study 
also reports that pharmacological stabilisation of HIF-1 by desferroxamine increases mRNA 
levels of TRPA1 (Hatano et al., 2012).  
In addition to this TRPA-1 is also a target of the prolyl hydroxylases (which also target HIF-1) 
and in hypoxia it allows sensitisation of TRPA-1 activity and could possibly act to influence 
lifespan (So et al., 2016). 
Further linking these signalling pathways together is the report that HIF-1 activity in C. elegans 
is temperature dependent. At higher temperatures (25C) hif-1(ia4) mutant worms have an 
extended lifespan but at low temperatures (15C) this effect is not seen (Leiser et al., 2011). 
From these studies it is clear that the TRPA-1 temperature sensing pathway and the HIF-1 
hypoxia signalling pathway have a close relationship and may be linked. Therefore, in the 
context of lifespan regulation, the interaction between these pathways can be further explored 
by investigating the actions of HIF-1 and TRPA-1 signalling pathway elements in C. elegans. 
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5.2.3 Aims and Objectives 
The roles of the different components in the TRPA-1 temperature and HIF-1 hypoxia 
signalling pathways can be investigated, and their effect on lifespan can be measured and 
analysed by mathematical analysis to provide more data upon how these factors affect 
lifespan. The relationship between HIF-1 and TRPA-1 specifically can be further investigated 
in mammalian cells to identify cross talk between pathways and specific roles of pathway 
components. This can be applied to C. elegans to see how worms react to activation of 
pathways by environmental changes or pharmacological treatment.  
The specific objectives are to measure and analyse lifespan of different C. elegans mutants 
(of both pathways) in normoxic and hypoxic conditions to investigate the effect on lifespan by 
using the Bilogistic model. This study will also measure the effect that TRPA1 activation has 
on HIF-1 levels in human mammalian cells and the effect it has upon C. elegans lifespan. 
Activation of the different factors will be conducted by environmental and pharmacological 
activation to identify their effect on lifespan of wild type and mutant worms. 
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5.3 Methods 
5.3.1 C. elegans lifespan assays 
The C. elegans strains N2 (wild isolate), and daf-16(mu86), hif-1(ia4), trpa-1(ok999), egl-
9(sa307) and egl-9(n586) were acquired from the Caenorhabditis genetics center (CGC), 
University of Minnesota. C. elegans were maintained at 20C on solid NGM media 
supplemented with nystatin (10g/ml) and seeded with OP50 E. coli unless otherwise stated. 
A synchronised population of worms using alkaline hypochlorite treatment were generated 
for lifespan assays which were conducted on solid NGM plates additionally supplemented 
with FuDR (50M). 50 or more L4 stage synchronised worms were transferred to fresh NGM 
plates containing FuDR and were further transferred to new plates weekly or more frequently 
if OP50 had depleted or if there were unwanted bacterial or fungal contamination. Day 0 is 
the first day of adulthood and the beginning of the lifespan assay and worms were measured 
almost daily for events such as death or censorship. 
5.3.2 C. elegans lifespan assays from digital recordings 
In hypoxic environments, C. elegans lifespan assays were conducted by digital recording 
using flatbed photo scanners. Oxygen and temperature was regulated by placing scanners in 
chambers with controlled oxygen levels (1%) and the temperature (20°C) was regulated using 
a climate control system in the room. The Epson Perfection V800 Photo Scanner was used 
to scan NGM plates and take images of the plates. Once images were acquired plates were 
analysed manually by comparing images from different time points, if worms had moved 
position then they were classified as alive, had they not moved they were classified as dead. 
Additionally, worms missing (crawled off the plate) were classified as censored along with 
worms which were seen to have had internal hatching of eggs (bagging), bacterial or fungal 
contamination, vulval protrusion and rupturing. 
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5.3.3 Carvacrol dose response 
Worms were treated with carvacrol at varying concentrations. NGM plates used for lifespan 
assays were supplemented with 0mM, 50mM, 200mM and 500mM of carvacrol. At the 
beginning (day 0) of the lifespan assays worms were transferred to carvacrol plates and were 
maintained until completion of the lifespan assay. 
5.3.4 Curve fitting and statistical analysis of parameters 
Kaplan-Meier survival curves were constructed in GraphPad Prism 7. Survival proportions 
were calculated and the MATLAB (MathWorks) Curve fitting toolbox (R2016a, v9.0.0.370719) 
and sfit objects were used to fit the novel 5-parameter Bilogistic model (Chapter 3)  was used 
to fit lifespan data (Equation 1).  
𝑁(𝑡) = 𝑁0 [𝑓
1 + 𝑒−𝑘1𝑡1
1 + 𝑒𝑘1(𝑡−𝑡1)
+ (1 − 𝑓)
1 + 𝑒−𝑘2𝑡2
1 + 𝑒𝑘2(𝑡−𝑡2)
] 
Equation 1: The 5-parameter Bilogistic model 
 
Fitting of data was conducted by using a non-linear least squared fit method (Trust-Region 
algorithm) to estimate parameters.  When fitting the survival data, other settings were kept to 
default: Robust=Off, DiffMinChange=0.00000001, DiffMaxChange=0.1, MaxFunEvals=600, 
MaxIter=400, TolFun=0.000001, TolX=0.000001. 
After parameters were obtained, GraphPad Prism was used to perform an ordinary two-way 
Analysis of Variance (ANOVA), with all groups compared to one another (non-repeated 
measure). In conjunction to this ANOVA, Tukey’s multiple comparison test was also 
conducted. Statistical p-values p<0.05, p<0.01, p<0.001 and p<0.0001 shows a statistically 
significant difference between groups and is indicated in the figures. 
5.3.5 Plasmid cloning 
Plasmids used were pHRE-MP-GLuc HIF responsive plasmid DNA (Cavadas and Cheong, 
2014) and pcDNA3.1/neo(+)-human TRPA1 plasmid DNA (Hatano et al., 2012). Plasmids 
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were transformed into mammalian cells using the heat shock method and purified using the 
Pureyield Plasmid Midiprep System (A2492; Promega). 
5.3.6 Mammalian cell growth and maintenance 
HEK-293 and HepG2 cell lines were cultured in DMEM (41966-029; Gibco Life Technologies) 
and RPMI-1640 (R8758) respectively supplemented with 10% Foetal Bovine Serum (FBS) 
and 5% Penicillin-Streptomycin. 
When cells reached 70-80% confluency they were passaged using Trypsin-EDTA  solution 
(T4174) and re-seeded into new flasks at the desired concentration. Growth media was 
replaced every 72 hours until cells required further passage. Cells were maintained in a CO2 
incubator at 37°C in an atmosphere of 5% CO2/ 95% air. 
When adherent HepG2 cells reached 70-80% confluence they were passaged and were 
seeded in a 24 well plate with 500l of media per well. Cells were maintained at 37°C in 5% 
CO2/ 95% air for 24 hours.  
5.3.7 Transient Transfection 
A calcium phosphate co-precipitation method (Chen, 2012) was used for transient 
transfection of seeded cells. After the transfection solution (Table 2.2) was added, cells were 
incubated at 37°C in 5% CO2/95% air for 48 hours. 
5.3.8 Cell treatments 
24 hours post transfection growth media was replaced with fresh media and then treated 
using a number of different conditions. Treatment of cells lasted 24 hours. Cells were exposed 
to hypoxic conditions (1% O2, 94% N2, 5% CO2) in a hypoxia O2 Control InVitro Glove Box 
(Coy laboratories) and the fresh growth media was pre-exposed to hypoxia for at least 16 
hours before application to cells. Additionally, carvacrol was used at varying doses of 5M, 
20M, 50M, 200M and 500M to treat cells. 
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5.3.9 Gaussia Luciferase assay  
The pHRE-MP-GLuc HIF plasmid construct was used to measure HIF activity in mammalian 
cells (Figure 2.5). Conditioned media was collected 24 hours post-treatment and was read on 
a SpectraMax Gemini EM Microplate Reader (Molecular Devices) at the ambient 
temperature. The SoftMax Pro Software (v5.0) was used to configure the plate reading 
settings: Top read, Luminescence, Emission: Lm1 461nm, Reads/Well: 6 (Figure 2.6). 
5.3.10 Statistical analysis 
Average (relative) luminescence for individual treatments in the Gaussia Luciferase assay 
was calculated (±SEM) using GraphPad. An Ordinary One-Way ANOVA with Tukey’s multiple 
comparisons test was used to compare individual treatments in the Gaussia Luciferase assay. 
Statistical p-values p<0.05, p<0.01, p<0.001 and p<0.0001 shows a statistically significant 
difference between groups and is indicated in the figures. 
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5.4 Results 
5.4.1 C. elegans in normoxia at 20C 
Using the 5-parameter Bilogistic model, specific differences in the lifespan of C. elegans 
worms under different temperature and oxygen condition were identified. Furthermore, the 
role of signalling factors in these two pathways and their impact upon lifespan provide insight 
into how temperature and oxygen regulate lifespan. 
In normoxic conditions at normal (20C) growth temperature both TRPA-1 and DAF-16 have 
a shortened lifespan compared to N2 wild type worms (Figure 5.1). Parametric analysis 
shows that, only DAF-16 worms have a significantly higher late phase death rate (Figure 
5.1c). Neither mutation appears to affect the f parameter nor the early time phase and 
although not statistically significant the late time phases are lower in both mutants compared 
to wild type (Figure 5.1b, d). Surprisingly, mutations to the factors in the hypoxia pathway do 
not show a significant change on lifespan as both hif-1(ia4) and egl-9(sa307) mutants tend to 
show similar lifespan and parameters as wild type worms (Figure 5.2a, b, c, d). 
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Figure 5.1: Lifespan and parameters of wild type (N2), trpa-1(ok999) mutant and daf-
16(mu86) mutant worms in normoxia grown at 20C. (a) representative survival curves, (b) f 
parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. N2 (n=21), trpa-1(ok999) (n=8), daf-16(mu86) (n=8) Data is shown as mean ± SEM. 
**** p<0.0001. 
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Figure 5.2: Lifespan and parameters of wild type (N2), hif-1(ia4) mutant and egl-9 (n586) and 
egl-9 (sa307) mutant worms in normoxia grown at 20C. (a) representative survival curves, 
(b) f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) 
time phases. N2 (n=21), hif-1(ia4) (n=11), egl-9(n586) (n=6), egl-9(sa307) (n=6) Data is 
shown as mean ± SEM. 
 
5.4.2 C. elegans in normoxia at 15C 
As shown previously (section 3.4) when lowering the temperature from 20C to 15C, an 
extension in lifespan in wild type worms and all mutant worms except the hif-1(ia4) mutants 
is observed (Figures 5.1, 5.2, 5.3 and 5.4). Lowering the temperature results in an extension 
of both time phases in wild type worms and trpa-1(ok999) mutants (Figures 5.1 and 5.3). daf-
16(mu86) mutants show a decrease in the early phase death rate at the lower temperature 
while egl-9(sa307) shows an increase in the late time phase (Figures 5.2, and 5.4).  
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Figure 5.3: Lifespan and parameters of wild type (N2), trpa-1(ok999) mutant and daf-
16(mu86) mutant worms in normoxia grown at 15C. (a) representative survival curves, (b) f 
parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. N2 (n=27), trpa-1(ok999) (n=12), daf-16(mu86) (n=5) Data is shown as mean ± SEM. 
# shows statistical comparison to 20C.  #### p<0.0001, ###p<0.001, #p<0.05. 
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Figure 5.4: Lifespan and parameters of wild type (N2), hif-1(ia4) mutant and egl-9 (n586) and 
egl-9 (sa307) mutant worms in normoxia grown at 15C. (a) representative survival curves, 
(b) f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) 
time phases. N2 (n=27), hif-1(ia4) (n=5), egl-9(n586) (n=3), egl-9(sa307) (n=3) Data is shown 
as mean ± SEM. # shows statistical comparison to 20C.  ##p<0.01. 
 
5.4.3 Effect of hypoxia on C. elegans 
In addition to temperature affecting lifespan, changes in oxygen levels also alter the lifespan 
of C. elegans (Figure 5.5). Although some lifespan extension is observed particularly in the 
later stage of life, hypoxia does not show statistically significant changes to parameters in 
both wild type worms and hif-1(ia4) mutants for the data gathered in our experiments (Figure 
5.5a). However, trpa-1(ok999) mutants show similar overall lifespan changes as wild type 
worms in response to hypoxia, but the trpa-1(ok999) mutants report a significant difference 
in death rates compared to normoxic conditions. In trpa-1(ok999) mutants, hypoxia leads to 
a decrease in early phase death rate and an increase in late phase death rate, resulting in a 
slightly extended lifespan (Figure 5.5c). Mutants can also be compared to wild type to identify 
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the role the protein plays. There is no significant difference between wild type and hif-1(ia4) 
mutants. However, trpa-1(ok999) mutants show an increase in late phase death rate. 
Although trpa-1(ok999) mutants begin to live longer than wild type, they die more quickly in 
the late phase compared to wild type and thus die at similar times (Figure 5.5c). In wild type 
worms grown in hypoxic conditions, early phase death rate is significantly higher compared 
to late phase death rate and similar results are seen in hif-1(ia4) mutants but in trpa-1(ok999) 
mutants this is not seen as the late phase death rate increases (Figure 5.5c). 
 
Figure 5.5: Lifespan and parameters of wild type (N2), hif-1(ia4) mutants and trpa-1(ok999) 
mutants in normoxia and hypoxia at 20C using digital lifespan assays. (a) representative 
survival curves, (b) f parameters, (c) early (k1) and late (k2) phase death rate and (d) early 
(t1) and late (t2) time phases. N2 hypoxia (n=6), N2 Hypoxia (n=3), hif-1(ia4) hypoxia (n=6), 
hif-1(ia4) normoxia (n=3), trpa-1(ok999) hypoxia (n=6), trpa-1(ok999) normoxia (n=3). Data 
is shown as mean ± SEM. ****p<0.0001, **p<0.01, *p<0.05. 
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5.4.4 Manual vs digital lifespan assays 
As manual lifespan assays cannot be conducted easily in hypoxic conditions alternative 
methods to manual measurements were implemented. However, it is important to identify if 
the change in methodology has any affect upon lifespan by comparing manual counting 
method for lifespan assays against the digital lifespan assay which used flatbed scanners. 
The lifespan curves appear to show that lifespan is lower when conducted by digital lifespan 
assays, and possible reasons why this may occur will be discussed later. Wild type worms do 
not show statistically significant differences in parameters if conducted by either by manual 
lifespan assays or digital lifespan assays (Figure 5.6). However other mutants (hif-1(ia4) and 
trpa-1(ok999)) show a shorter overall lifespan and therefore any comparison between manual 
and digital lifespan assays must be made carefully (Figure 5.7 and 5.8). Hif-1(ia4) mutants 
show an increase in later phase death rate and a lower late time phase in digital lifespan 
assays compared to manual lifespan assays (Figure 5.7). Similarly, trpa-1(ok999) mutants 
show an increase in early phase death rate in digital lifespan assays. 
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Figure 5.6: Lifespan and parameters of wildtype (N2) worms comparing manual lifespan 
assay and digital lifespan assay conducted at 20C in normoxia. (a) representative survival 
curves, (b) f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and 
late (t2) time phases. Manual (n=21), Digital (n=3). Data is shown as mean ± SEM. 
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Figure 5.7: Lifespan and parameters of hif-1(ia4) mutants comparing manual lifespan assay 
and digital lifespan assay conducted at 20C in normoxia. (a) representative survival curves, 
(b) f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) 
time phases. Manual (n=11), Digital (n=3). Data is shown as mean ± SEM. *p<0.05 
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Figure 5.8: Lifespan and parameters of trpa-1(ok999) mutants comparing manual lifespan 
assay and digital lifespan assay conducted at 20C in normoxia. (a) representative survival 
curves, (b) f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and 
late (t2) time phases. Manual (n=8), Digital (n=3). Data is shown as mean ± SEM. ***p<0.001 
 
 
5.4.5 Carvacrol dose response on mammalian cells 
TRPA-1 has been shown to play an important role in lifespan therefore its mechanism of 
action was further investigated in mammalian cells. Hypoxic treatment of HEK-293 and 
HepG2 cells increased HIF activity (Figure 5.9a and b). Overexpressing TRPA-1 and adding 
carvacrol to cells results in a significant reduction in HIF activity with a minimum concentration 
of 50M of carvacrol required to significantly reduce HIF levels (Figure 5.9c and d). This is 
observed in both HEK-293 and HepG2 cells. The growth and morphology of cells appears to 
be unaffected by carvacrol as there is a similar level of growth and the cell morphology does 
not appear to change between control and treated cells (Figure 5.9e i & ii and f i & ii).  
163 
 
 
Figure 5.9: The effect of hypoxia and carvacrol on HIF-1 in mammalian cells. Hypoxia leads 
to an increase in HIF activity in both (a) HEK293 and b) HepG2 cells. Treatment with carvacrol 
decreases HIF activity in both (c) HEK293 and (d) HepG2 cells. In both cell lines cell growth 
and morphology appears to be similar for both (e i and f i) 0M (control) and (e ii and f ii) 
50M. HEK293 Normoxia(n=5) HEK293 Hypoxia (n=5), HepG2 Normoxia(n=5) HepG2 
Hypoxia (n=5).HEK293 D/R (n=9) HepG2 D/R (n=6).  Data is shown as mean ± SEM. 
****p<0.0001, ***p<0.001, **p<0.01. 
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5.4.6 Carvacrol dose-response on C. elegans in normoxia and hypoxia 
C. elegans dose-response to carvacrol shows relatively few differences in worm lifespan. In 
most cases, addition of carvacrol appears to reduce the lifespan of C. elegans (Figures 5.10a- 
5.16a). Although there are some differences in parameters when treated with carvacrol, there 
does not appear to be consistent effects on lifespan. 
In wild type worms carvacrol reduces lifespan and causes the phases to merge as normally 
without carvacrol there is a significant difference between early and late death time phases, 
yet with increasing carvacrol dosage this significant difference between the time phases is 
lost. (Figure 5.10 c and d). In hypoxic conditions, this is not observed, rather there are 
differences in death rates as early phase death rate is significantly higher compared to late 
phase death rate (Figure 5.14). With the addition of carvacrol this effect is reduced due to a 
slight decrease in early phase death rate and a slight increase in late phase death rate (Figure 
5.14c).  
Carvacrol has a similar effect on hif-1(ia4) mutants as in wild type worms as with carvacrol 
treatment phases merge together and there is a reduction in lifespan. However, in hypoxia 
this is not observed as time phases are already not significantly different to one another 
(Figure 5.11d and 5.15d). 
Generally, trpa-1(ok999) mutants show similar overall lifespan with or without carvacrol 
(Figure 5.12 and 5.16). In normoxia, 200mM of carvacrol leads to a significantly higher death 
rate in the early phase compared to late phase (Figure 5.12c). In hypoxia the opposite is 
observed with the early phase death rate significantly lower than the late phase death rate 
(Figure 5.16c). At 200mM of carvacrol hypoxia results in a significant increase in the late 
phase death rate, which is also significantly higher than the other concentrations of carvacrol 
(Figure 5.16). 
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Figure 5.10: Lifespan and parameters of wild type (N2) C. elegans in normoxia treated with 
carvacrol (0mM control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) 
f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3). Data is shown as mean ± SEM. ****p<0.0001 
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Figure 5.11: Lifespan and parameters of hif-1(ia4) mutants in normoxia treated with carvacrol 
(0mM/control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) f 
parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3). Data is shown as mean ± SEM. **p<0.01 
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Figure 5.12: Lifespan and parameters of trpa-1(ok999) mutants in normoxia treated with 
carvacrol (0mM/control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) 
f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3). Data is shown as mean ± SEM. *p<0.05. 
 
Carvacrol treatment of daf-16(mu86) mutants also shows differences in lifespan with a 
general decrease in lifespan at increasing concentrations (Figure 5.13a). In particular the late 
phase death rate is significantly higher with the increasing concentration of carvacrol. 
However, there is an unexpected decrease again at the highest dose of 500mM, which is 
indicative of phases merging (Figure 5.13c). Additionally, as previously shown (section 3.4.3), 
daf-16(mu86) mutants have a significantly higher late phase death rate in normoxic conditions 
compared to wild type. With increasing carvacrol concentrations, the difference between the 
late phase death rates increases except for treatment with 500mM (Figure 5.13). 
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Figure 5.13: Lifespan and parameters of daf-16(mu86) mutants in normoxia treated with 
carvacrol (0mM/control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) 
f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3) *shows statistical comparison to other doses, # shows statistical 
comparison to WT. Data is shown as mean ± SEM. ****p<0.0001, **p<0.01, *p<0.05. 
####p<0.0001 
 
There is no significant difference between wild type worms and hif-1(ia4) mutants treated with 
carvacrol (Figure 5.10, 5.11, 5.14 and 5.15). However, a difference is observed between wild 
type and trpa-1(ok999) mutants in hypoxic conditions (Figure 5.14 and 5.16). There is a sharp 
increase in late phase death rate in trpa-1(ok999) mutants subjected to hypoxia (Figure 
5.16c). 
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Figure 5.14: Lifespan and parameters of wild type (N2) C. elegans in hypoxia treated with 
carvacrol (0mM/control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) 
f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3). Data is shown as mean ± SEM. *p<0.05 
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Figure 5.15: Lifespan and parameters of hif-1(ia4) mutants in hypoxia treated with carvacrol 
(0mM/control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) f 
parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3). Data is shown as mean ± SEM. 
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Figure 5.16: Lifespan and parameters of trpa-1(ok999) mutants in hypoxia treated with 
carvacrol (0mM/control, 50mM, 200mM and 500mM). (a) representative survival curves, (b) 
f parameters, (c) early (k1) and late (k2) phase death rate and (d) early (t1) and late (t2) time 
phases. Carvacrol D/R (n=3) *shows statistical comparison to other doses, # shows statistical 
comparison to WT in hypoxia, % shows statistical comparison to trpa-1(ok999) mutants in 
normoxia. Data is shown as mean ± SEM. ****p<0.0001, ####p<0.0001, %%%%p<0.0001. 
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5.5 Discussion 
This chapter has focused on investigating the role of different factors suggested to be 
important in hypoxia and temperature signalling which also acts to regulate lifespan. Mutant 
C. elegans worms were subjected to different lifespan modifiers such as different 
temperatures and oxygen concentrations and pharmacological agents. By using the Bilogistic 
model, differences in early and late phase death rates and time phases were identified, 
quantified and compared. Additionally, the interaction between the hypoxia and temperature 
pathways were investigated in both mammalian cells and C. elegans by treatment with 
carvacrol to activate TRPA-1. A dose-response was conducted which allowed quantitative 
measurement of HIF levels in the mammalian cells and identification of parameter changes 
in worms.  
It was expected that in normal conditions (i.e. normoxia and 20C) mutations would alter the 
lifespan of worms. However only a few differences in lifespan of worms were observed. 
Although lifespan appears to change, it is only in daf-16(mu86) mutants in which significant 
differences in lifespan parameters is seen in particular the later phase death rate. Other 
mutants do not necessarily show differences in lifespan as differences may only occur in 
specific temperature or oxygen conditions. 
As has previously been shown a reduction in temperature extends the lifespan of wild type 
worms (Klass, 1977).  Temperature has a more varied effect on mutant worms depending on 
the mutation and the degree of temperature change. In most mutants used, except for hif-
1(ia4) mutants and the egl-9 (n586) mutants, the reduction in temperature results in an 
extension in the late phase time phase or a decrease in the late phase death rate. An 
explanation for the absence of effect in hif-1(ia4) and egl-9(n586) mutants could be that they 
may have a temperature sensitive role. However, this also shows that not all mutations have 
the same effect as the two different egl-9 mutations (egl-9(n586) and egl-9(sa307)) do not 
produce the overall same effect on lifespan. This is due to the egl-9(n586) mutation being a 
substitution and the egl-9(sa307) mutation is a 243 base pair deletion, so that there may still 
be some activity in the egl-9(n586) mutation.  
173 
 
In hypoxic conditions, there is a general but not always significant increase in lifespan. In wild 
type worms a significant increase in lifespan is not observed but this may be due to the low 
number of realisations (n=3). The general increase in lifespan follows similar trends as 
previous studies in hypoxia, however, due to the differences in methodologies there still 
remain difficulties in comparing studies (Leiser et al., 2013). Additionally, the lifespan and 
parameters of hif-1(ia4) mutants are not changed in hypoxic conditions which is also 
supported by a previous study (Leiser et al., 2013). The trpa-1(ok999) mutants have a more 
varied response to hypoxia as in hypoxic conditions, trpa-1(ok999) mutants show a decrease 
in early phase lifespan and an increase in late phase lifespan suggesting that hypoxia results 
in worms dying slowly in early lifespan but more quickly in later lifespan. Additionally, 
comparison with wild type worms in hypoxia shows an increase in late phase death rate of 
trpa-1(ok999) mutants. Our data suggests that trpa-1 is affected by hypoxia with a reduction 
in lifespan regulation. The sensitisation of trpa-1 by hypoxia has previously been reported in 
mice (So et al., 2016). 
The measured differences between wild type and mutant worms are dependent on the 
method of lifespan measurement. It is observed that measurement using the scanner reduces 
lifespan in all cases; an explanation for this is that on the surface of the scanner the heat 
generated on the glass may affect lifespan. Another explanation is the light generated from 
the scanners whilst taking scans. Although it has previously been stated that the light from 
the scanners only show small differences in lifespan further research into the effect of visible 
light shows that this may not be the case as worm lifespan shows sensitivity to visible light 
radiation (Stroustrup et al., 2013, De Magalhaes Filho et al., 2018). Although this 
methodology of digital recordings of lifespan in hypoxia is not fully optimised it does provide 
a more complete solution than other hypoxic measurement of lifespan. This methodology 
allows multiple plates of worm to be observed and recorded whilst in completely hypoxic 
conditions for the entirety of their lifespan.  
Primarily the in vitro investigation in mammalian cells allowed the interaction between HIF 
and TRPA-1 to be identified. It is known that TRPA-1 is activated by carvacrol leading to 
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calcium entry and signalling (Hasan et al., 2017). Additionally, it is known that HIF activity 
increases in hypoxic conditions. This short study expands on these findings and shows that 
increasing carvacrol concentrations reduces HIF activity in both HEK293 and HEPG2 cell 
with a minimum effective dose of 50M. We conclude from our mammalian cell studies that 
carvacrol affects TRPA-1 signalling and HIF activity and therefore would be an ideal 
pharmacological agent to treat worms with to further investigate how the HIF-1 and TRPA-1 
signalling pathways regulate lifespan and additionally show if this signalling link is applicable 
to C. elegans. Although interactions from PHDs/HIFs to TRPA-1 have been identified we 
report the first plausible interaction from TRPA-1 to HIF-1 (Hatano et al., 2012, Nagarajan et 
al., 2017). Additionally, it has been extensively reported that other Ca2+ channels (TRPC and 
TRPM) regulate HIF-1 (mRNA levels, translation, stabilisation and translocation) activity 
(Azimi, 2018). This supports our findings that TRPA-1 acts to regulate HIF activity in 
mammalian cells. 
The carvacrol dose response treatment on C. elegans has varied effect between the different 
mutants, conditions and concentrations used. Worms are able to survive in the presence of 
carvacrol, although previous studies have shown that carvacrol has nematocidal effects with 
100% mortality within 24 hours (Lei et al., 2010, Yu, 2000). Again, the difference in the results 
is likely due to differences in methodology, as the previous study used worms in a liquid 
culture with a growth temperature between 22C and 25C which may be detrimental to the 
worms. However, as our study did not find nematocidal activity from carvacrol, and thus it 
was used to investigate its effect upon different mutants (Lei et al., 2010, Yu, 2000). Another 
possibility as to why carvacrol does not have a consistent effect in its dose-response is that 
in our study carvacrol was added to the melted NGM agar before pouring in to plates but 
other studies apply carvacrol on top of the agar. This may possibly account for different effects 
of carvacrol. In wild type and most other mutants, there is a small reduction in lifespan but in 
trpa-1(ok999) mutants, more specific changes have been identified. In these mutants, 
differences are observed at 200mM in both hypoxia and normoxia, however, there is much 
variation among replicates. From the lifespan curves however, it is clear that in normoxia and 
at all doses of carvacrol used lifespan is mostly similar and suggests that carvacrol does not 
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have a defined effect. In trpa-1(ok999) mutants this is expected because there is no TRPA-1 
for carvacrol to act upon. But in wild type and other mutants, this lack of effect suggests that 
carvacrol is not necessarily acting upon TRPA-1. This can be explained by the differences 
between TRPA-1 homology in humans and C. elegans. It has been reported that there is only 
a 41% similarity between human and C. elegans TRPA-1, and this may be why carvacrol may 
not act upon C. elegans TRPA-1 in the same way as it acts upon human TRPA-1 (Kindt et 
al., 2007). Overall, carvacrol does not display a consistent effect on the different worm 
lifespans making it difficult to assess how as a chemical activator of TRPA-1 it could influence 
lifespan by targeting other components of either pathway. However, the results shown are 
based upon 3 replicates and analysed and shown in a similar manner as to previous chapters 
for consistency, further experimental realisations may allow for more consistent results. 
5.5.1 Future work 
Having shown a number of changes in lifespan (and parameters from the novel 5-parameter 
Bilogistic model) of multiple different mutant worms in response to temperature and hypoxia, 
it is important to investigate these factors mechanistically. By measuring gene expression, 
protein expression or activity of the different factors in response to the different conditions 
and pharmacological treatment, it would provide a more detailed picture on the relationship 
between the factors. Once again this can be done in the different mutants and also at different 
time points throughout the worms lifespan to identify the relationship dynamics in the ageing 
worm. Additionally, further investigation could be conducted specifically to investigate the 
relationship between TRPA-1 and HIF-1. For example, in mammalian cells the calcium 
currents could be investigated to measure TRPA-1 ion channel opening and further signal 
transduction which may affect HIF-1. Alternative approaches to activate TRPA-1 can be 
considered to determine the relationship between the two pathways. 
Additionally, this study utilises scanners to carry out digital lifespan assays and to maintain a 
record of worm lifespan. Ideally this methodology would need to be improved to reduce the 
number of variables which may affect worm lifespan so to reduce differences between manual 
lifespan assays and digital lifespan assays. 
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5.6 Conclusion 
This study investigates the lifespan of C. elegans in relation to temperature and hypoxia 
signalling. Genetic mutations, temperature changes and oxygen levels and treatment with 
pharmacological agents all effect the lifespan of C. elegans. Specific changes in lifespan 
parameters have provided an insight into whether early or late phase of worms are affected 
and also the magnitude of effect which take place. A relationship between TRPA-1 and HIF 
has also been established in mammalian cells but our data suggests that this pathway is not 
applicable to C. elegans. Finally, a pilot methodology for measurement of worm lifespan in 
continuous hypoxia has been introduced. These studies are expected to facilitate the 
understanding of how hypoxia and temperature affect lifespan and how the two pathways 
interact with one another. 
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Chapter 6.0: General Discussion 
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6.1 Discussion 
Two phases of lifespan have been described in C. elegans in a number of different studies 
(Zhao et al., 2017, Hahm et al., 2015, Zhang et al., 2016). The majority of studies analysing 
lifespan generally use non-parametric analysis methods which provide limited conclusions. 
Relatively few studies use parametric lifespan analysis and those that do tend to use 
monophasic parametric models which by construction are incapable of modelling two phases 
of lifespan. The initial objective of generating a parametric model capable of modelling 
biphasic lifespan was achieved and has been shown to provide a more meaningful 
interpretation of data than existing non-parametric and parametric models as early and late 
lifespan death rates and time phases can be defined. Furthermore, due to the superior fitting 
with the Bilogistic model this confirms that lifespan in C. elegans can be biphasic. Additionally, 
this novel Bilogistic model has been shown to accurately fit lifespan data from not only worms 
but also from other species such as flies, bees and mice. In C. elegans, the Bilogistic model 
is able to fit different mutants and temperature conditions in which the effect of these changes 
on the parameters can be identified.  
Interventions are important in altering lifespan. To be able to predict the effect of interventions 
would be beneficial as it would provide information on the optimum time point for intervention. 
In C. elegans one of the easiest interventions is to change the temperature. An initial objective 
of generating two predictive models capable of modelling intervention data was achieved by 
using the Bilogistic model. The two predictive models were shown to predict the effect of 
switching the temperature between high detrimental conditions and low favourable conditions 
which were compared to experimental data. However, the predictive model based on 
chronological age is not entirely capable of predicting the effect of temperature intervention 
but by incorporating biological age the predictions improve as the predicted average lifespan 
is closer to experimental average lifespan. This suggests that at a given time the chronological 
age is less important than the survival proportions as high survival proportion are more 
indicative of a healthier population compared to those with a lower survival proportion. An 
additional important output from this intervention investigation is the identification of critical 
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time points which indicate time points at which the average lifespan is pre-determined and 
time points at which interventions are too late and so result in minimal effects. Generally, the 
more time spent in favourable conditions results in a higher average lifespan. This suggests 
that time spent in favourable conditions must be prolonged for as long as possible and time 
spent in detrimental conditions should be avoided to gain maximum benefit. Additionally, 
many early environmental conditions have lasting effects later on in lifespan. For example, 
early detrimental conditions may act as a stressor which the worm is capable of adapting to 
and by introducing a favourable intervention it can lead to further lifespan extension compared 
to if the early detrimental condition was not experienced. This is supported by reports which 
look at intervention in developmental stages of worms and show similar findings on the 
importance of the larval stage (Zhang et al., 2015). TRPA-1 based lifespan extension in 
response to low temperatures compared to wild type was not seen as previously reported 
(Xiao et al., 2013). Although, our findings do suggest that TRPA-1 is more sensitive to low 
temperatures compared to high temperatures. Additionally, trpa-1(ok999) mutants show an 
impaired ability to adapt to interventions (both high to low and low to high temperatures). This 
suggests that TRPA-1 does play a role in detecting temperature and regulating lifespan in C. 
elegans however other factors which respond to temperature cannot be ruled out. Overall this 
suggests that TRPA-1 may not actively act to increase average lifespan or that the 
temperature range at which it does act may be outside the range investigated. Generally 
TRPA-1 as a cold sensor has been a much debated topic and a more detailed investigation 
into its function and response to temperature would need to be conducted (Caspani and 
Heppenstall, 2009). Both of the predicted models presented can be applied to a range of 
different intervention types, however the prediction accuracy is dependent on the initial input 
data used by the model. 
In addition to TRPA-1, a number of other factors reported to be involved in the temperature 
and hypoxia signalling pathways were investigated. Daf-16(mu86) mutants show that the 
increase in late phase death rate is what reduces lifespan. Furthermore, by reducing 
temperature there is an increase in lifespan in most mutants which is considered to be due to 
changes in late phase death rate and time phases. In hypoxic conditions trpa-1(ok999) 
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mutants die more quickly earlier but more slowly later suggesting that in hypoxia trpa-1 
normally acts to prevent earlier death but also may play a role in promoting death later on. 
This links well to previous reports in which TRPA-1 is regulated by hypoxia, and the effect of 
this regulation may have an impact upon lifespan (Takahashi et al., 2011). In mammalian 
cells, the link between HIF and TRPA-1 was investigated and shown that pharmacological 
activation of TRPA-1 by carvacrol acts to reduce HIF activity and may act via calcium 
signalling (Hasan et al., 2017). Worms treated with carvacrol to activate TRPA-1 show greater 
levels of survival than that which has previously been reported (Lei et al., 2010). Generally, 
the lifespan of carvacrol treated worms is lower than non-treated, however this effect on 
lifespan is generally not significant or consistent. This may be due to carvacrol not specifically 
targeting TRPA-1 in C. elegans or that there may be erratic activation of TRPA-1 by the 
compound resulting in varied effects. Worms which were treated with carvacrol and 
additionally grown in a hypoxic environment did not provide conclusive data into identifying 
the effect of both TRPA-1 and HIF-1 activation. Another explanation for the varied effects of 
carvacrol in these studies is that the carvacrol is added to molten NGM agar and so may not 
have a direct impact on the worms. The chemical activation of TRPA-1 did not show any 
significant consistent change to lifespan and does not appear to affect HIF-1 in the same way 
that was seen in mammalian cells and so the interaction is not yet pertinent to C. elegans. 
Overall the Bilogistic model has provided a way to collate and analyse lifespan data to identify 
the proportion of worms that die in the early and late phase of lifespan and from the parameter 
values changes to early and late phase death rate or time phases can be identified (Figure 
6.1). By using this method to investigate the TRPA-1 and HIF-1 signalling pathways this 
model has provided further insight into the role played on lifespan and when these factors are 
important, yet the exact role played by the individual factors is yet to be determined. 
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Figure 6.1: The Bilogistic model; a novel mathematical model which can be used to collate 
and analyse lifespan data outputting 5 parameter values defining early and late phases. 
 
6.1.1 Future Work 
For future investigations into lifespan, we propose that the Bilogistic model is used to analyse 
lifespan data to gain maximum information. As the Bilogistic model has been identified as a 
superior model for fitting C. elegans lifespan data it could still be compared to a number of 
other proposed models. Additionally, the Bilogistic model can be applied to a range of other 
time to event data sets for example survival of other animals, tumour growth, bacterial growth 
or inactivation or even to applications outside of biology such as investigation of component 
failure in engineering. 
The biphasic nature of lifespan is an important area to be studied further, particularly as 
biphasic dynamics are seen in a range of organisms. It would be important to identify 
(transcriptional and translational) universal mechanisms which result in biphasic lifespan. 
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Furthermore, lifespan, genetic, molecular and physiological measurements can be conducted 
relatively easily and quickly in worms compared to other organisms. 
In future investigations on the effects of intervention on lifespan, different interventions could 
be used for example environmental interventions such as hypoxia or pharmacological 
interventions to identify critical time points at which each intervention is important. The 
biological and chronological models can also be applied and tested against these different 
interventions and can be used to generate lifespan predictions. Temperature interventions 
can also be investigated further in more detail, with a range of different temperatures or more 
time points can be considered to further characterise the role of TRPA-1. However other 
factors which are temperature sensitive such as the AFD neurons must also be studied to 
identify differential regulation of lifespan in response to temperature.  
The interaction between the HIF-1 and TRPA-1 signalling pathways also need to be 
investigated further. In mammalian cells, additional studies could be conducted to identify the 
specific signalling pathway from TRPA-1 to HIF-1 for example by investigating TRPA-1 ion 
channel function and signal transduction. In C. elegans alternative methods could be used to 
investigate the role of the different factors regulating lifespan, for example using RNAi to 
inhibit gene expression or to overexpress genes with different output measures such as gene 
or protein expression. Furthermore, alternative approaches to activation of HIF-1 and TRPA-
1 could be conducted to identify relationship changes. 
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6.2 Conclusion 
This thesis proposes a Bilogistic model used to model the lifespan of C. elegans and other 
species in a range of conditions. It shows an improved methodology to investigate lifespan 
by providing more specific outcomes and the ability to be used for predictive modelling of 
interventions. Additionally, this thesis describes the roles played by factors involved in 
hypoxia and temperature signalling and proposes a link between TRPA-1 and HIF-1. It can 
be confirmed that the specific objectives have been met: 
 A novel mathematical model capable of modelling biphasic lifespan data has been 
generated. Additionally with this model we are able to confirm that C. elegans can 
display biphasic lifespan. Comparison of this novel model with other existing models 
with RMSE and residual analysis shows that the novel Bilogistic model provides a 
more versatile and superior fitting capability and that this model is applicable to flies 
bees and mice. 
 Two predictive models were designed to predict the effect of temperature 
interventions on lifespan. The biological model provides better predictions of 
intervention compared to the chronological model in wild type worms. A number of 
critical time points in both wild type and trpa-1(ok999) mutants were identified showing 
time points at which changes to average lifespan occur. 
 The Bilogistic model was used to identify parameter changes in response to 
mutations, temperature and oxygen changes. Additionally in mammalian cells it has 
identified that TRPA-1 activation results in a reduction of HIF activity. This link has not 
been shown to be applicable to C. elegans. 
Overall this thesis has used mathematical modelling techniques effectively to investigate 
how TRPA-1 and HIF-1 signalling regulate lifespan.  
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8.1 Tables showing total dead, censored animals and number of 
trials 
 
Table 8.1a: Experiments in Chapter 3.0 
 
Table 8.1b: Experiments in Chapter 4.0 
 
Experiments in Chapter 3.0 Dead Censored n (Trials)
N2 15°C 711 330 20
N2 20°C 564 189 15
N2 25°C 557 143 14
N2 30°C 144 6 3
N2 338 115 9
daf-16(mu86) 248 52 6
wDah 1038 90 10
dFOXO 1047 34 10
Caged 400 0 4
Hived 200 0 4
Male Control 295 5 3
Female Control 242 38 3
Male Rapamycin 120 36 3
Female Rapamycin 120 16 3
Mouse
C. elegans
Drosophila
Bees
Experiments in Chapter 4.0 Dead Censored n (Trials)
N2 15°C 1018 373 27
N2 25°C 828 172 20
N2 15°C - 25°C (Day 5) 137 13 3
N2 15°C - 25°C (Day 10) 122 28 3
N2 15°C - 25°C (Day 13) 145 5 3
N2 15°C - 25°C (Day 16) 123 77 4
N2 15°C - 25°C (Day 20) 112 38 3
N2 25°C - 15°C (Day 1) 141 9 3
N2 25°C - 15°C (Day 3) 138 12 3
N2 25°C - 15°C (Day 5) 116 34 3
N2 25°C - 15°C (Day 8) 131 69 4
N2 25°C - 15°C (Day 12) 144 6 3
trpa-1(ok999)  15°C 476 114 12
trpa-1(ok999)  25°C 289 61 7
trpa-1(ok999)  15°C - 25°C (Day 5) 122 28 3
trpa-1(ok999)  15°C - 25°C (Day 10) 124 26 3
trpa-1(ok999)  15°C - 25°C (Day 13) 129 21 3
trpa-1(ok999)  15°C - 25°C (Day 16) 113 37 3
trpa-1(ok999)  15°C - 25°C (Day 20) 136 14 3
trpa-1(ok999)  25°C - 15°C (Day 1) 120 30 3
trpa-1(ok999)  25°C - 15°C (Day 3) 134 16 3
trpa-1(ok999)  25°C - 15°C (Day 5) 121 29 3
trpa-1(ok999)  25°C - 15°C (Day 8) 114 36 3
trpa-1(ok999)  25°C - 15°C (Day 12) 128 22 3
C. elegans
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Table 8.1c: Experiments in Chapter 5.0  
 
Experiments in Chapter 5.0 Dead Censored n (Trials)
N2 20°C (Normoxia) 815 238 21
trpa-1(ok999)  20°C (Normoxia) 328 64 8
daf-16(mu86)  20°C (Normoxia) 341 59 8
hif-1(ia4)  20°C (Normoxia) 445 112 11
egl-9(sa307)  20°C (Normoxia) 242 58 6
egl-9(n586)  20°C (Normoxia) 272 28 6
N2 15°C (Normoxia) 1018 373 27
trpa-1(ok999)  15°C (Normoxia) 476 114 12
daf-16(mu86)  15°C (Normoxia) 223 27 5
hif-1(ia4)  15°C (Normoxia) 209 49 5
egl-9(sa307)  15°C (Normoxia) 122 28 3
egl-9(n586)  15°C (Normoxia) 118 32 3
N2 (Normoxia) 170 0 3
N2 (Hypoxia) 358 0 6
hif-1(ia4)  (Normoxia) 163 0 3
hif-1(ia4)  (Hypoxia) 425 0 6
trpa-1(ok999)  (Normoxia) 165 0 3
trpa-1(ok999)  (Hypoxia) 405 0 6
N2 0mM (Normoxia) 131 19 3
N2 50mM (Normoxia) 129 21 3
N2 200mM (Normoxia) 109 41 3
N2 500mM (Normoxia) 131 19 3
hif-1(ia4)  0mM (Normoxia) 131 19 3
hif-1(ia4)  50mM (Normoxia) 128 22 3
hif-1(ia4)  200mM (Normoxia) 136 14 3
hif-1(ia4)  500mM (Normoxia) 144 6 3
trpa-1(ok999)  0mM (Normoxia) 139 10 3
trpa-1(ok999)  50mM (Normoxia) 138 12 3
trpa-1(ok999)  200mM (Normoxia) 139 11 3
trpa-1(ok999)  500mM (Normoxia) 134 16 3
daf-16(mu86)  0mM (Normoxia) 139 11 3
daf-16(mu86)  50mM (Normoxia) 133 17 3
daf-16(mu86)  200mM (Normoxia) 122 28 3
daf-16(mu86)  500mM (Normoxia) 147 3 3
N2 0mM (Hypoxia) 186 0 3
N2 50mM (Hypoxia) 168 0 3
N2 200mM (Hypoxia) 185 0 3
N2 500mM (Hypoxia) 165 0 3
hif-1(ia4)  0mM (Hypoxia) 261 0 3
hif-1(ia4)  50mM (Hypoxia) 208 0 3
hif-1(ia4)  200mM (Hypoxia) 188 0 3
hif-1(ia4)  500mM (Hypoxia) 192 0 3
trpa-1(ok999)  0mM (Hypoxia) 229 0 3
trpa-1(ok999)  50mM (Hypoxia) 227 0 3
trpa-1(ok999)  200mM (Hypoxia) 235 0 3
trpa-1(ok999)  500mM (Hypoxia) 189 0 3
C. elegans
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8.2 MATLAB script for Chronological model for intervention from 
15°C to 25°C 
    clear all 
%Median N2 35 (15C) 20  16  13  10  5   0 (25C) 
        %n2 15 and 25 all realisations median 
f=[0.5276   0.448682    0.68265 0.119627    0.6424  0.517   
0.3246]; 
k1=[0.5199  1.0729  0.68545 1.1916  1.482   1.866   1.566116]; 
k2=[0.7094  1.062505    9.4775  20.5533 0.8518  1.497   
1.881]; 
t1=[17.06   15.9109 17.715  14.1178 13.03   11.01   7.594]; 
t2=[22.71   21.5673 21.505  17.07   14  13.22   11.48]; 
 figure( 'Name', '15 vs 25'); 
N2_15MS=@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
N2_25MS=@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
Average_Lifetime=zeros(35,1); 
    figure( 'Name', 'Tempswitch'); 
    for i=1:35 %day switch 
a1=N2_15MS(i); %y value (percent alive) for given switch day 
at N2_15  
a2=N2_25MS(i); %y value (percent alive) for given switch day 
at N2_25 
t_avg_N215= 
integral(@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)),0,i)/100; 
%average lifetime (integral) of N2 15 from 0 to switch time 
t_avg_N225= 
integral(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)),i,Inf)/10
0; %average lifetime (integral) of N2 25 from switch time to 
end 
a=a1/a2; %rescaling N2 25 to N2 15 
t_avg=(t_avg_N215)+(a*(t_avg_N225)); %Average lifetime of N2 
15 from 0 to switch time + rescaled N2 25 from switch time to 
end 
Average_Lifetime(i,1)=t_avg; %Generate average lifetime table 
N2_25MSresc=@(x)a*MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7));% 
Post switch curve rescaled to switch day 
fplot((N2_15MS),[0,i,-1,105],'Linewidth',3);% plot n2_15 
hold on 
fplot((N2_25MSresc),[i,35,-1,105],'Linewidth',3); %plot n2 25 
post switch 
hold on 
xlim([0 35]); 
ylim([0 105]); 
hold on 
    end 
    title('Switch 15-25') 
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j= [20  16  13  10  5]; %days with actual data  
for i=1:35 %day switch    
    h=figure; 
a1=N2_15MS(i); %y value (percent alive) for given switch day 
at N2_15  
a2=N2_25MS(i); %y value (percent alive) for given switch day 
at N2_25 
t_avg_N215= 
integral(@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)),0,i)/100; 
%average lifetime (integral) of N2 15 from 0 to switch time 
t_avg_N225= 
integral(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)),i,Inf)/10
0; %average lifetime (integral) of N2 25 from switch time to 
end 
a=a1/a2;%rescaling N2 25 to N2 15 
t_avg=(t_avg_N215)+(a*(t_avg_N225)); %Average lifetime of N2 
15 from 0 to switch time + rescaled N2 25 from switch time to 
end 
Average_Lifetime(i,1)=t_avg; %Generate average lifetime table 
N2_25MSresc=@(x)a*MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
%Post switch curve rescaled to switch day 
N2_15MS=@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3);% plot n2_15 
hold on 
N2_25MS=@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3);% plot n2_25 
hold on 
fplot((N2_15MS),[0,i,-1,105],'Linewidth',3); % plot n2_15 from 
0 to switch time 
hold on 
fplot((N2_25MSresc),[i,35,-1,105],'Linewidth',3); %plot 
switched 25 from switch time to end 
hold on 
if i==j(1) %if switch day is same as actual switch day 20 
    N2_15MS20=@(x)MSModel(x,f(2),k1(2),k2(2),t1(2),t2(2)); 
fplot((N2_15MS20),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(2) %if switch day is same as actual switch day 16 
     N2_15MS16=@(x)MSModel(x,f(3),k1(3),k2(3),t1(3),t2(3)); 
fplot((N2_15MS16),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(3) %if switch day is same as actual switch day 13 
     N2_15MS13=@(x)MSModel(x,f(4),k1(4),k2(4),t1(4),t2(4)); 
fplot((N2_15MS13),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(4) %if switch day is same as actual switch day 10 
     N2_15MS10=@(x)MSModel(x,f(5),k1(5),k2(5),t1(5),t2(5)); 
fplot((N2_15MS10),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(5) %if switch day is same as actual switch day 5 
    N2_15MS5=@(x)MSModel(x,f(6),k1(6),k2(6),t1(6),t2(6)); 
fplot((N2_15MS5),[0,35,-1,105],'-o','Linewidth',3); 
else  
end 
xlim([0 35]); 
ylim([0 105]); 
title(['Day ' num2str(i) ' Switch 15-25']); 
hold on 
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 %saveas(h,sprintf('Day %d TempSwitch15_25.pdf',i)); 
end 
openvar('Average_Lifetime'); 
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8.3 MATLAB script for Chronological model for intervention from 
25°C to 15°C 
clear all 
%Median N2  16(25C) 12  8   5   3   1   0(15C) 
%n2 15 and 25 all realisations median 
f=[0.3246   0.1533  0.37975 0.1395  0.5949  0.9479  0.5276]; 
k1=[1.566116    14.17   0.6985  1.141   0.4822  0.681845    
0.5199]; 
k2=[1.881   1.492   0.7714  0.4329  0.7844  0.406   0.7094]; 
t1=[7.594   7.128   9.191   6.551   11.936  18.58892    
17.06]; 
t2=[11.48   10.56   15.725  15.21   19.65917    31.69869    
22.71]; 
 figure( 'Name', '25 vs 15'); 
N2_25MS=@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)); 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
N2_15MS=@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
Average_Lifetime=zeros(16,1); 
    figure( 'Name', 'Tempswitch'); 
%collated figures     
    for i=1:16 
a1=N2_25MS(i); 
a2=N2_15MS(i); 
t_avg_N225= 
integral(@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)),0,i)/100; 
t_avg_N215= 
integral(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)),i,Inf)/10
0; 
a=a1/a2; 
t_avg=(t_avg_N225)+(a*(t_avg_N215)); 
Average_Lifetime(i,1)=t_avg; 
N2_15MSresc=@(x)a*MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_25MS),[0,i,-1,105],'Linewidth',3); 
hold on 
fplot((N2_15MSresc),[i,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
hold on 
    end 
        title('Switch 25-15') 
%print('Tempswitch25_15', '-dpdf' ); 
%individual figures 
j= [12  8   5   3   1]; 
for i=1:16 
    %Tempswitch=char(i); 
    h= figure; 
    %( 'Name', Tempswitch(i,1)); 
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a1=N2_25MS(i); 
a2=N2_15MS(i); 
t_avg_N225= 
integral(@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)),0,i)/100; 
t_avg_N215= 
integral(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)),i,Inf)/10
0; 
a=a1/a2; 
t_avg=(t_avg_N225)+(a*(t_avg_N215)); 
Average_Lifetime(i,1)=t_avg; 
N2_15MSresc=@(x)a*MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
N2_15MS=@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
N2_25MS=@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)); 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,i,-1,105],'Linewidth',3); 
hold on 
fplot((N2_15MSresc),[i,35,-1,105],'Linewidth',3); 
hold on 
if i==j(1) 
    N2_15MS12=@(x)MSModel(x,f(2),k1(2),k2(2),t1(2),t2(2)); 
fplot((N2_15MS12),[0,35,-1,105],'Linewidth',3); 
elseif i==j(2) 
     N2_15MS8=@(x)MSModel(x,f(3),k1(3),k2(3),t1(3),t2(3)); 
fplot((N2_15MS8),[0,35,-1,105],'Linewidth',3); 
elseif i==j(3) 
     N2_15MS5=@(x)MSModel(x,f(4),k1(4),k2(4),t1(4),t2(4)); 
fplot((N2_15MS5),[0,35,-1,105],'Linewidth',3); 
elseif i==j(4) 
     N2_15MS3=@(x)MSModel(x,f(5),k1(5),k2(5),t1(5),t2(5)); 
fplot((N2_15MS3),[0,35,-1,105],'Linewidth',3); 
elseif i==j(5) 
    N2_15MS1=@(x)MSModel(x,f(6),k1(6),k2(6),t1(6),t2(6)); 
fplot((N2_15MS1),[0,35,-1,105],'Linewidth',3); 
else  
end 
xlim([0 35]); 
ylim([0 105]); 
title(['Day ' num2str(i) ' Switch 25-15']) 
hold on 
%saveas(h,sprintf('Day %d TempSwitch25_15.pdf',i)); 
end 
openvar('Average_Lifetime'); 
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8.4 MATLAB script for Biological model for intervention from 15°C 
to 25°C 
clear all 
%Median N2 35 (15C) 20  16  13  10  5   0 (25C)    
f=[0.5276   0.448682    0.68265 0.119627    0.6424  0.517   
0.3246]; 
k1=[0.5199  1.0729  0.68545 1.1916  1.482   1.866   1.566116]; 
k2=[0.7094  1.062505    9.4775  20.5533 0.8518  1.497   
1.881]; 
t1=[17.06   15.9109 17.715  14.1178 13.03   11.01   7.594]; 
t2=[22.71   21.5673 21.505  17.07   14  13.22   11.48];  
 figure( 'Name', '15 vs 25'); 
N2_15MS=@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
N2_25MS=@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
Average_Lifetime=zeros(35,1); 
    figure( 'Name', 'Tempswitch'); 
%collated figures     
    for i=1:35 
a1=N2_15MS(i); 
a2=N2_25MS(i); 
t_N2_at_yN215 = 
fzero(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7))-a1, 50); 
N215_tminusN225_t=(i-t_N2_at_yN215); 
N2_switchedMS=@(x)MSModel(x-
N215_tminusN225_t,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_15MS),[0,i,-1,105],'Linewidth',3); 
hold on 
fplot((N2_switchedMS),[i,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
t_avg_N215= 
integral(@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)),0,i)/100; 
%average lifetime (integral) of N2 15 from 0 to switch time 
t_avg_N2_switchedMS= integral(N2_switchedMS,i,Inf)/100; 
%average lifetime (integral) of N2 25 from switch time to end 
t_avg=(t_avg_N215)+(t_avg_N2_switchedMS); %Average lifetime of 
N2 15 from 0 to switch time + switched N2  from switch time to 
end 
Average_Lifetime(i,1)=t_avg; %Generate average lifetime table 
    end 
    title('Switch 15-25') 
%print('Tempswitch15_25', '-dpdf' ); 
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%individual figures 
j= [20  16  13  10  5]; 
for i=1:35 
    %Tempswitch=char(i); 
    h=figure; 
    %( 'Name', Tempswitch(i,1)); 
a1=N2_15MS(i); 
a2=N2_25MS(i); 
t_N2_at_yN215 = 
fzero(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7))-a1, 50); 
N215_tminusN225_t=(i-t_N2_at_yN215); 
N2_switchedMS=@(x)MSModel(x-
N215_tminusN225_t,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_15MS),[0,i,-1,105],'Linewidth',3); 
hold on 
fplot((N2_switchedMS),[i,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
if i==j(1) 
    N2_15MS20=@(x)MSModel(x,f(2),k1(2),k2(2),t1(2),t2(2)); 
fplot((N2_15MS20),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(2) 
     N2_15MS16=@(x)MSModel(x,f(3),k1(3),k2(3),t1(3),t2(3)); 
fplot((N2_15MS16),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(3) 
     N2_15MS13=@(x)MSModel(x,f(4),k1(4),k2(4),t1(4),t2(4)); 
fplot((N2_15MS13),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(4) 
     N2_15MS10=@(x)MSModel(x,f(5),k1(5),k2(5),t1(5),t2(5)); 
fplot((N2_15MS10),[0,35,-1,105],'-o','Linewidth',3); 
elseif i==j(5) 
    N2_15MS5=@(x)MSModel(x,f(6),k1(6),k2(6),t1(6),t2(6)); 
fplot((N2_15MS5),[0,35,-1,105],'-o','Linewidth',3); 
else  
end 
xlim([0 35]); 
ylim([0 105]); 
title(['Day ' num2str(i) ' Switch 15-25']); 
hold on 
 %saveas(h,sprintf('Day %d TempSwitch15_25.pdf',i)); 
end 
openvar('Average_Lifetime'); 
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8.5 MATLAB script for Biological model for intervention from 25°C 
to 15°C 
clear all 
%Median N2  16(25C) 12  8   5   3   1   0(15C) 
%n2 15 and 25 all realisations median 
f=[0.3246   0.1533  0.37975 0.1395  0.5949  0.9479  0.5276]; 
k1=[1.566116    14.17   0.6985  1.141   0.4822  0.681845    
0.5199]; 
k2=[1.881   1.492   0.7714  0.4329  0.7844  0.406   0.7094]; 
t1=[7.594   7.128   9.191   6.551   11.936  18.58892    
17.06]; 
t2=[11.48   10.56   15.725  15.21   19.65917    31.69869    
22.71]; 
 figure( 'Name', '25 vs 15'); 
N2_25MS=@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)); 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
N2_15MS=@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
Average_Lifetime=zeros(16,1); 
    figure( 'Name', 'Tempswitch'); 
%collated figures     
    for i=1:16 
a1=N2_25MS(i); 
a2=N2_15MS(i); 
t_N2_at_yN225 = 
fzero(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7))-a1, 50); 
N225_tminusN215_t=(t_N2_at_yN225-i); 
N2_switchedMS=@(x)MSModel(x+N225_tminusN215_t,f(7),k1(7),k2(7)
,t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,i,-1,105],'Linewidth',3); 
hold on 
fplot((N2_switchedMS),[i,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
t_avg_N225= 
integral(@(x)MSModel(x,f(1),k1(1),k2(1),t1(1),t2(1)),0,i)/100; 
%average lifetime (integral) of N2 25 from 0 to switch time 
t_avg_N2_switchedMS= integral(N2_switchedMS,i,Inf)/100; 
%average lifetime (integral) of N2 Switch from switch time to 
end 
t_avg=(t_avg_N225)+(t_avg_N2_switchedMS); %Average lifetime of 
N2 25 from 0 to switch time + N2 Switched from switch time to 
end 
Average_Lifetime(i,1)=t_avg; %Generate average lifetime table 
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    end 
        title('Switch 25-15') 
%print('Tempswitch25_15', '-dpdf' ); 
%individual figures 
j= [12  8   5   3   1]; 
for i=1:16 
   %to plot actual data with predictions 
    %Tempswitch=char(i); 
    h= figure; 
    %('Name', Tempswitch(i,1)); 
a1=N2_25MS(i); 
a2=N2_15MS(i); 
t_N2_at_yN225 = 
fzero(@(x)MSModel(x,f(7),k1(7),k2(7),t1(7),t2(7))-a1, 50); 
N225_tminusN215_t=(t_N2_at_yN225-i); 
N2_switchedMS=@(x)MSModel(x+N225_tminusN215_t,f(7),k1(7),k2(7)
,t1(7),t2(7)); 
fplot((N2_15MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,35,-1,105],'Linewidth',3); 
hold on 
fplot((N2_25MS),[0,i,-1,105],'Linewidth',3); 
hold on 
fplot((N2_switchedMS),[i,35,-1,105],'Linewidth',3); 
hold on 
xlim([0 35]); 
ylim([0 105]); 
if i==j(1) 
    N2_15MS12=@(x)MSModel(x,f(2),k1(2),k2(2),t1(2),t2(2)); 
fplot((N2_15MS12),[0,35,-1,105],'Linewidth',3); 
elseif i==j(2) 
     N2_15MS8=@(x)MSModel(x,f(3),k1(3),k2(3),t1(3),t2(3)); 
fplot((N2_15MS8),[0,35,-1,105],'Linewidth',3); 
elseif i==j(3) 
     N2_15MS5=@(x)MSModel(x,f(4),k1(4),k2(4),t1(4),t2(4)); 
fplot((N2_15MS5),[0,35,-1,105],'Linewidth',3); 
elseif i==j(4) 
     N2_15MS3=@(x)MSModel(x,f(5),k1(5),k2(5),t1(5),t2(5)); 
fplot((N2_15MS3),[0,35,-1,105],'Linewidth',3); 
elseif i==j(5) 
    N2_15MS1=@(x)MSModel(x,f(6),k1(6),k2(6),t1(6),t2(6)); 
fplot((N2_15MS1),[0,35,-1,105],'Linewidth',3); 
else  
end 
xlim([0 35]); 
ylim([0 105]); 
title(['Day ' num2str(i) ' Switch 25-15']) 
hold on 
%saveas(h,sprintf('Day %d TempSwitch25_15.pdf',i)); 
end 
openvar('Average_Lifetime'); 
 
